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SOMMAIRE
La capacité du système nerveux central (SNC) à survivre et à se régénérer par
suite de lésions traumatiques ou lors des maladies dégénératives est fortement
compromise chez les vertébrés supérieurs adultes. Le manque de survie découle de la
perte du support trophique provenant des cellules environnantes et des cellules cibles
(Burek and Oppenheim. 1996; Jacobson et al., 1997), ainsi que d’une perte générale de
l’habilité à répondre aux signaux trophiques (Shen et al., 1999). De son coté, la
régénération limitée est attribuable à un environnement hautement inhibiteur et une perte
intrinsèque de la capacité de croître. Les deux scénarios aboutissent finalement à la mort
neuronal par apoptose.
Les stratégies décrites dans cette thèse tentent de stimuler la régénération et la
survie des cellules ganglionnaires de la rétine (CGR) adulte en réactivant leurs
programmes intrinsèques de croissance et de survie. Plus spécifiquement, nous avons
testé l’hypothèse selon laquelle certains gènes impliqués dans le développement
ordonné du système nerveux peuvent être modulés chez l’adulte dans le but de
stimuler la croissance axonale et de provoquer la survie. À cette fin, nous avons
premièrement augmenté le niveau endogène du facteur de Croissance des fibroblastes-2
(FGF-2). Cette molécule s’avère être un puissant stimulateur de croissance axonale chez
les CGR lors du développement (Dingwell et al., 2000). En utilisant des adéno-virus
associés recombinants (AAV.FGf-2), nous avons introduit le gène codant pour fGf-2
dans les CGR matures, leurs fournissant ainsi des niveaux élevés de ce facteur. Nous
démontrons ici que, par suite d’une blessure du nerf optique, cette approche augmente de
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façon significative la repousse axonale des COR et engendre une neuroprotection
robuste mais transitoire.
Ultérieurement, nous avons cherché à identifier les mécanismes moléculaires
responsables de la croissance axonale induite par FGF-2. Nous avons d’abord déterminé
le niveau d’activation de certaines voies de signalisation susceptibles d’être stimulées
par le récepteur de FGF (FGfR). Nos résultats ont démontré que l’activation de la kinase
«extracellular-signal regulated kinases 1/2 » (Erkl/2) est amplifiée dans les rétines
traitées avec l’AAV.f0f-2. Au contraire, des voies de signalisations comme celles de
la phospholipase Cy, de la «phosphoinositide-3-kinase > et de la protéine kinase C n’ont
pas été stimulées. De plus. l’inhibition pharmacologique de Erkl/2 amène une réduction
d’environ 80% du nombre d’axones de COR pouvant se régénérer. Ceci établit un rôle
important pour Erkl/2 dans la croissance axonale provoquée par fGf-2.
En raison de l’importance de la phosphorylation dans la survie et la régénération
neuronale, nous avons étudié le rôle du récepteur à protéine lyrosine phosphatase Sigma
(RPTPa): un régulateur de la phosphorylation intracellulaire. L’implication de RPTPY
dans le développement du SNC est illustrée par son haut niveau d’expression dans le
tissu nerveux embryonnaire et par le fait que son absence chez des souris transgéniques
entraîne une réduction globale de la taille de leur cerveau (Elchebly et al., 1999; Wallace
et al.. 1999). En démontrant une hausse significative de la régénération des CGR lésées
chez des souris RPTPr (-/-), nous proposons que cette phosphatase inhibe la croissance
axonale chez l’adulte. Nous avons également détecté une forte activation endogène de
Erkl/2 et de Aki à chez les souris RPTPa (-/-), suggérant que ces voies peuvent être
impliquées dans l’augmentation de la repousse axonale observée chez ces animaux.
VLes données présentées dans cette thèse suggèrent que la modulation des gènes
impliqués dans le développement du SNC offre une stratégie prometteuse pour favoriser
la croissance du SNC adulte lésé.
Mots clefs: Système Nerveux Central, facteur de Croissance de fibroblastes-2,
Récepteur à Protéine Tyrosine Phosphatase-Sigma, Régénération Axonale, Survie
Neuronale, Thérapie Génique, Cellule Ganglionnaire de la Rétine, Erkl/2.
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SUMMARY
The ability of the central nervous system (CNS) to regenerate and survive
following traumatic injury or disease is severely compromised in aduit higher
vertebrates. Current data ascribes this lack of CNS regrowth to both a highly
growth-prohibitive environrnent ami to the neurons own loss of intrinsic growth
capacity. The lack of neuronal survival following CNS injury is mostly attributed to
inadequate trophic support from neighboring and target ceils (Burek and
Oppenheim, 1996; Jacobson et al., 1997) as well as the neuron’s overail loss of
trophic responsiveness (Shen et al., 1999); both scenarios ultimately resulting in
neuronal apoptosis.
The strategies described in this thesis attempt to promote the regeneration
and the survival of aduit lesioned retinal ganglion celis (RGCs) by reactivating their
intrinsic growth and anti-apoptotic programs. More specifically, we tested the
bypothesis that genes involved in the order]y development of the nervous
system can 5e modulated in the adu]t to ensure adequate neuroprotection and
stimulate axonal regrowth. In this aim, we first chose to increase levels of
fibroblast growth factor-2 (f0f-2), a potent stimulator of ROC axon growth during
development (Dingwell et al., 2000). Using recombinant adeno-associated virus
(AAV), we introduced the gene coding for fGf-2 into mature ROCs, thus ensuring
a sustained upregulation of this neurotrophic factor. We provide evidence that this
approach significantly enhances ROC axonal regrowth following acute optic nerve
injury and promotes robust but transient neuroprotection.
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We subsequently souglit to elucidate the molecular signaling mechanisms
that regulate fGF-2-induced RGC axon groÏh. To address this question. we first
proceeded to screen candidate pathways known to be recruited upon stimulation of
FGF receptor (fGfR). Our data demonstrate that the extracellular-signal regulated
kinases 1/2 (Erk 1/2) were stimulated in AAV.fGf-2 treated retinas, but flot other
pathways such as phosphoinositide 3-kinase, phospholipase Cy or protein kinase C.
Inhibition of Erk 1/2 with the pharmacological inhibitor PD98059 led to a 8O ¾
reduction in the number of regenerating RGC fibers and thus established Erk 1/2 as
an important signaling pathway in fGf-2 mediated axonal re-growth.
As both neuronal survivai and regenerative signais rely heaviiy on
phosphorylation events. we investigated the role of Receptor Protein Tyrosine
Phosphatase-Sigma (RPTP-a). a regulator of intracellular phosphorylation. RPTP
a’s involvement in CNS development is illustrated both by its high levels of
expression in the embiyonic nervous system and by an overali reduction in brain
size in transgenic animais lacking this protein (Elchebly et al., 1999; WalÏace et al.,
1999). By demonstrating that RPTP-a (-/-) mice show a significant increase in RGC
axon regrowth following acute injury when compared to wild type littermate
controls, we provide evidence that RPTP-a hinders CNS regeneration in the aduit.
This increased growth cannot be attributed to developmental defects as we found
that knockout animais have normal retinal and optic nerve histologies and show
identical time-courses of ROC death following lesion. Lastly. we show high levels
of Erk 1/2 and Akt activation in RPTP-a (-/-) mice. suggesting that these pathways
may be implicated in the increased axonal growth observed in these animais.
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The data presented in this thesis suggest that the modulation of genes
involved in the sound development of the CNS is an adequate strategy to promote
regenerative growth of aduit injured CNS neurons.
Kev words: Central Nervous System. fibroblast Growth Factor-2, Receptor
Tyrosine Phosphatase-Sigma. Axonal Regeneration. Neuronal Survival, Gene
Transfer. Retinal Ganglion Celis. MAPK
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PREFACE
The principal focus of this thesis was to study the invoïvement of fGf-2 and
RPTP-a in the regeneration and survival of retinal ganglion celis (RGCs), a
prototypic central nervous system (CNS) neuronal population. In order to
familiarize the reader with the subject at hand, this thesis includes a thorough
introduction on axonal growth by RGCs, the consequences of acute axonal injury
(both on survival and regeneration) and a review of current strategies that may be
employed to modulate gene expression to stimulate neuronal survival and axon
regrowth. The remainder of the thesis is manuscript-based: it comprises three
original research articles that have been published in (or submitted to) peer
reviewed journals, followed by a general discussion covering key topics pertaining
to the articles.
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Chanter I
1. GENERAL INTRODUCTION
71.1 CENTRAL NERVOUS SYSTEM REGENERATION: A HISTORICAL
PERSPECTIVE
The regeneration of the injured CNS lias been a daunting task since the dawn of
modem neurobiology. CNS neurons severed from tlieir targets are incapable of
surviving, regrowing axons and restoring function to affected structures. For these
reasons, traumatic injuries and diseases of the CNS are of an irreversible nature.
Although tlie intrinsic inability of lesioned CNS neurons to re-establisli function was
documented as far back as Ancient Egypt (Jackowski, 1995), it was only in the early
1 900s, with the advent of histological and electropliysiological tools. that CNS
regeneration began to be thoroughly explored.
In the late 1 $OOs, neuroscientists first described that rather than being completely
incapable of regeneration, transected CNS axons undergo a phase of abortive sprouting.
It was however Santiago Ramén y Cajal, the father of modem neurobiology, using the
novel reduced silver nitrate staining method, who confirmed without a doubt the
existence of a phase of regenerative sprouting in the lesioned optic nerve, spinal cord
and cerebral cortex (Ramon y Cajal, 192$). These attempts at regrowth were
characterized by club-like terminais, hypertrophic varicosities and irregular branched
growth; all suggesting that the sprouting events were flot to yield full biown axonal
growth. Nevertheless, these “frustrated regenerative acts” as they were named, gave the
first indication that the CNS was capable ofmounting a response to counter injury.
In the peripheral nervous system (PNS), Cajal noticed that regenerating fibers
were oriented towards and associated with Schwann cells. This lead Cajal to postulate
that these guai ceils were a source of both trophic and tropic factors for the growing
3axons. He went on to hypothesize that regenerative failure in the CNS was due to the
absence of Schwanri ceils and the growth-promoting factors they secrete. These
conclusions prompted Cajal and lis student Tello to examine the outcome of conferring
a PNS environment to transected CNS axons. To this effect, Tello transplanted
peripheral nerve segments to the lesioned cortex of a rabbit (Tello, 1911). Thirty days
later. he was able to observe growth of central cortical axons through these grafts. Tello
pursued this work by graffing sciatic nerves to transected optic nerve stumps and noted a
similar regenerative phenomenon. The main conclusion of these studies was that CNS
neurons were intrinsically capable of regenerating their axons when exposed to a
permissive PNS environment and that this response was supported by growth promoting
factors secreted by Schwann cells in the degenerating grafis (Ramon y Cajal, 192$).
Nevertheless, there was skepticism as to the exact origin of the neurons growing into the
PN grafis. Were they CNS axons or axons originating from peripheral bundies
associated with the nerve or surrounding muscles?
It was not until the early 19$Os that Albert Aguayo and colleagues managed to
unequivocally trace and confirm the origins of the regenerating axons. Using the
techniques of retrograde tracing with horseradish peroxidase and fluorescent dyes, they
were able to label celI bodies and axons of regenerating CNS neurons from spinal cord
(Richardson et al.. 1980; David and Aguayo, 1981; Richardson et al., 1982), brain
(Benfey and Aguayo, 1982), cerebellum (Dooley and Aguayo, 1982) and retina (So and
Aguayo, 1985).
These studies were seminal to our understanding of the regenerative potential of
CNS neurons and paved the way to designing strategies for CNS repair. This work also
4established a proof of principie for future investigations into the molecular basis of CNS
survival and regeneration.
1.2 AXON CR0WTH IN TUE CNS
In order to better understand the dynamics required for axonai growth during
aduit CNS regeneration, I wiil first describe this process in the developing nervous
system.
1.2.1 A Complex Neura] Network
The nervous system is an intricate structure that receives sensory input from the
environment, integrates the significance of the stimulus and consequently produces an
adequate physiological response. It is made up of two structurally distinct yet
interconnected components. the PNS and the CNS. The CNS (the brain and spinal cord
in vertebrates) acts as the main processing unit of the nervous system. It receives motor
and sensory information from a subset of PNS neurons and then uses other PNS fleurai
components to generate a behaviorai motor response.
The extreme complexity of these systems in humans is illustrated by the
networks of hundreds of billions of neurons, each of which communicates with
thousands of other neurons. It is thought that a singie cubic centimeter of human brain
contains over 50 million nerve cells (Kandel and Siegelbaum, 2000). b establish
appropriate functional synaptic connections, a neuron must extend its axon over long
distances into the maze of chemical signais and physical barriers and ensure that this
axon arrives in proximity of the adequate target and generates a working contact. This
5growth process relies essentially on the axons ability to read and interpret molecular
growth and guidance cues.
1.22 Growth Cone Dynamics
«I had the good fortune to behold for the first time that fantastic ending of the growing
axon. In mv sections of the spinal cord of three day chick embryo. this ending appeared
as a concentration of protoplasm of conical forrn, endowed with amoeboid movements.
h could be compared with a living battering ram, soft and flexible, which advances.
pushing aside mechanically the obstacles which it finds in its path, until it reaches the
region of its peripheral termination. This curious terminal club, I christened the growth
cone. »
Santiago Ramon y Cajal. 1890,
Recollections ofMy Life
The oracular Cajal divulged this first accurate description of the neuronal growth
cone over a century ago. Roughly two years later, while studying retino-tectal
projections. Cajal was inspired by the leukocyte chemotaxis phenomenon and proposed
that the growth cone is guided by “chemical flows” which aÏlow it to find the secretory
target (Ramon y Cajal. 1893). Another century woutd pass before these ‘chemicals
flows” were identified and the mechanisms by which they act were elucidated.
As put forth by Cajal, the growth cone is a locomotory and sensory structure that
transduces environmental cues and assures sound axonal growth and accurate
connections. It comprises three principal regions: filopodia which are long finger-like
6extensions of bundled fibriilary (F)-actin, the fan-like lameliipodia rich in cross-linked
F-actin and a central core that contains mitochondria, microtubules and other organelles
(figure 1. A. p.9) (Dent and Gertler, 2003; Huber et al.. 2003).
The filopodia are the major sensory elements of the growth cone. These highly
motile protrusions probe the environment and transduce extracellular signais via a
network of receptors on their outer membrane. The guidance cues encountered by the
growth cone aiong its trajectory can be either attractive or repulsive, acting over iong
distances (chemoattraction and chemorepuision) or short distances (contact-dependent
attraction and repuision) (Huber et al., 2003). Once the receptors on the growth cone
corne in contact with a given cue. it can respond by either advancing, stalling, turning or
retracting. Axonal pathfinding is therefore dictated by the growth cones response to a
series of attractive and repuisive cues which draw out the advancing axons trajectory.
The progression or the retraction of the growth cone is controlied by a balance of
actin polymerization and depoiymerization at the leading edge of both the ifiopodia and
larnellipodia (Mailavarapu and Mitchison, 1999). The bundied f-actin in the periphery
of the fiiopodia is connected to the microtubuie network in the central core (figure 1,
p.9). Upon contact of growth cone receptors to an adhesive substrate, an attractive
molecule will stimuiate the fiiopodia to contract and pull the growth cone forward. Actin
then polymerizes at the leading edge (+) of the filopodia and lamellipodia and
disassernbles at the trailing edge (-). The force generated by the addition of actin to the
(+) end drives the filopodium forward. New membrane and receptors are then added at
the leading edge to ensure that the growth/guidance process is adequately maintained.
Microtubules subsequently assemble and extend from the axon shafi in the centrai core
7towards the growth cone and thus leave behind a new segment of axon (Dent and
Gertler, 2003). When subjected to repulsive cues, actin at the leading edge (+)
depolymerizes resuhing in the retrograde flow of f-actin and thereby causing the growth
cone to stop, tum or retract.
1.2.3 Growth Cone Remodeting
Appropriate axonal navigation necessitates that the motor components of the
growth cone function in response to the sensory apparatus of the filopodia. The
coordinated function of these two elements implies that the receptors on the growth cone
membrane not only mediate adhesion, but are also responsible for transducing an
intracellular response via a network of secondary messengers capable of modifying the
axonal cytoskeleton (Huber et al., 2003).
A possible mechanism linking adhesion molecule and growth factor signaling to
the growth cone actin cytoskeleton involves Rho signaling pathways (Hall. 1998). The
Rho family of smaÏl GTP-binding proteins influences actin filament assembly and
disassembly as well as other growth cone remodeling events such as myosin-dependent
retrograde flow of actin (Dickson, 2001). Rho GTPases are controlled via the state of
their bound guanine nucleotide. When bound to GTP, they are able to recruit effector
proteins and perform their tasks. Once the GTP is hydrolyzed to GDP by an intrinsic
GiPase. the effectors are released and they are rendered inactive.
The best characterized members of the Rho familv are Rho A. Cdc42 and Rac.
Activation of Cdc42 or Rac in neuronal celis induces formation of filopodia and
lamellipodia, respectively. and promotes neurite extension (Hall, 199$). Conversely,
$activation of Rho A in neuronal ceils provokes growth cone collapse and neurite
retraction.
The equilibrium between activated GTP bound and inactivated GDP bound Rho
is directed by the adverse activities of guanine nucleotide exchange factors (GEFs) and
GTPase activating proteins (GAPs). These effectors can be activated directly or lateraily
by growth cone receptors goveming the growthlguidance process. This mechanism
therefore allows the receptors to control the cytosekeletal rearrangements necessary to
ensure proper and directed axonal growth. Based on these findings, a simplified model
of Rho GTPase dependent growth cone dynamics invoives attractive guidance cues that
activate Cdc42 and Rac whiie growth inhibitory and repuisive signais activate Rho A
(figure 1. B, p.9).
FIGURE 1.
A) Leading Edge
f-actin)
The organization of the neuronal growth cone.
The growth cone is composed offan-like structures called lamellipodia and finger-like protrusions
named filopodia. Lamellipodia are rich in cross-linked F-actin filaments while the filopodia are
cornposed of bundled F-actin. The actin network in the periphery is linked to microtubules found in
the central core of the growth cone and axon shaft. Once the growth cone advances, the actin cyto
skeleton supports the transiocation and polymerization of microtubules into more peripheral
regions of the growth cone. Actin polymerization at the pltis (+) end (teading edge of the growth
cone) and depolymerization at the minus (-) end (the central growth cone) govern growth cone
progression and retraction.
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Rho GTPases and growth cone
dynamïcs.
Rho-like GlPases (e.g. Cdc 42, Rac I
and Rho A) are controlled by the
opposing activities of Rho GTPase
activating proteins (GAPs) and Rho
GTPase nucleotide exchange factors
(GEfs). GAPs turn Rho GlPases off
by activating endogenous GTPases
whilc GEfs tum them on by facilitat
ing the exchange of GDP to GTP.
Once in an activated state, Cdc 42
provokes the formation of filopodia,
Rac stirnulates the formation of
lameilipodia and Rho A causes
Microtubules
Core
growth cone collapse.
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1.2.4 The Retino-Collicular Pathway as a Model to Study CNS Repair
The visual system bas a rich history as the model pathway for the CNS. From the
early pioneering work of Santiago Ramon y Cajal b the modem experiments of Aibert
Aguayo, the retino-collicular pathway’s experimental accessibility (outside the brain
proper) and compartmentalized layout has made it a system of choice for the study of
the CNS. 0f ail the cellular populations within the retina, retinai ganglion cells (RGCs)
lend themselves particularly well to study neuroprotective and regenerative strategies.
Their somata lie within the eye, while their axons project into the optic nerve and
synapse with sub-cortical regions of the brain. This anatomical design permits for easy,
minimally intrusive access as well as for selective labeling and manipulation of these
ceils.
Following transection of the optic nerve, RGCs die by apoptosis (Semkova and
Krieglstein, 1999; Sofroniew et al., 2001) (described in section 1.4). The pattem of ce!!
death following optic nerve transection is well documented and can be easily evaluated,
thus facilitating the assessment of survival enhancing strategies (Berkelaar et al., 1994).
The optic nerve itself is a convenient mode! for the study of CNS regeneration (Vidai
Sanz et al.. 1987; Chierzi et al., 1999; Lebmann et al., 1999; Leon et ai., 2000; Sapieha
et al., 2003). Lesion paradigms such as the micro-crush lesion, offer a neatly defined
injury site with minimal cavitation (Selles-Navarro et al., 2001); a phenomenon seen in
conventionai crush and cutting lesions (Gifiochristos and David, 1988). These
advantages allow for an accurate measurement of axonaÏ regrowth into the CNS
environment and thus make the optic nerve a choice system for investigation.
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In this thesis, the rodent retino-collicular system was employed as model of the
CNS. Using the optic nerve micro-crush lesion modeÏ, we studied the role offGF-2 and
RPTPa in the regeneration of acutely injured ROC axons. Altematively, with the optic
nerve axotomy injury paradigm, we investigated the role of these two proteins in the
neuroprotection of RGCs. The following sections describe the events leading to ROC
generation during development and their axonal growth within the optic nerve.
1.3 THE GENESIS 0F RGCs AND AXONAL GROWTH FROM THE RETINA
TO THE MIDBRAIN
One of the most studied and best understood examples of axonal growth and
guidance in the CNS is that of RGCs. The orderly wiring of RGCs to their midbrain
targets is a truly elegant example of the awesome complexity of axonal growth and
navigation. RGC axons are the only anatomical and functional pathway between the
neural retina and the brain; appropriate axonal targeting to the mesencephalon,
diencephalon and telencephalon is essential for vision. To ensure accurate targeting,
ROC axons must travel within the eye, reach the optic disk, extend through the optic
nerve, grow across the optic chiasm into the optic tract and connect with appropriate
targets in the midbrain. This whole process is made up of several distinct steps: RGC
generation, axon initiation, axon outgrowth and navigation and finally target recognition
and innervation. These developmental stages of ROC axon growth are discussed bellow.
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1.3.1 Origins ofthc Eye and Cellular Determination in the Developing Retina
The eye and its fleurai retina originate from evaginations of the embryonic
diencephalic wafl and remain connected to the brain by the optic staik. This transitory
bridge serves as the initial substrate for RGC axonal growth to the brain (Isenmann et
al.. 2003). A series of invagination events in the optic vesicle and optic stalk resuit in the
formation of an opening termed the choroid fissure. In addition to being the site of
formation of the retinal artery, it wiil be through this canai that the first RGC axons
travel.
The retina is derived from a sheet of neuroepitheiiai ceils that robustly express
Pax-6; a criticai gene for eye deveiopment in species as distantly related as humans and
flues (Ziman et ai., 2001). Aithough the exact mechanism is flot ciearly understood, the
generation of the various retinai ccli types occurs in a polar fashion across the thickness
of the neuroepitheiium. It is specuiated that asymmetric segregation of mRNAs coding
for ccli fate determination genes as well as the segregation of proteins such as Numb,
which inhibit Notch signaling and control neural celi fate. may be involved (Cayouette
and Raff, 2002). The positional information may appear during gastrulation and
neurulation when positionai patteming genes are activated. Differentiation of retinai
precursor celis starts in the center of the muer layer of the optic cup and radiates
outwards towards the periphery (Prada et al., 1991; Hoit and Harris, 1993). The
positionai information of precursor ceils dictates celluiar specificity and consequently
influences vision acuity, sensitivity and movement anaiysis. RGCs are the first retinai
ceil types to differentiate, followed by horizontal celis, cone photoreceptors, amacrine
celis, rod photoreceptors, bipolar ceils and lastly Millier glia (Cepko et al., 1996).
1—,
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1.3.2 Determinants of RGC Differentiation
The developrnent of RGCs is driven by several protein factors including Sonic
Hedgehog (Shh) and fibroblast growth factor-2 (FGF-2). These molecules and their roles
in RGC generation are described in the following sections.
1.3.2.1 Sonic Hedge Hog trnd RGC Generation
Shh is a member of the hedgehog family of signaling proteins known to play
multiple roles in CNS development. For example. Shh influences the proliferation of
neuronal precursors, controls axon growth and induces oligodendrocyte formation
(Ingham and McMahon. 2001). It is synthesized as a 45 kDa protein that is later
proteolytically cleaved into a 19 kDa N-terminal secreted protein and a 25 kDa C-
terminal secreted protein. It is the 19 kDa fragment that exerts all known biological
function. Shh exerts its biological activity by binding to Patched, a 12-pass
transmembrane protein found on the ceil surface. This in tum relieves Smoothened, a 7-
pass transmembrane G-protein-coupled receptor, of its normal inhibited state.
Smoothened, considered as signaling arm of Shh, consequently either activates or
represses gene expression (Ingham and McMahon, 2001).
In the developing vertebrate retina, Shh acts as a mitogen (Jensen and Wallace,
1997). It exerts its function early in the process of determining the RGC phenotype by
activating Pax genes such as Pax-6. The latter stimulates basic helix-loop-helix (bHLH)
transcription factors such as Math5 in mice (Xath 5 in Xenopus, atonal in drosophila).
These bHLH genes are expressed in the early stages of retinal development (E 11-E 15 in
mice). They activate the transcription factor Bm3b, necessary for RGC differentiation
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after the initial stage of commitment to this ceflular fate (Gan et al.. 1999). Shh is then
expressed and secreted by already differentiated RGCs and stimulates its own
production. thereby ensuring the concentric differentiation of retinal precursor ceils
towards a ROC phenotype (Zhang and Yang, 2001).
1.3.2.2 Fibroblast Growth factor-2 and RGC Generation
The FGF family of neurotrophic factors plays multiple roles in the development
and maintenance of the CNS and retina (reviewed in Eckenstein, 1994 and Hicks. 199$).
0f the 23 currently identified members of this family, fGf-2 (basic FGF; bfGF) is the
best characterized. f0f-2 was discovered in 1984 and, as its name suggests, was
described as a mitogenic factor for fibroblasts (Thomas et al., 1984). It exerts its
biological function by binding its high affinity FGF receptors (f0fR) and activating an
array of signaling pathways such as mitogen activated protein kinase (MAPK) Erk 1/2,
PI-3K, PKC or PLCy (Boilly et al., 2000) (described in section 1.7.2).
f0F-2 has been isolated in large quantities from the CNS (Eckenstein et al.,
1991 a; Eckenstein et al., 1991 b). In the retina, fGF-2 immunoreactivity is present in the
outer and inner nuclear layers throughout life and associated with ROCs between E14
and El 8, a period during early development when ROCs are forming (de Iongh and
McAvoy, 1993). At this time, FGF receptors (FGFR) are expressed throughout the
whole of the neuroepithelium (Wanaka et al., 1991). Moreover, FGF-2 is expressed in
the embryonic retinal pigment epithelium (RPE) and has been shown to enhance retinal
growth and differentiation (Hicks, 199$). When FGf-2 is added to naive retinal explants
from rats, an increased rate of ROC differentiation is observed. Conversely, treatment
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with antibodies against FGf-2 slows their appearance (Zhao and Barnstable, 1996).
Furthermore. overexpression of fGf2 in Xenopus laevis retinal precursors. favours
RGC production while reducing the number of Millier guai celis (Patel and McFarlane.
2000). These data suggest that FGf-2 plays an important role in stimulating the
differentiation of RGCs in the neural retina.
1.3.3 Initiation ofAxon Growth
The first RGCs originate in proximity to the optic fissure. The initial navigational
assignment of ROC axons is to extend to the optic nerve head; thus, the first ROCs only
travel short distances before entering the optic nerve. The process of axonogenesis is
morphologicaiiy characterized by a thickening of the cytoplasm on the vitreai side of
RGCs (HoIt, 1989). Initial ROC axon growth within the retina occurs in contact with
endfeet neuroepithelial ceils which are sirnultaneousiy differentiating into Millier ceils.
The first axons to grow, terrned the pioneering axons. extend directiy to the fissure
(Silver and Sidman, 1980). In rats, the first axons exit the retina at E13. These initial
ROC axons must reiy entireiy on growth cone guidance cues in the neuroepithelium.
More peripheral and therefore younger ROCs, arise in an outwardiy concentric manner
and elaborate their axons inward. To reach the optic nerve head, these newly formed
RGC axons (the mai ority of retinai axons) use the established pioneer axons as guides in
addition to the growth promoting Millier endfeet (Siiver and Sidman, 1980; Hoit, 1989;
Wiliiams et ai., 1991). They corne in contact and fasciculate with the existing axons by
interacting with growth promoting moiecules on the axons themseives. for example, Li,
a member of the immunoglobulin superfamiiy, is present at points of contact between
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new and elaborated axons and is thouglit to encourage axonai fasciculation on the way to
the optic nerve head (Brittis and Siiver. 1995). Inhibition of Li causes retinai axons to
stray and grow within the retina instead of heading directly for the optic nerve head
(Brittis et al., 1995).
In addition to the cues on the axons themselves, the moiecular environrnent of
RGCs exerts a great influence on axonal outgrowth and pathfinding. for example, RGC
axons grow along the vitreai surface of the retinal neuroepithelium while dendrites
arborize on the opposite side. When RGC axons contact Millier celi endfeet, they tum
900 and head towards the fissure (Hoit. 1989). Interestingly, in expiant cultures, the
axonai growth promoting properties of Millier ceils remain confined to the endfeet on
which robust axonai growth can be supported. Upon mechanicai rernovai of the guai
endfeet, however, RGC growth is suppressed (Stier and Schiosshauer, 1995).
furthermore, RGCs cuitured on a bed of Millier ceii somata eiaborate dendritic
processes (Bauch et ai., 1998). RGCs plated next to Millier ceiis were abie to grow
axons, aithough growth cones coiiapse when they corne in contact with the giia. The
exact repuisive signai that mediates the Mifiier-somata induced repuision of RGC axons
has yet to be identified; however. these observations suggest that Millier ceii bodies are
inhibitory towards ROC axons whiie their endfeet constitute a permissive substrate.
Another inhibitory mechanism that prevents axonai extension into the retinai
periphery invoives a ring of chondroitin-sulfate proteogiycans (CSPGs), found in the
extraceiiuiar matrix (ECM) adjacent to nascent RGCs (Brittis et al., 1992). When this
ring is experimentaiiy degraded during the period of ROC deveiopment, axons project
abnormally into the periphery. The moiecuiar environment ensures that nascent RGC
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axons remain confined within the central retina to a zone delimited by ROC ceil bodies
on one side and Millier endfeet and vitreal basal lamina on the other. The mechanism
described here illustrate a well coordinated molecular environment that ensures proper
growth of RGC axons and safeguards against disordered axon growth within the retina.
1.3.4 Mo]ecular Determinants of Intraretinal Axona] Growtb
Millier celi endfeet are distributed in a continuous layer across the vitreal side of
the retina (Holt. 1989), interspersed with basal lamina (Easter et al., 1984; Ledig et al.,
1 999b). This disposition permits receptors on ROC growth cones to come in contact
with several ECM molecules such as laminin, fibronectin and nidogin, heparan sulfate
proteoglycans such as agrin and perlecan as well as other CSPGs (Halfier, 1998). Proper
ROC navigation is dependent on an adequate balance of attractive and repulsive
directional cues present along its pathway. In the process of axonal elongation. growth
cone adhesion to its substrate is an obligatory step to generate the necessary forces
needed for axon outgrowth. In addition. the activation of intracellular signaling cascades
is essentiai to link the extracellular cues to the axonal cytoskeleton. The following
sections describe the receptors and ligands known to influence ROC growth. A general
summary of these moiecules found along the retino-collicular pathway is outlined in
figure 2 (p.24).
1.3.4.1 Laminins and Integrins
Laminin (LN) is an abundant growth promoting ECM molecule. LN receptors,
termed integrins, are heterodimers of Œ and f3 subunits which iink the axonai plasma
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membrane to the ECM. Integrins are important constituents of focaL adhesion sites:
macromolecular signaling complexes that transmit extraceliular signais to the
cytoskeleton (Hynes. 1992: Aota and Yamada, 1997). At these sites, the cytoplasmic
tyrosine kinases pp6Orc and ppl25 FAK (focal adhesion kinase) transduce an array of
signais from integrins and growth factor receptors. fAKs are normally expressed in
ROC filopodium: however. when tyrosine kinase activity is inhibited. axonal growth is
blocked and the FAKs translocate to central regions of the growth cone (Worley and
Hoit, 1996). pp60CrC is also expressed in ROC growth cones and plays a role in neurite
outgrowth (Maness et al., 198$; Bixby and Jhabvala, 1993). The interplay between these
two kinases is illustrated by the requirement of FAK activity in order for pp6Oc to
phosphorylate its substrates (Schaller et al.. 1999). Therefore. following integrin
binding. fAK is activated and recruits pp60rctO focal adhesion sites, allowing the latter
to phosphorylate the cytoskeletal proteins required to ensure axonal growth.
1.3.4.2 Cetlular Adhesion Molecutes
Developing RGC axons as well as the substrates on which they grow abound
with celi adhesion molecules (CAMs). The immunoglobulin (1g) super family is a
subfamily of adhesion molecules containing one to seventeen Ig-like domains (Huber et
aÏ., 2003). Members of this famiÏy are widely expressed on the surface of MLiller ceil
endfeet, basal lamina and on previously elongated pioneer axons, where they act as
growth cone guiding cues. The most studied Ig-superfamily CAMs are the neural CAMs
(NCAMs) and the closely related Li. They are expressed on elongating axons of
vertebrates as distantly related as fish and mammals. When NCAM function is inhibited
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in chick embryos, RGC axons extend to the contra-lateral side and fail to exit the retina
(Pollerberg and Beck-Sickinger, 1993). Similarly, blockage of Li in rats promotes axons
to grow at right angles to the pre-laid fascicles (Brittis et al., 1995).
Another large family of CAMs is the cadherins (calcium-dependent adherent
proteins). The Neural (N)-cadherins, for example, are important in early axon
fasciculation and growth and help stabilize retinal axons at their synaptic targets
(Ranscht. 2000). Cadherins are linked to the actin cytoskeleton by their cytoplasmic
domain via catenins. This interaction with the cytoskeleton, however, is flot the driving
force behind cadherin-induced axonal growth. Instead. a signaling mechanism, thought
to be mediated by the cytosolic protein 120Ctfl must be triggered in addition to ceil-ceil
adhesion for cadherins to stimulate axonal outgrowth (Shapiro and Colman, 199$;
Provost and Rimm, 1999). pi2O a member of the catenin family and originaÏly
described as a substrate of pp60c.src binds to the juxtamembrane region of N-cadherin.
Overexpression of 120Ctfl resuits in long filopodial-like structures in fibroblasts
(Reynolds et al., 1996), thereby making it an interesting effector of N-cadherin-induced
axonal elongation.
The interest in CAMs as modulators of axonal growth stems from their capacity
to act both as adhesion molecules and intracellular signal transducers (Walsh and
Doherty, 1997). Although the exact mechanisms goveming CAM-induced growth
remain ambiguous, one possibility lies in that stimulation of either N-CAM, N-cadherin
or Li can lead to the phosphorylation of FGFR. Once activated, FGFR will recruit its
downstream signaling cascades including MAPK and PLCy, both shown to play a role in
axonal growth (Doherty and Walsh, 1996). This coupling of fGfR and CAMs during
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axonal growth was demonstrated when the expression of a dominant-negative FGFR
blocked NCAM mediated FGFR activation and consequently impaired axonal outgrowth
(Saffeil et al., 1997). Thus, FGFR can be a signaling partner of CAMs and an important
mediator of axonal initiation and elongation.
1.3.4.3 Receptor Protein Tyrosine Phosphatases
Axonal growth and guidance require the presence of many receptor types at the
growth cone (e.g. integrins. CAMs. growth factor receptors) to sense, interpret and
transmit extraceilular signais to intraceilular effectors. The mechanisms underiying the
integration of extraceilular cues is flot fully understood; however, a large number of
these signais are relayed via tyrosine phosphorylation. Protein tyrosine kinases (PTKs)
piay important roles in signai transduction and it is now ciear that protein tyrosine
phosphatases (PTPs) are equally crucial. These two groups of enzymes exert opposite
activities, yet act in concert to ensure adequate cellular functioning (Ostman and
Bohmer, 2001).
PTPs are largeiy classified in two categories: the transmembrane and non
transmembrane. The former are termed receptor PTPs (RPTPs) because they contain a
iigand-binding site on their extraceliular domain. 0f the five major classes of RPTPs,
there is increasing evidence for the role of type lia RPTPs in axon guidance and growth
(Stoker, 2001). Type lia RPTPs are CAM-iike proteins that have large extraceliuiar
domains made of 1g and fibronectin type III (FNIII) repeats, a structure akin to NCAMs
and thus placing them in the 1g superfamily. On the cytosolic side, type lia RPTPs are
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composed of two phosphatase domains giving them the ability to modulate intracellular
phosphoiylation events.
One member of this family that is of particular interest in RGC axonal growth is
RPTP-o The avian orthologue of RPTPG, CRYPŒ, is strongly expressed in ROC axons
during development (Stoker et al., 1995; Ledig et al., 1999b) and bas been shown to
influence axonal growth in developing Xenopus (Johnson et al., 2001) and chick retinas
(Ledig et al., 1 999a). Expression of dominant negative CRYPŒ increases the length of
RGC neurites by 50% in cultured Xenopus retinal explants (Jobnson et al.. 2001).
Moreover, the ligands for RPTPG have recently been identified as the heparan sulfate
proteoglycans (HSPG) agrin and collagen XVIII (Aricescu et al., 2002). These
molecules are expressed along the basal lamina and glial endfeet of the retina, two areas
where ROC axon grow during development. These findings make RPTPcr an interesting
target for modulation to enhance RGC axon growth.
1.3.4.4 fibroblast Growth factors and RGC Growth
RGC development and axonal growth require stimulation by growth factors. One
of the key families of neurotrophic factors involved in the development and modeling of
the retina are the FGFs. As mentioned above, there is ample evidence that FGF s are
influential in the differentiation of ROC progenitors (Park and Hollenberg, 1989; Pittack
et al., 1991; Guillemot and Cepko, 1992). A role of f0fs in axonal growth is suggested
by the observation that these growth factors are abundantly expressed in developing
RGCs and throughout the entire optic pathway (de Iongh and McAvoy, 1993; McFarlane
et al., 1995), while their receptors are expressed in the growth cones of extending ROC
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axons (Cirillo et al., 1990). Moreover, f0f-2 has been shown to be a potent stimulator
of RGC axonal outgrowth in Xenopus (Mcfarlane et al.. 1995) and expression of a
dominant negative. kinase defective FGFR resuits in a 40% reduction in the rate of ROC
outgrowth.
1.3.5 Entering the Optic Nerve
Growth cones undergo a variety of morphological changes along their trajectory.
Their shape varies from a simple club-like structure to a highly elaborated cone with
multiple filopodia (Holt, 1989). Interestingly, these structural changes depend on the
growth cones position along its path; the more complex the steering decisions, the more
complex the growth cone. for example. cones tend to be simple throughout the retinal
surface and in the optic nerve where limited navigational decisions need to be taken. In
contrast, they become much more structured in Pvo zones along the pathway where
crucial steering choices are made. These growth crossroads are the optic nerve head and
the optic chiasm.
The exit of RGC axons from the retina is regulated by netrin-1 (Deiner et al.,
1997), an axon guidance cue expressed by neuroepithelial celis at the optic nerve head
(figure 2, p.24). In vitro, RGC axons are attracted to artificially formed gradients of
netrin- 1. This tuming is accompanied by a profound transformation in growth cone
morphology similar to that seen in vivo at the optic nerve head (Holt, 1989; de la Torre
et al., 1997). The attraction of ROC growth cones seems to be govemed by the Deleted
in Colorectal Cancer (DCC) receptor for netrin- 1, which is expressed in ROC axons and
when stimulated can increase cAMP levels (de la Torre et al., 1997). In vivo, the
attractive nature of netrin- 1 is most likely contact-dependent, as homozygote knockout
mice for netrin-1 are able to reach the optic nerve head, but then instead of entering,
continue to grow errantly within the retina (Deiner et al., 1997).
The attraction of RGCs by netrin-1 can be transformed into a repulsive signal by
altering intracellular cAMP levels or inhibiting protein kinase A (PKA) (Ming et al.,
1 997b). Elevated levels of cAMP provoke actin polymerization while reduced levels
lead to depolymerization. This conversion is primordial for the orderly exit of axons
from the optic nerve head. For example. laminin. which has been shown to reduce the
netrin-1-DCC-mediated increase in cAMP levels and therefore transform growth cone
attraction to repulsion (Hopker et al., 1999), is abundant on the vitreal surface of the
retina. Therefore, when axons reach the optic nerve head, the presence of netrin-1 will
establish lower cAMP Jevels on the vitreal side ofthe growth cone. Conversely, the high
levels of netrin-1 in the optic nerve head will increase cAMP concentrations in that
region of the growth cone. This gradient will favor growth cone actin polymerization on
the optic nerve head side and consequently leads to axonal prolongation into the optic
nerve, whereas depolymerization is likely to occur on the vitreal side (Dingwell et al.,
2000). Once out of the eye, a sheath of semaphorines wrapped around the optic nerve
prevents defasciculation through chemorepulsive forces (Figure 2, p.24).
FIGURE 2.
A)
Eye-
ONH
Netrin
Temporal Projections
(Ipsi]ateral side)
Nasal Projections
(Contralateral side)
B)
Low Higli
Guidance cues in the developing retino-collicular system.
A) A vast number of guidance cues are expressed along the developing retino-coilicular system. For
example, a ring ofnetrins found at the optic nerve head (ONH) helps RGC axons leave the eye and enter the
optic nerve. Once axons exit the retina, proper axonal fasciculation is maintained through chemorepulsive
forces exerted by a sheet of semaphorins around the optic nerve. At the optic chiasm, siits prevent the
premature midline crossing of RGC axons. To properly interpret their environment, RGC axons express
numerous receptors and adhesion moiecules (inset) including the receptor for FGFs, fibroblast growth
factor receptor (fGFR), the sut receptor Roundabout (Robo), the netrin receptor deleted in colorectal cancer
(DCC), the ephrin receptor (Eph), receptor protein tyrosine phosphatase-Sigma (RPTP), neuronal ceil adhe
sion molecule (NCAM), Li, and integrins. (B) The topographical innervation of the superior coliiculus is
dictated by concentrations ofephrins (and repulsive guidance molecule (RGM)) expressed along an anterior
(A) - posterior (P) gradient and the conesponding nasal (N) - temporal (T) gradient of Eph receptors.
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1.3.6 Decisions at the Optic Chiasm
In primates, RGC axons from the temporal haif of the retina project onto
ipsilateral subcortical regions of the brain, while axons originating from the nasal haif
cross-over at the optic chiasm to the contralateral side of the brain (Figure 2. p.24). In
albino rats. 99% of ROC axons cross-over at the chiasrn and only 1 % project to the
ipsilateral side (Isenmann et al., I 999b).
The navigational decisions made at the chiasm are important for the proper
topographical wiring of ROC axons yet the molecular factors mediating these events are
poorly understood. Although local guidance cues contribute to the final path taken by
the axon, it is also possible that the destiny of ROC axons, is determined prior to
arriving at the chiasrn. For example. axons originating in the ventro-temporal retina
persistently form ipsilateral projections. Interestingly, it was found that the Zic2 zinc
finger transcription factor is expressed excïusively in the ventro-temporal retina at a time
when ipsilateral projections are being formed (Herrera et al., 2003). Moreover, both gain
of function and loss of function experirnents dernonstrate that Zic2 by itself can redirect
contralateral projections to ipsilateral ones. Another example of a change in neuronal
biochemistry that can affect ROC decisions at the chiasm cornes frorn mice deficient in
OAP-43. Here, the knockouts showed randomized ROC crossing and abnormal
ipsilateral turning (Sretavan and Kruger, 199$). Furtherrnore. as mentioned above,
albino animals have a greatly reduced number of ipsilateral projections (Isenmann et al.,
1 999b). This has been attributed to a defect in the lyrosinase gene; a finding that was
confirrned in animals with eye-specific albinism (Oa-1 knockout mice) (Incerti et al.,
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2000). These examples provide evidence that the fate of axonal projections at the
chiasm, may be govemed by the biochemical make-up ofRGCs themselves.
As RGC axons segregate at the optic chiasm it is important that nerve integrity
be maintained. This is ensured by a family of inhibitory proteins known as the Siits.
These proteins are structurally similar to other ECM molecules that contain EGF repeats.
leucine-rich repeats and a laminin G domain. When sut proteins bind to their receptor
Roundabout (Robo), they inactivate Cdc-42 and provoke growth cone collapse (Huber et
al., 2003). Siits are expressed in the anterior and posterior regions of the developing
optic chiasm where they prevent premature midiine crossing of RGC axons. The spatial
expression pattern of Siits 1 and 2 in the visual system indicates that they form an
inhibitory wall, funneling growing axons along appropriate traj ectories at the chiasm.
They help maintain adequate fasciculation through chemorepulsive forces and their
layout contributes to the formation of the optic chiasm (PÏump et al., 2002) (Figure 2,
p.26). In transgenic mice deficient in Siits 1 and 2, certain RGC axons cross prior and
form a secondary chiasm. This phenotype does flot involve ah RGC axons (Plump et al.,
2002), most likely due to variable expression of the Robo receptor, and therefore
indicates that other directional cues are required.
1.3.7 Innervation of the Superior Colliculus
Retinal innervation ofthe superior colliculus (one ofthe major subcortical targets
of RGC axons) occurs along a specific anterior/posterior and dorsah/ventral arrangement.
Axons projecting from the temporal retina innervate the anterior superior colliculus,
while axons from the nasal side target posterior regions. In addition, axons originating
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from the dorsal retina reach the ventral superior colliculus, while those from the ventral
side project to dorsal regions. Retinal projections are highly organized in that adjacent
RGCs in the retina project to adjacent midbrain targets while maintaining their spatial
organization. In order to accurately preserve this orderly distribution, guidance cues are
distributed in a gradient like pattem. A gradient of guidance molecules requires far
fewer proteins than the colossal task of assigning a distinct receptor-ligand to each axon
target combination and is therefore a considerably more efficient targeting mechanism
(Sperry 1963).
Evidence for a chemical gradient that directs axonal growth came from
experiments where RGC axons were collected from the posterior (temporal) or anterior
(nasal) retina of a chick and plated on the membranes collected from the posterior or
anterior tectum (avian superior colliculus) (Bonhoeffer and Huf, 1985). It was noticed
that ROCs harvested from the posterior retina would only grow on the anterior tectal
substrate whereas RGCs from the anterior retina would grow on both anterior and
posterior tectal membranes. These observations indicated that a repulsive molecule was
present in the posterior tectum and led to the identification of a vast family of receptor
tyrosine kinases, the Eph kinases, and their membrane bound ligands: the ephrins
(Bonhoeffer and Huf, 1985). It was later found, in both chicks and mice, that specific
ephrins are expressed down an antero—posterior gradient in the superior colliculus,
whereas a conesponding naso-temporal gradient of Eph receptors is present in the retina.
Thus, axons traveling from the temporal retina, where Eph receptors abound, tend to
avoid the inhibitory signals from ephrins expressed in the posterior colliculus. In the
2$
nasal retina. axons express fewer Eph receptors and are consequently capable of
innervating more posterior regions ofthe superior colliculus (figure 2 B. p.24).
An additional guidance molecule that has been recently identified in the chick
tectum is the Repulsive Guidance Molecule (RGM) (Monnier et al.. 2002). As with
ephrins. RGM is expressed along a concentration gradient from the anterior to the
posterior pole of the tectum. RGM is capable of provoking the collapse of temporal (but
flot nasal) growth cones at concentrations significantly lower than ephrins. It will be
interesting to further study the role and mechanism of action of this molecule in higher
vertebrates.
1.4 OPTIC NERVE AXOTOMY
following traumatic injury to the mammalian CNS. neurons die by apoptosis.
necrosis or a medley of both. Neurons that have their axons sheared open will undergo
fundamental cellular and biochemical changes. Notably, the physical separation of the
celi body from its target resuits in the absence of retrograde transport of neurotrophic
factors thought to be required for survival (Oppenheim, 1991). Furthermore, calcium
influx destabilizes the cytoskeleton and contributes to the activation of apoptotic
pathways and the ensuing cellular degradation. Neurons that survive are severely
impaired and rendered inactive, at least transiently, by the dramatic variations in their
ionic and metabolic environment. In brief, aduit mammalian CNS neurons are unable to
regenerate an axon and their soma dies or atrophies afler lesion (Ramon y Cajal, 192$).
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1.4.1 Acute Optic Nen’e Injury and RGC Death
The optic nerve is formed by RGC axons extending from the retina to the brain
and is therefore the transmission cable of visual input to the image processing centers of
the brain. Any damage to this structure will compromise vision. Optic nerve afflictions
include: i) glaucoma, in which an increase in intraocular pressure ravages the optic nerve
al the optic nerve head: ii) multiple scierosis. an autoimmune disease in which optic
nerve myelin is degraded; iii) cancerous tumors which compress the nerve. and iv) acute
trauma such as an orbital fracture. Although full transection (axotomy) ofthe optic nerve
is unlikely to occur and traumatic injury of the optic nerve is very rare (Steinsapir and
Goldberg, 1994). the optic nerve axotomy produces a weÏÏ characterized time course of
RGC death. permitting the accurate evaluation of neuroprotective and regenerative
strategies. In addition, RGCs die by apoptosis afler optic nerve axotomy as they do in
glaucoma (Garcia-Valenzuela et al., 1995) and other CNS diseases. Thus, strategies to
promote celi survival or regeneration in this system may be extrapolated to other
neurodegenerative diseases affecting other neuronal populations. as well as for the
treatment oftraumatic CNS injuries such as spinal cord lesion.
1.4.2 Pattern ofRGC Ccl] Death in the Axotomy Model
Transection of the adult rat optic nerve leads to a bi-phasic pattem of ce]] death.
In the first and protracted phase, within 4 to 5 days afier lesion, only a minute number of
RGCs die. In the second and rapid stage, however, there is massive ceil death. Seven
days afier axotomy, only 50 % of RGCs survive and, of these, less than 10 % remain 14
jdays after injury. Interestingly. approximately 5 % of RGCs remain viable up to 20
months afier transection (Villegas-Perez et al., 1993).
following optic nerve axotomy, RGC deatli lias been described as apoptotic
(Berkelaar et al., I 994b; Garcia-Valenzuela et al., 1994). Apoptosis is an energy
consuming process that requires de novo protein synthesis. Apoptosis is characterized by
ceil shrinkage, condensation of nuclear chromatin. intranucleosomal DNA
fragmentation, breakdown of the nuclear membrane and formation of small membrane
bound vesicles termed apoptotic bodies (Garcia-Valenzuela et al., 1994; Ceilerino et al.,
2000; Nijhawan et al., 2000). The latter are then phagocytosed by microglial ceils, thus
avoiding an inflammatory response.
Although apoptosis is the active process by which RGCs die afier axonal
transection. a certain number of ceils die by necrosis due to mechanical or inflammatory
damage inflicted by the injury (Thanos et al., 1993; Bien et aI., 1999). Necrosis typically
occurs afier toxic insuit, hypoxia, energy depletion or other exogenous insuits. It resuits
in a sweiling of the ceil body and mitochondria, followed by perforation of the celi
membrane resulting in the leakage of cellular contents and consequent inflammatory
response. It is likely that there is a continuum between axotomy-induced apoptotic and
necrotic ceil death as both modes share common characteristics (Nicotera et al.. 1999).
1.5 APOPTOSIS
The apoptotic machinery is present in ail ceils and is therefore considered to be
an intrinsic suicide program. Neuronal survival relies on a detailed interaction between
the celi and its environment. The fleuron is thought to be continuously on the verge of
apoptosis, requiring survival signais to prevent its death (Raff. 1992; Raff et al., 1993).
Neurotrophins, cytokines, growth factors, and other peptide ligands stimulate
transmembrane receptors. which activate intracellular pathways and ultimately inhibit
this internai death program (reviewed in Jacobson et al., 1997).
The apoptotic pathway can be induced either by stimulation of celi surface death
receptors (Ashkenazi and Dixit, 199$) or through a mitochondrial pathway (Green and
Reed, 199$). Both modes of activation resuit in the regulation of members of the Bd-2
and caspase families (Merry and Korsmeyer, 1997; Green and Reed, 199$; Yuan and
Yankner, 2000).
1.5.1 The Bc]-2 Family
The activation of the apoptotic program is regulated by members of the Bd-2
famiiy (reviewed in Merry and Korsmeyer, 1997). A subset of this family is said to be
pro-apoptotic (Bad. Bax, Bak, Bok, Bid and Bik) and another anti-apoptotic (Bd-2, Bd
XL, Bd-w, Mci-1 and A-1) (Kearns et ai., 1996). Bd-2 proteins are situated on the
cytoplasmic side of the outer mitochondriai membrane, the nuclear envelope and the
endoplasmic reticuium.
Although there appears to exist several possible mechanisms by which members
ofthe Bd-2 family control apoptosis, one ofthe key functions is to control the release of
pro-apoptotic factors, such as cytochrome C (cyt C), from the mitochondria.
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The balance between pro-apoptotic and anti-apoptotic members ofthe Bd-2 farnily is paramount to the survival of
CNS neurons. When anhi-apoptotic members sucli as Bad are phosphorylated by growth factor-induced signaling
cascades, they are sequestered in the cytoplasm by the protein 14-3-3. Cont’ersely, dephosphorylated Bad translo
cates to the mitochondria and shifis the balance between anti- and pro-apoptotic Bd-2 family members. Conse
quently, cytochrome C is released from the mitochondrial inter-membrane space, binds to Apaf-1 (Apoptosis
protease activated factor) and together recrctit and activate the pro-caspase-9. This complex known as the apopto
some, then releases active caspase-9 which in turn activates downstream effector caspases such as
caspase-3, caspase-6 and caspase-7 and ultimately provokes neuronal apoptosis.
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Growtli factor-induced signaling cascades phosphorylate anti-apoptotic members
such as Bad thereby making them targets for lie cytoplasm by the protein 14-3-3. In
contrats, wlien in a non-phosphorylated state, Bad transiocates to the mitochondria and
shifis the balance between anti- and pro-apoptotic Bd-2 family members.
Consequently, there is leakage of cyt C which brakes the electron transfer chain
and impairs energy production, increases the generation of reactive oxygen species and,
most importantly for apoptosis, cyt C activates Apoptosis Protease Activated Factor-1
(Apaf-1) and pro-caspase-9 (Reed, 1997) (Figure 3, p.32). During apoptosis, cyt C leaks
from the mitochondria and binds Apaf-1. This complex then recruits pro-caspase-9 and
becomes the apoptosome, which can go on to activate the caspases-3, 6 and 7. also
known as the executioner caspases.
A possible mode of action for anti-apoptotic members of Bd-2 is that Bd-2 and
Bcl-XL inhibit cyt C release by binding and forming heterodimers with pro-apoptotic
Bd-2 members such as Bax. Furthermore, Bd-X1 can directly sequester Apaf-I via its
(Bd-2 homology) BH4 domain. These events block Bax homodimerization and thus
avert the formation of cyt C permeable channels. Other postulated pro-survival
mechanisms mediated by members of the Bd-2 family involve preventing the release of
pro-apoptotic elements from the mitochondria (e.g. Smac, Diablo, cyt C and
HtrA2/OMI) (Saeïens et al., 2004). This may be achieved through maintaining
mitochondrial membrane integrity by ensuring proper ATP for ADP exchange by the
adenosine nucleotide translocator tANT), or by acting directly on the voltage dependent
anion channel (VDAC). These mechanisms which involve the interplay of pro-survival
3Bd-2 members with various mitochondrial exchange pore proteins safeguard against
mitochondrial swelling and rupture (Bortner and Cidlowski. 2002).
Bel-2 is expressed at high levels duringdeveiopmentand is downreguiated in the
aduit CNS and retina (Merry et al., 1994; Levin et al., 1997; Merry and Korsmeyer.
1997). Conversely, Bel-X1 is expressed throughout adulthood in the CNS and in ROCs
(Isenmann et al., 1997; Levin et al., 1997; Krajewska et al.. 2002), suggesting that it can
promote the survival of adult fleurons. Interestingly, optic nerve axotomy leads to an
increase in Bax expression in transected RGCs while levels of Bd-X1 decline (Isenmann
et al., 1997; Levin et al., 1997). These newly skewed proportions of anti- to pro
apoptotic members can contribute to axotomy-induced ROC ceil death (Isenmann et al.,
1997). Additional evidence stems from experiments where neuronal death was delayed
when axotomized RGCs were transduced with Bax antisense oligonucleotides
(Isenmann et al., 1999a) or injected with a permeable form of Bel-X1 (Isenmann et al.,
1 999a). furthermore. aduli transgenic mice that overexpress Bel-2 show considerably
higher numbers of RGCs afier axotomy than wild-type littermates (Cenni et al., 1996;
Porciatti et al., 1996). Together, these resuits indicate that an increase in Bax leads to
RGC apoptosis, while an increase in Bcl-2/Bcl-X1 protects RGCs from axotomy
induced death.
1.5.2 Caspases
During apoptosis, a vast array of intracelÏular proteins are cleaved and degraded.
The family of cysteine-activated aspartate-specific proteases, known as caspases, was
identified as the principal effectors of this protein breakdown. Caspases are catalytically
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inactive zymogens (pro-enzymes) that require proteolytic cleavage to become activated
(Thomberry and Lazebnik, 199$). They are classified with respect to the sequence of
their amino-terminal pro-domain. Caspases that have death effector-domains. such as
caspase-$ and 10, are activated when recruited to the intracellular death domains of
receptors like CD95 (Apo- I /Fas) or tumor necrosis factor (TNF) receptor. Altematively.
caspases which have caspase-activating recruitment domains (CARDs), such as caspases
1, 2, 4, 5, 9, 11 and 12, are activated by multimeric complexes such as the Apaf
1/cytochrome C/caspase-9. Caspase bearing short pro-domains, such as caspase-3. can
be activated by a majority ofthe aforementioned caspases. Additionally, caspases can be
classified either as regulatory caspases that activate other caspases (e.g. 8, 9, 10) or as
executioner (effector) caspases that actively dismantie the ceil by acting on various
protein substrates (e.g. 3, 6, 7).
In fleurons, there are two well characterized caspase pathways involved in
apoptotic celi death. The first requires binding of fas Ligand and/or TNF to their celi
surface receptors (Fas and TNF Receptor). This binding induces the receptors
trimerization (Nagata, 1997) and once activated, the receptors subsequently recruit
adaptor proteins such as Fas Associating Protein with Death Domain (fADD/MORTI),
which sun-imon pro-caspase-$ to the receptor where it becomes activated (Boldin et al.,
1995; Muzio et al., 1996; Srinivasula et al., 1996). Once in an active state, casapase 8
will tum on other effector caspases such as caspase-3, 6 and 7 (Boldin et al., 1995;
Muzio et al., 1996; Srinivasula et al., 1996). In addition, caspase-$ can cleave and
activate pro-apoptotic Bd-2 family member Bid, thereby provoking its translocation to
the mitochondria and promoting cyt C release and consequently amplifying the caspase
n
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response (Li et al., 1998; Luo et al.. 1998). 0f interest, Fas and TNF monomers have
aiso been shown to self assemble independent of ligand binding, yet in this scenario.
celis do flot show recruitement of Caspase-8 (Seigel et al. 2000).
The other major caspase pathway invoives the apoptosome complex described
above, where Apaf-1 associates with caspase-9 after cyt C leakage from the
mitochondria. The formation of the complex leads to caspase-9 activation, which is then
free to activate other effectors such as caspase-3. 6 and 7.
In RGCs, caspase-3 activation lias been associated with RGC death afier optic
nerve axotomy (Kermer et ai., 1999; Kermer et ai., 2000b) and was found to be activated
in an ocular hypertension rat giaucoma model (McKinnon et al., 2002). Moreover,
inhibition of caspase-3 by protein inhibitors was shown to decrease the extent of ceil
death ensuing from optic nerve injury (Kermer et ai., 1998; Chaudhary et al.. 1999). The
signais upstream of caspase activation in retinal degeneration remain a matter for debate.
Nevertheiess, caspase activity is far down the chain of events and occurs in the late
stages of RGC degeneration. In order to achieve an efficient and sustainabie approach
for treating RGC apoptosis, it is imperative to address the causes and early initial events
that lead to celi death rather then tend to the finai consequences of the degenerative
process.
1.5.3 Signaling and Apoptosis
Neuronal survival relies on the constant inhibition of the cell’s intrinsic death
program by neurotrophic factor signaling (Raff et al., 1993; Burek and Oppenheim,
1996). The exact nature of the stimulus required to tilt the balance in favor of survivai is
Jlikely quite complex and has yet to be fully defined. In the PNS, for instance, prevention
of apoptosis can be achieved with single peptide trophic factors (Hamburger, 1993
Huang and Reichardt. 2001) such as nerve growth factor (NGf) or ciliary neurotrophic
factor (CNTf). Survival of PNS neurons can also 5e maintained by either increasing
intracellular levels of cAMP (Rydeil and Greene, 1982) or by depolarizing the neurons
(Franklin et al., 1995).
Conversely, CNS neurons appear to necessitate multi-factorial stimulation to stay
alive (Snider, 1994; Meyer-franke et al.. 1995). Meyer-franke et al. (1995) postulated
that the survival of RGCs requires sustained stimulation by the various factors secreted
from different celi types distributed along the optic pathway. for example, FGF-2
secreted from retinal celis, insulin-like growth factor-1 (IGf-1) and leukemia inhibitory
factor (LIF) from astrocytes, a yet to be identified factor from oligodendrocytes and
brain derived neurotrophic factor (BDNF) from the target celis in the superior colliculus
(Meyer-franke et al., 1995). In addition, in vitro paradigms indicate that the response of
CNS neurons to trophic peptides can be greatly enhanced by either depolarization or an
increase in cAMP levels (Hack et al., 1993; Hanson et al., 1998; Meyer-Franke et al..
1998). The multiple and varied stimulations required to maintain CNS neurons alive
illustrate the intricacies that must 5e addressed when devising neuroprotective strategies
for lesioned RGCs.
Neurotrophic factors, such as the neurotrophins (NGF, BDNF, NT-3, NT-4),
CNTF and the FGFs, bind to and activate ceil surface receptor tyrosine kinases (RTK).
Ligand binding stimulates the autophosphorylation of tyrosine residues on the
cytoplasmic moieties of the receptors. These phosphotiyrosines then activate distinct
jsignaling cascades as they become docking sites for signaling molecules such as
phosphoinositide-3 kinase (PI-3K), phospholipase Cy and adaptor proteins such as Shc,
Grb2 and Sos which trigger other transduction pathways (Figure 4. p.4l). Here, we will
focus on two pathways of particular importance for RGC survival: the PI-3K!Akt
pathway and the Ras/Raf/MAPK pathway (Datta et al.. 1999; Grewal et al.. 1999).
1.5.3.1 The PI-3K/Akt Pathway
PI-3K is present in the cytosol of neurons including RGCs and is activated by
either the stimulation of RTKs, receptors indirectly coupled to tyrosine kinase (e.g.
integrins), or receptors coupled to seven transmembrane G-protein receptors (Datta et
al., 1999). Activation of these receptors resuits in the direct recruitment of PI-3K to
intracellular tails ofthe phosphoryÏated receptor, or indirectly via the Ras pathway. Once
stimulated, PI-3K promotes the formation of 3’-posphorylated phosphoinositides. These
lipids in turn bind Akt and provoke its translocation from the cytoplasm to the plasma
membrane (Franke et al., 1995; Franke et al., 1997), where it comes in close proximity
with 3’-phosphoinositide-dependent protein kinases (PDKs). These kinases (which are
themselves regulated by phospholipids) phosphorylate and activate the serine/threonine
kinase Akt (Alessi et al., 1997).
Akt inhibits apoptosis by acting on several substrates (Figure 4, p.4 1):
1) It phosphoiylates pro-apoptotic Bad. When pro-apoptotic Bd-2 family
members, such as Bad, are in an unphosphorylated state, they tend to form heterodimers
with anti-apoptotic proteins such as Bcl-XL, consequently shiffing the pro- to anti
apoptotic equilibrium. The pro-apoptotic proteins subsequently form homodimers and
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integrate into the mitochondrial membrane. ultimately resulting in apoptosis (Gross et
al., 1998). Conversely. if Bad is phosphorylated. it will become a target for protein 14-3-
3. which will sequester it in the cytosol thereby blocking apoptosis (Zha et al., 1996).
2) It inactivates 1KB kinase (IKK). thereby releasing 1KB (the repressor element
of NfKB) and permitting NfKB-dependent transcription of survival genes.
3) It phosphorylates the pro-apoptotic transcription factors forkheads. which
favors their association with 14-3-3 protein and thus prevents their entry into the nucleus
(Brunet et al., 1999). Akt has also been shown to phosphorylate and therefore activate
the transcriptional activator cAMP-response element binding protein (CREB) and thus
enhancing CREB-dependent transcription (Du et al., 1998). CREB is thought to mediate
the transcription of pro-survival genes (Riccio et al., 1999).
4) It phosphorylates and therefore directly inactivates caspase-9. This mechanism
does not seem to be conserved throughout different species as the phosphorylation site
for Akt found in human caspase-9 is flot present in mice (Fuchs et al., 199$).
Although the PI-3K/Akt pathway is important for the prevention of apoptotic celi
death by certain stimuli in a variety of neurons, other signaling cascades are ofien
required. for example, IGF is neuroprotective for axotomized RGCs via a PI-3K
dependent pathway (Kermer et al., 2000a), whereas BDNF induced neuroprotection is
flot compromised when the PI-3K is pharmacologically blocked (Kiocker et al., 2000).
furthermore, RGC survival mediated by TrkB (the BDNF receptor) is achieved solely
via the MEK!MAPK pathway (Cheng et al., 2002a).
40
figure 4. Neuronal survival induced by growth factors.
The binding ofneurotrophic factors such as NGF, BDNF, NT-3, NT-4, CNTF and FGfs
provokes the dimerization and auto-phosphorylation of receptor tyrosine kinases. The
phosphorylated tyrosine residues on the intracellular tails of the receptor provide
docking sites for a variety of signaling and adaptor proteins. for example, following
ligand binding, phosphoinositide 3-kinase (PI-3K) as well as the docking proteins
growth factor receptor-bound protein 2 (Grb2). fGfR substrate-2 (fRS-2) and Shc are
recruited to the activated receptor. PI-3K subsequently activates 3’-posphorylated
phosphoinositides which transiocate Akt to the inner surface of the plasma membrane
where it is phosphorylated and activated by 3’-phosphoinositide-dependent protein
kinase (PDK) (also activated by PI-3K). Akt then phosphorylates Bad, forkhead, and
caspase-9 consequently blocking the apoptotic pathway. Altematively, Akt
phosphorylates the cAMP-response element binding protein (CREB), resulting in the
transcription of pro-survival genes or Akt phosphorylates 1KB kinase (IKK) thus
releasing 1KB (the repressor element of NfKB) and permitting NfKB-dependent
transcription of survival genes. Concurrently, the recruitment of FRS-2, Grb2 and Shc,
attracts son of sevenless (SOS) nucleotide exchange factor which, stimulates the Ras
Raf-MEK-Erk pathway and activates pp9O ribosomal S6 kinase (RSK). As with Akt,
RSK also phosphorylates Bad and CREB and the two may act synergistically to promote
survival.
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1.5.3.2 The MEKIMAPKPathway
The mitogen-activated protein kinase (MAPK) pathway is involved in a vast
array of cellular functions from growth to apoptosis (Grewal et al., 1999). As mentioned
above, upon neurotrophic stimulation. Shc. Grb2, SOS and other adaptor proteins are
recruited to the activated RTKs cytosolic domain (Figure 4, p.41). This cascade of
events leads to the activation of the small GTP-binding protein Ras and the subsequent
phosphorylation of Raf, MAP kinase! extracellular signal-regulated kinase (ERK) kinase
(MEK) and ERK (Bonni et al.. 1999). MAPK’s modulation of apoptosis is achieved by
the recruitment of members of the pp9O ribosomal S6 kinase (RSK). The latter, as did
Akt, phosphorylates Bad, thereby preventing its death promoting functions. 0f interest,
Akt and RSK each phosphorylate Bad on a different serine residue, indicating that the
MAPK and PI-3K pathways could act synergistically to prevent apoptosis (Datta et al.,
1999). Moreover, RSKs also phosphorylate CREB and therefore stimulate the
transcription of survival genes such as Bd-2 (Riccio et al., 1999).
1.5.4 RGC Axotomy and Trophic Deprivation
RGCs, as other CNS neurons, receive trophic support from their midbrain targets
(Bhattachaiyya et al., 1997; Grimes et al., 1997; Riccio et al., 1997; Senger and
Campenot, 1997). During development, RGCs undergo a period of ceil death. This celi
death can be exacerbated by partial or total removal of the superior colliculus and/or the
lateral geniculate nucleus (their targets in the brain) (Hughes and Lavelle, 1975; Hughes
and McLoon, 1979). In contrast, increasing the size of the target diminishes the extent of
normally occurring death (Sengelaub and Finlay, 1981). These observations are in
‘f3
agreement with the neurotrophic hypothesis suggesting that developing neurons are in
competition for a limited supply oftrophic factors secreted by their targets. Moreover. in
the aduit CNS. fully transected neurons tend to die. whereas neurons that have branched
projections remain alive afier axotomy given that one ofthe collateral branches remains
intact (Bemstein-Goral and Bregman, 1997: Bernstein-Goral et al., 1997). This indicates
that the intact collateral branches remain channels for retrograde trophic support. 0f
interest, RGCs transected doser to the optic nerve head degenerate at a faster rate than
those axotomized doser to their targets with longer segments of intact axon in place
(Berkelaar et al.. 1994). Together, these data suggest that CNS neurons require a target
derived retrograde signal to survive.
The role of retrograde trophic support in the maintenance of aduit neurons is
however somewhat controversial. For example, when both the aduit superior colliculus
and lateral geniculate nucleus are chemically destroyed with kainate, a paradigm where
axonal terminaIs remain intact, there is no effect on the survival of mature RGCs
aithougli their primaiy source of retrograde trophic support is removed (Perry and
Cowey, 1979). Likewise, pharmacological inhibition of retrograde transport with
lidocaine in neonatal rats, results only in a minor increase in celi death (Fagiolini et al..
1997). These results could 5e attributed to the high levels of trophic factors, such as
BDNF and FGF-2, that are produced in the retina proper (Gao et al., 1997; Herzog and
von Bartheld, 1998). For example, Millier ceils are an important source of trophic
factors in the inner retina. These glial ceils envelope RGCs and can therefore influence
their microenvironment. It has been demonstrated that conditioned medium from MUller
celis is more effective at promoting survival during the period of naturally occurring
44
ROC death than extracts from the superior colliculus (Armson et al., 1987).
Furthermore, this conditioned medium from Miiller ceils has been shown to promote
neurite outgrowth from ROCs. The Millier ceil medium, however. loses its potency as
ROCs mature whule the collicular extract retains its neuroprotective quality.
Remarkably, afler optic nerve injury, reactive Millier ceils regain the ability to promote
survival of mature ROCs thus indicating that these celis may be essential in the intrinsic
response to retinal injury. There are a number of trophic factor sources within the visual
system. for example, the superior colliculus produces BDNF (Sievers et al., 1989). the
astrocytes in the optic nerve and superior colliculus produce CNTF and LIF (Stockli et
al., 1991; Yamamori, 1991), celis of the outer nuclear layer and inner nuclear layer
produce fGF-2 (Sapieha et al., 2003). Therefore, it is unlikely that retrograde trophic
factor deprivation is the only factor ieading to the death of aduit. axotomized ROC s. For
example, if this hypothesis were true, treatment with neurotrophic factors should block
ROC death. Although trophic supplementation for axotomized ROCs has been
intensiveiy expÏored and is currentiy the most effective strategy to promote ROC
survival, the effects are of a rather modest magnitude and a transient nature (Mansour
Robaey et al., 1994; Aguayo et al., 1996; Ciarke et al., 1998; Di Polo et al., 1998; Shen
et al., 1999). These observations suggest that other factors should also be considered
during axotomy-induced degeneration.
for example, following axonal transection, a large percentage of neurotrophic
receptors such as TrkB are downregulated from the celi surface (Cheng et al., 2002a).
furthermore, these neurons have reduced levels of cAMP after injury as a resuit of
impaired synaptic connections or lower activity (Northmore, 1987). This loss of cAMP
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lias been shown to prevent the ability of MAPK to transiocate following trophic
stimulation (Shen et al.. 1999). In fact. treatment with cAMP. or artificiai induction of
depolarization with K and Ca2 channel agonists, was required to reverse the obsen’ed
lack of trophic responsiveness by recruiting TrkB (the high affinity receptor for BDNF)
from intra-cellular stores to the ceil membrane (Meyer-franke et al.. 1998).
Aiternatively. upregulation of TrkB within RGCs using AAVs has aiso proven to be an
effective approach to enhance responsiveness to BDNF (Cheng et al., 2002a). These
observations indicate that axotomized RGCs not only lack trophic stimulation, but also
lose their ability to respond to trophic signais.
1.6 AXON REGENERATION IN THE CNS
In contrast to their PNS counterparts. lesioned CNS neurons are flot oniy unable
to survive but are aiso incapable of regenerating their axons. There exists a number of
factors that can hinder mature CNS axons regrowth. for example, reduced trophic
support, lower cAMP levels, inhibitory myelin proteins and a fortified repulsive guai
scar. Importantly, it lias been demonstrated that, wlien aduit RGCs are given a
permissive PNS environment, a certain percentage gains the ability to survive and
regenerate their axon (Ramon y Cajai, 1928; David and Aguayo. 1981) (Richardson et
al., 1980; Villegas-Perez et ai., 1988). These findings demonstrate that given the right
conditions (e.g. a permissive environment), axon regrowth can be achieved in the aduit
injured CNS. Finding the optimal determinants and stimulatory conditions to regenerate
mature CNS neurons remains one ofthe great challenges in modem neurobiology. In the
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following section I will examine the role of the inhibitory CNS environment versus the
intrinsic capabilities of CNS neurons to regenerate.
1.6.1 The Inhibitory CNS fnvironment
The success of peripheral nerve grafis as bridges for CNS axonal growth
suggested that components of the injured CNS environment such as myelin and the guai
scar are important factors contributing to regeneration failure.
1.6.1.1 CNSMyeIin
The inhibitory properties of CNS myelin were examined in the pioneering work
of Martin Schwab and colleagues back in the late 80s. Their investigations showed that
the growth inhibitory properties of a certain fraction of myelin preparation could be
partially reversed by using a function blocking antibody raised against this fraction that
they named IN-1. These observations eventually lcd to the discovery of a 250 kDa
glycoprotein with axon growth inhibitory properties that was given the name Nogo
(Caroni and Schwab, 198$).
Subsequently, another component of CNS myelin, myelin-associated
glycoprotein (MAG), was found to play a growth inhibitory role (McKerracher et al.,
1994; Mukhopadhyay et ai., 1994). Originally described in 1973 (Everly et al., 1973),
this member of the immunoglobulin superfamily, has both adhesive and growth
inhibitory properties. Interestingly, MAO promotes neurite growth of El 8 RGCs yet
inhibits growth of postnatal ROCs (DeBellard et al., 1996), suggesting that either its
receptor or one of its co-receptors could be developmentally expressed.
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The most recent myelin growth inhibitor to be identified was oligodendrocyte
myelin glycoprotein (OMgp) (Kottis et ai.. 2002; Wang et al.. 2002b). OMgp is a
glycosyl-phosphatidylinositol (GPI)-linked glycoprotein with high leveis of expression
in mature oligodendrocytes (Quarles, 1997).
Remarkably, it was recently demonstrated that ail tbree inhibitory molecules bind
to the Nogo receptor (NgR) (Foumier et ai., 2001: Liu et al., 2002; Wang et al., 2002b).
Because NgR is a GPI linked protein lacking a transmembrane domain, it requires a
binding molecule to transduce its inhibitory signal. One binding/transduction partner that
was recently identified is the receptor p75 (Wang et ai., 2002a; Wong et al., 2002). In
fact, neurites cuitured from p75 deficient mice were not inhibited by myelin (Wang et
al., 2002a), suggesting a direct role of p75 in mediating the growth inhibitory effects of
myeiin. These novel findings indicate that it couid be feasible to override the growth
inhibitory effects of myelin by biocking a single target, such as the Nogo receptor, on
which ail of the myeiin induced signaling converge. If accurate, this would greatly
faciiitate the design of therapeutic approaches to counter the growth inhibitory activity
of CNS myeiin.
1.6.1.2 TIte Guai Scar
Axonai injury in the CNS produces a scar that is inhibitory towards axon
regrowth (Beny et al., 1983). The guai scar was first described in the 50s, as a physicai
barrier consisting of coliagen aggregates, dense conjunctive tissue, neovascuiarization,
macrophage infiltration and a guai iimitans (Ciemente and Van Breemen, 1955; Scott
and Ciemente, 1955). It is now weli established that the guaI scar is aiso rich in growth
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inhibitory molecules. The lack of scar formation in the injured CNS of neonatal rats
sparked further interest for its potential role in regenerative failure in the aduit nervous
system (Fawcett and Asher. 1999).
In the days ensuing a lesion, monocytes and macrophages enter the injured zone
via the ruptured circulatory system. At this time point, the transected axons are
undergoing what Cajal termed “short distance frustrated regenerative acts” (Ramon y
Cajal, 1928). This phenomenon could potentially be attributed to the macrophages’
degradation of inhibitory myelin or their secretion of growth promoting molecules such
as fGfs (Nathan, 1987; Fawcett and Asher, 1999). Next, meningeal celis.
oligodendrocyte precursors as well as fibroblasts enter the lesion site and intertwine with
the capillaries. forming a dense conjunctive meshwork. Astrocytic processes later cross
through the neuropile and interact with meningeal ceils to create a tight barrier with the
mesenchyme known as the guai limitans (Maxwell et al., 1990). The growth inhibitory
molecules in the scar abound on the various ceIl types present in scar. For example.
oligodendrocyte precursors express the chondroitin sulfate proteoglycan (CSPG) NG2
(Levine et al., 2001), while meningeal ceils produce semaphorine III, tenascins and
different proteoglycans (Ajemian et al., 1994; Ness and David. 1997; Pasterkamp et al.,
1999). 0f these, the most prominent inhibitors of axon growth in the guai scar are the
CSPGs NG2, phosphacan, veriscan and neurocan. Although little is known about their
mechanism of action, it seems that the glycosaminoglycan (GAG) chains are important
for the transduction of the inhibitory signal, as enzymatic removal of these chains
improves regeneration and functional recovery (Bradbury et al., 2002). Thus,
paradoxically although CSPGs ensure proper axon path finding during deveiopment,
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they becorne key molecules responsible for regenerative failure following injury in the
aduit CNS.
1.6.2 Intrinsic Regenerative Ability of RGCs
CNS neurons lose their intrinsic ability to grow axons shortly afier postnatal
development. Studies comparing RGC growth at different developmental periods have
revealed that ceils in cultures from E20 RGCs (1 day prior to birth) extend their axons
1 O times as fast as those from postnatal P8 rats (Goldberg et al., 2002a). Moreover.
when transplanted into the developing brain, embryonic RGCs regenerate their axons
significantly further. Interestingly, the loss of intrinsic axon growth capability afler birth
is accompanied by an increased abilily to elaborate dendritic arbors. These data
demonstrate a developmental switch in growth programs. Further investigations have
attributed this change to retinal amacrine cells which signal to ROCs and ineversibly
alter their ability to grow axons (Goldberg et al., 2002a).
There are several developmentally regulated changes that occur while the neuron
is maturing. For example, there are pronounced differences between immature and
mature cytoskqueletal proteins. This can include differences in post-translational
modifications such as acetylation, phosphorylation. tyrosinationldetyrosination as well
as the binding of several forms of stabilizing proteins such as microtubule associated
proteins (MAPs), ail of which either enhance of hinder the axons ability to extend
(reviewed in Dent and Gertler; 2003).
One of the inherent differences that may contribute to the mature neuron’s
inabiiity to regenerate when compared to its embryonic counterpart is the changes in
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endogenous cAMP levels. Adult neurons have lower levels of cAMP and this decrease is
thought to reduce their ability to regrow an axon afier transection (Cai et al.. 2001).
Varying levels of this cyclic nucleotide can determine the growth con&s response to
guidance cues and neurotrophic factors (Ming et al., 1997a; Song et al., 1997; Song and
Poo, 2001). 0f relevance to axonal regeneration, increasing cAMP levels was shown to
override the inhibitory effects of MAO and myelin (Cai et al., I 999a) and convert MAO
mediated repulsion to attraction (Song et al., 199$). Moreover, injection of permeable
cAMP analogues into the dorsal root ganglion (DRG) increased regeneration in the CNS
dorsal column (Neumann et al.. 2002; Qiu et al., 2002). This approach also yielded
increased growth when DRGs were subsequently cuftured on either pemiissive or
inhibitory substrate (Neumann et al.. 2002).
Modification of cAMP levels alters the growth cone response to guidance eues
(Song et al., 1997); therefore, aithougli axons are stimulated to regenerate, they may
grow astray by their newly skewed intemal chemistry. One plausible approach to
overcome this issue is to examine the downstream molecules induced by elevated cAMP
levels that allow a neuron to grow an axon on myelin. This question was addressed by
Cai et al. (2002) in a study where they identified the enzyme Arginase 1 as one of the
key downstream components in the cAMP pathway. Arginase 1 is involved in the
synthesis of polyamines. and overexpression of either Arginase I or the addition of
polyamines stimulated axonal growth on myelin (Cai et al.. 2002). This approach allows
to reap the benefits of elevated cAMP levels without actually increasing cAMP levels
and consequently modifying growth cone tuming.
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1.6.3 Survival versus Regeneration of Lesioned CNS Neurons
The previous section focused on why aduit CNS neurons are less prone to
regenerate; however, there is evidence that aduit mammalian RGCs are capable of
regrowing axons within the injured optic nerve. Early evidence came from a study where
Berry and colleagues introduced pre-degenerated segments of sciatic nerve into the
vitreous chamber (Berry et ai., 1996). Twenty days later, between 0.6% and 10% of
RGCs grew axons 3 to 4 mm into the optic nerve. The conclusion from this study was
that trophic factors iiberated from the implant stimulated axonai growth.
The obvious questions then arise: what signais are required to stimulate the
regeneration of transected CNS neurons and do these differ from the signais necessary
for their survivai? It seems intuitive that a neuron needs to survive in order to regenerate;
however, is survivai in itseif sufficient? For instance, in the exampie above, Schwann
celis in the degenerated nerve implant may have provided neuroprotective signais to the
axotomized RGCs (Maffei et ai., 1990); yet, it is impossible to determine if these
survival signais are themselves contributing to axonai growth. In order to fuily isoiate
the survival variable from the growth variable, investigators have used transgenic
animais mutated for apoptotic genes. For exampie, transgenic mice that overexpress Bd
2 retain 65% of their RGCs at 6 months afler axotomy (Bonfanti et ai., 1996; Cenni et
al., 1996). In these mice, 100% of RGCs survived 1 month afier intracranial optic nerve
crush as compared to 44% in wild type mice (Chierzi et ai., 1999). Nevertheiess, the
levei of axon regeneration in these mice remained identical to controls uniess they were
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treated with the IN-1 antibody. This held true even when RGCs were presented with the
permissive environment of a peripheral nerve grafi (moue et al., 2002).
In experiments where RGCs were transfected with Bel-2, postnatal RGCs
survived in vitro without any trophic stimulation. yet were unable to extend axons on
their own (Goldberg et al., 2002a). Similarly. Bax -I- DRG sensory neurons can be
cultured without neurotrophic factors, but neurotrophins greatly enhance their axonal
outgrowth (Lentz et al.. 1999). The separation of survival and regeneration may explain
why a small population of RGCs remains viable for up to 20 months afler axotomy
(Villegas-Perez et al., 1993) without regrowing their axons. This phenomenon also
occurs in other CNS populations such as Purkinje cells (Dusart and Sotelo, 1994) and
cortico-spinal motor neurons (Schwab and Bartholdi. 1996). Taken together, these
studies indicate that CNS neurons that survive after lesion require extrinsic signals to
regenerate their axons. The question remains as to which stimulus or combination of
stimuli is required.
1.7 NEUROTROPHIC SUPPLEMENTATION FOR LESIONED NEURONS
Treatment of transected RGCs with trophic factors in order to prevent apoptosis
and stimulate regrowth has been an avenue of research for more than twenty years
(reviewed in Yip and So. 2000 and Chaum, 2003). As described above, axon transection
flot only reduces the availability of target-derived trophic factors but also compromises
the intrinsic ability of neurons to respond to these stimuli. An attractive neuroprotective
approach consists in boosting the levels of available neurotrophic factors. This is
exemplified in experiments where Schwann cells or peripheral nerve segments
introduced into tlie vitreous chamber of rats promoted both RGC survival and
regeneration (Maffei et al.. 1990; Berry et al., 1996). It is presumed that Schwann celis
or non-neuronal components of the grafi (Schwaim ceils and fibroblasts) released a
cocktail of trophic factors. Schwann celis, for example, secrete neurotrophins (e.g. NGF,
BDNF. NT-4/5) and other trophic factors. such as fGFs (e.g. fGF-2). ciliary
neurotrophic factor (CNTF). guai ceil une derived neurotrophic factor (GDNF) and
transforming growth factor-Betas (TGf-f3s) (Dezawa and Adachi-Usami, 2000). 0f
these factors, fGF-2 lias been associated with both survival and growth of RGCs and
tlierefore its role in retinai injury repair as well as its mechanisms of action will be
covered in greater detail in the following section.
1.7.1 fGf-2 and Retinal Injury
FGF-2 is expressed in the outer nuclear and inner nuclear layers of the aduit
retina (Sapieha et ai., 2003). foliowing injury to the retina, endogenous levels of fGf-2
are upregulated (Wen et al., 1995; Cao et al.. 1997; Wen et ai., 199$) and following
optic nerve injury, FGF-2 levels increase in photoreceptor ceils and guai celis of the
optic track (Kostyk et ai., 1994). These observations suggest that FGf-2 may be
involved in injuly repair. This daim lias been substantiated by a number of studies that
demonstrate a neuroprotective role for this factor. In the aduit retina, application offGf
2 protein to the distaily transected optic nerve stump of aduit rats enhances survival of
RGCs tliree-fold, 30 days afier axotomy ($ievers et al., 1927). fGf-2 has been effective
in deiaying inherited retinai dystrophy in rats (faktorovich et al., 1990, 1992), siowing
age reiated photoreceptor loss (Lin et ai., 1997) and preventing photoreceptor ioss afier
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light damage (LaVail et al.. 1992). furthermore, it has been shown to exhibit transient
protective effects in aduit rat models ofpressure-induced retinal ischemia models (Unoki
and LaVail. 1994; Zhang et al.. 1994). In vitro, FGF-2 stimulates neurite extension of
aduit rat RGCs (Bahr et al., 1989) and axon branching of cortical neurons (Szebenyi et
al., 2001). finally, our studies, presented in chapters 2 and 3 of this thesis, have
demonstrated a role for FGF-2 in RGC axon regeneration (Sapieha et al. 2003).
1.7.2 FGF Signaling
fGfs provoke a vast range of biological effects when bound to their high affinity
extracellular tyrosine kinase receptors, the fGFRs. There are cunentÏy four members of
this family. FGfR1 -4. FGFRs are transmembrane glycoproteins with three extracellular
Ig-loops (I, II and III), a hydrophobic transmembrane domain and an intracellular
tyrosine kinase domain (Johnson et al.. 1991). The Ig-Ioop III determines fGf binding
affinity to a given receptor and alternative spiicing of this loop gives rise to various
isoform for fGfR1-3, while fGFR4 is generated as a single splice product. 0f
importance, alI four fGfRs have been localized in the retina (Comish et al., 2004).
In vitro studies indicate that each receptor and its diverse isoforms show distinct
affinities for given fGf s (Ornitz et al., 1996). The ensuing signaling cascades are
however likely to be very similar as there is a great degree of structural homology
between the various receptors. In fact. a study in which chimeric fGFRs were made
from the cytoplasmic domains of FGfR1, FGFR2 and fGFR4 and the extracellular
domain of the PDGF receptor demonstrated that only the strength of tyrosine kinase
activity and flot the recruitment target of proteins was affected (Raffioni et al., 1999).
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This suggests that the signaling cascades are conserved tbroughout the vast fGf family
and numerous FGFRs and that only the intensity ofthe signais vary.
FGF activation of fGfRs is stabilized and enhanced by interaction with heparan
sulfate proteoglycans (HSPGs). The latter are expressed either on the ceil surface or in
the embryonic ECM. HSPGs enhance the signaling of fGfs by preventing their
diffusion from the target celis, by storing FGFs in the ECM, and by protecting them
against thermal and proteolytic denaturing (Moscatelli, 1987; Flaumenhafi et al., 1990).
In addition, HSPGs are thought to confer a steric advantage that facilitates and stabilizes
the interaction between fGFs and fGFRs (Omitz et al., 1992; Aviezer et al., 1994).
Similar to the mai ority of RTKs, fGfRs transmit their extraceilular signal to the
ceil via a network of phosphorylation dependent events. FGfRs are activated in a
stepwise fashion. first. a single fGf molecule binds to a single fGfR molecule, thus
forming a fGF/fGfR complex. Second, two independent FGF/FGFR complexes are
assembled with the assistance of HSPGs (Venkataraman et al., 1999; Stauber et al.,
2000), and lastly, intracellular phosphorylation cascades are stimulated. Upon activation,
FGFR1 bas 7 tyrosine residues in its cytoplasmic domain that can serve as substrates for
phosphorylation and the consequent recruitment of signaling effectors. In the following
sections, two of the most prominent pathways ensuing from fGFR stimulation are
described.
1.7.2.1 Tue SNT-1/fRS2 Pathway
A novel bridging/ adaptor protein was identified that is recruited via a
mechanism which does not involve the phosphorylation of proteins containing SH2.
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This protein was simultaneously reported by two groups and named SNT-1 (Wang et al..
1996) and FRS2 (Kouhara et al., 1997). Once activated, FRS2 recruits the adaptor
proteins Grb-2/Sos which recruit the small GTPase Ras to the FGFR complex and
consequently activate the MEK!MAPK pathway (Kouhara et al., 1997). Moreover,
tyrosine phosphorylation of FRS2 afier FGF stimulation can resuit in the activation of
the PI-3K!Akt pathway via the recruitment of Grb2 (Ong et al., 2001). 0f note, FRS2
can be constitutively associated with FGFRI, regardless of its state of activation (Ong et
al., 2000). Interestingly, Trk receptors also recruit FRS2. However, this occurs only
when Trks are activated (Ong et al., 2000; Yan et al., 2002). It is therefore possible that
FGFRI may influence Trk signaling by sequestering FRS2 from activated Trks.
1.7.2.2 The PL Cy Pathway
Upon phosphorylation of Tyr766 in the intracellular domain of FGFR1. PLCy is
recruited and associates via its SH2 domain (Mohammadi et al., 1991). PLCy is a
cytoplasmic protein that when activated cleaves phosphatidyl-inositol-4, 5-biphosphate
to yield inositol triphosphate (1P3) and diacylglycerol (DAG). 1P3 provokes the release
of intracellular Ca2 stores from the endoplasmic reticulum; DAG and Ca2 activate
protein kinase C (PKC). Thereafler, DAG lipase converts DAG to arachidonic acid
(AA). The later activates Ca2 channels causing Ca2 influx that stimulates the
Ca27calmodulin kinase II (CaMKII) and ultimately provokes neurite outgrowth
(Williams et al., 1995). The PLCy pathway seems to be involved in FGFR stimulated
axonal growth (Doherty and Walsh, 1996; Lom et al., 199$). In culture, the inhibition of
PLCy by small molecules considerably impairs RGC axonal growth (Saffeil et al.,
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1997). whereas inhibition of components of the PLCy pathway in the developing
Xenopus significantly reduces neurite outgrowth (Lom et al., 199$).
1.8. GENE MODULATION FOR TUE INJURED CNS, PART I: AUDING A
GENE
A shortcoming oftrophic factor supplementation strategies is the modest haif-life
of these proteins. Overcoming this issue to achieve sustained levels of trophic factors in
or around the injured neuronal population is essential to better assess the true potential
of these regenerative and neuroprotective strategies. An attractive method to achieve a
perpetual upregulation of trophic factors is to use gene transfer technology. This
approach is also commonly termed gene therapy. The following sections give an
overview of current developments in this domain.
1.8.1 Gene Transfer Techno]ogy
Gene therapy is the transfer of a gene into a ccli with the goal of preventing or
treating a disease. In contrast to most conventional medicines that alleviate symptoms or
non-specifically eradicate the cause, gene therapy alters a cell’s program in order to help
it or its neighboring ceils function soundly. For example, the newly introduced gene
(transgene) can increase the leveis of neurotrophic factors or their receptors which are
depleted as a resuit of injuiy (Cheng et al., 2002a). Furthermore, gene therapy can be
used to upregulate genes whose expression is confined to defined periods of
development (Sapieha et al., 2003). This can help the cells in their response to injury by
activating developmentally relevant programs such as those used for axonal growth.
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b date, most clinical studies involving gene therapy have been for cancer, where
the primary objective is to eliminate cancerous ceils. Here. the strategies are geared to
enhancing certain inherent cellular traits such as immunogenicity (Stopeck et al.. 1997)
or to provoke apoptosis (Boussif et al.. 1996: Swisher et al., 1999). In other approaches,
the transgene can yield a toxic end product such as a pro-drug or an enzyme (Ram et al..
1997) or a functional copy of a mutant or absent gene is delivered in cases such as
cystic fibrosis or mucopolysaccharidosis type VII, (Ohashi et al., 1997; Wagner et al.,
1998). Gene transfer can be performed in vivo, where the host is treated directly with the
vector, or ex vivo, where ceils are treated in vitro and later transplanted into the tissue of
choice.
Gene transfer offers a multilateral approach for treating a condition or illness;
different strategies to deal with different genetic malfunctions can be implemented. For
example, neurotrophin or growth factor therapy offers neuroprotection for a wide scope
of neurodegenerative diseases. Gene augmentation therapy compensates for defective
gene products or nuli mutations. Ribozyme therapy introduces a catalytic RNA which
degrades mutated gene products. Pro-apoptotic therapy induces the celI’s entry down the
apoptotic pathway; of interest for anti-tumor therapies. Conversely, anti-apoptotic
therapies sway the celi fate in favour of survival (Hauswirth and Beaufrere, 2000). In
order for gene therapy to be considered a suitable option, certain prerequisites must be
met; most evidently, knowledge of the genetic causes of the disease. Nevertheless, it is
important to note that although it was first conceived as a therapeutic approach aimed at
revolutionizing modem medicine, gene transfer technology has thus far proven more
effective as an investigational tool.
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1.8.2 Properties ofGene Transfer Vectors
Gene therapy requires an efficient means of introducing a transgene of choice
into a target celi. Over the past fifieen years, advances in molecular biology and
associated fields have permitted the conception of proficient vehicles for gene delivery.
In order for a vector to be considered suitable for therapeutic use, it must exhibit certain
desired properties:
1) Firstly, it must efficiently transfer the gene of choice. The vector must infect a
sufficient population of target cefls and lead to expression of physiological levels of the
transgene. This must be achieved with the titers available and a restricted volume of
injection due to the sensitivity of the neural environment.
2) In order to reap the benefit(s) of gene transfer, it is important to selectively infect the
target cells. This may entail infection ofihe afflicted celis or neighboring celis when the
gene’s end-product is secreted. The site of administration, the vector and the promoter
used. ah play crucial roles for the specificity of infection.
3) Stable and persistent expression of the gene at adequate levels is required to treat a
condition. The level and duration of expression will dictate the necessity for and the
intervals of re-administration and ultimately the clinical feasibility of the therapy.
4) The vectors must provoke minimal toxic and immunogenic responses. Cytotoxicity
can manifest itself as pharmacological side-effects (Bennett et al., 1994; Jomary, 1994;
Li et al., 1994) or as an immune response against viral DNA or viral proteins, and may
resuit in the loss ofthe host cells (Yang, 1994).
5) The vector’s pathogenicity must be eliminated. At present, most of the viral vectors
employed in gene transfers are attenuated forms ofpathogenic human viruses.
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6) Another issue, especially for vectors with clinical potential. is the ease of
manufacturing. If the teclmology is to be taken from the bench to the clinic, copious
amounts of a vector will need to be produced.
Three main classes ofvectors have been explored; the physical. the non-viral and
the viral. Physical transfer methods consist of electroporation or micro-injection
techniques (needle free-injectors or Gene Gun). The rates of DNA introduction are
limited; however, this approach is promising for certain specific applications such as in
vitro or ex-vivo strategies. Non-viral protocols include introduction of naked DNA or
DNA complexed with cationic molecules such as liposomes (Wolff. 1998; Weir. 1999).
They are considered to be less efficient transducers with mostly transient expression
(Hangai et al., 1996). Their advantage lies in the possibility of introducing large DNA
inserts. In terms of rates of transfection. viral vectors such as adenovirus, adeno
associated virus and retroviruses have been the most efficient.
1.8.3 Viral Vectors for Retinal Gene Transfer
The major advantage of gene therapy for the retina is that, with a single
intraocular injection, sustained expression of a given gene can be achieved. This reduces
the need to repeatedly breach the blood-retinal barrier (BRB), thus reducing the damage
inflicted by eveiy injection. The vectors that are the most widely used in retinal gene
therapy are described below. for a detailed account on how to produce viral vectors.
please refer to Appendix B.
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1.8.3.1 Adenovirus (Ad)
Ad vectors are an efficient tool to study the effect of in vitro and in vivo gene
expression on neuroprotection. The major advantages of this system are that Ad can
efficiently infect post-mitotic ceils and that it can be easily grown to high titers. Ad
contains a linear double-stranded DNA genome of approximately 36 kilobases (kb)
encapsidated in an icosahedral protein sheli. Immediate early genes (El, E2, E3 and E4)
orchestrate viral gene transcription and suppression of the host immune response, while
late genes are necessary for viral assembly (Shenk. 1995). Most recombinant Ad belong
to the group C Ad type 2 or 5. Ad vectors were initially generated with deletions of the
early region I (AE1) that contains genes required for virus replication (Bett et al., 1994);
this renders vectors replication defective and more suitable for gene transfer into
mammalian celis. A major disadvantage ofthese early Ad vectors is the strong cytotoxic
and immune response elicited upon infection of the host ceils (Kovesdi et al., 1997).
Recent versions of Ad vectors have been produced in which the entire viral genome,
except for the terminal repeat regions required for viral assembly, lias been replaced by
exogenous gene sequences. These so-called “gutless” vectors exhibit considerably
reduced immune response (Morsy et al., 1998; Schiedner et al., 199$b), but can only be
produced in the presence of a helper virus that provides all the proteins required for viral
replication (Parks et al., 1996).
1.8.3.1.1 Ad Tropism in lie Retina
Although Ad vectors show efficient transduction in a wide variety of cell types in
vitro, the cellular tropism for viral infection in vivo appears to be more complex. Our
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studies using Ad vectors injected into the vitreous chamber of aduit rat eyes
demonstrated that Millier ceils. the predominant guai ceil in the retina, is the main target
for Ad infection in vivo (Di Polo et al., 199$). This approach has proven to be useful for
the delivery of genes encoding diffusible neurotrophins in order to promote
neuroprotection of axotomized retinal ganglion celis. Ad vectors have also been shown
to efficiently transduce the retinal pigment epithelium (RPE) following subretinal
injections (Bennett et al., 1994; Li et al., 1994). Together, these studies indicate that
non-neuronal cells in the adult retina are the preferred cellular targets for recombinant
Ad. Nevertheless, some experimental conditions support limited Ad transduction of
retinal neurons. for example, intraocular administration of Ad in animais at early
developmental stages may result in modest infection of photoreceptors (Bennet et al.,
1996). In addition. introduction of Ad to the brain (e.g. superior coliiculi) or to the
transected optic nerve stump results in retrograde transport of viral particles that mediate
gene expression in retinal ganglion cells (Cayouette and Gravel, 1996; Kugler et al.,
2000). Because ah these studies involved transgenes directed by the ubiquitous
cytomegalovirus (CMV) promoter, it is likely that the presence of cellular receptors for
Ad in non-neuronal retinal cehl types mediates the observed viral tropism in vivo. The
coxsackievirus and adenovirus receptor (CAR) protein involved in Ad attachment and
infection has been identified (Bergelson et al., 1997). In addition, integrins avB3 and
Œb135 participate in Ad internalization (Wickman et al., 1993). The specific cellular
localization of these receptors in the retina remains to be defined.
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1.8.3.2 Adeno-associated Virus (AA V)
AAV is a member of the pan’oviridae family initially identified as a contaminant
of Ad stocks. AAV requires a lielper virus (e.g. Ad or herpes simplex virus) for
replication. The wild-type virus houses a single stranded genome of 4680 base pairs (bp)
containing two genes, rep and cap. that encode proteins involved in replication and
encapsidation. respectively. The AAV genome is flanked by two identical 145-bp
inverted terminal repeats (ITRs) which are essential for packaging. replication or
integration. Recombinant AAV vectors derived from human parvovirus AAV-2 have
been produced by substituting ail viral sequences, except for the TIRs, for a transgene of
interest (McLaughlin et al., 1982; Samulski et al., 1989). However, packaging of
functional AAV particles requires the presence of the rep and cap proteins typically
provided in trans. The recombinant AAV system has several advantages for in vivo gene
transfer research: i) it is flot pathogenic and lias flot been implicated in the etiology of
any known human disease (Berns and Boliensky, 1987); ii) it mediates long-term
transgene expression that persists for several months in vivo (Dudus et al., 1999; Guy et
al., 1999b); iii) the absence of viral sequences resuits in minimal immune response or
cytotoxicity in the target tissues (Xiao et al., 1996, 1998); and iv) it can efficiently infect
post-mitotic celis in vivo (Podsakoff et al., 1994).
In tlie absence of helper virus, wild-type AAV can integrate at a specific site on
the q arm of chromosome 19 to establish latent infection (Kotin et al., 1990). However,
the lack of rep proteins lias been shown to compromise integration specificity leading to
random insertion of recombinant AAV (Flotte et al., 1994; Ponnazhagan et al., 1997).
Aithougli viral integration into the genome may contribute to the stability of AAV
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mediated transgene expression. a careful evaluation of the risks associated with
insertional mutagenesis is required before implementing AAV-based therapies. A
disadvantage of AAV vectors lias been the size constraint for packaging genes larger
than 4.7 kb. Although methods bave been developed to increase tlie size of delivered
transgenes by trans-spiicing of Pvo independent vectors co-administered to the same
tissue (Yan et al., 2000), this remains a limitation of tlie AAV system. The laborious
work needed to produce AAV vector stocks bas ofien been regarded as a disadvantage
of this vector system; however, the recent availability of reagents and improvements in
the protocols, described below. have greatly facilitated the preparation of high-titer and
pure AAV stocks.
1.8.3.2.1 AAV Tropism in lie Retina
AAV-mediated gene expression can be restricted to photoreceptor celis when
under the control of a well cbaracterized murine rhodopsin promoter sequence (Flannery
et aÏ., 1997). More recently, retinal ganglion cells have been identified as the primary
targets for AAV infection in the inner retina following intravitreal injection of viral
vectors (Cheng et al., 2002a) Thus, subretinal injection of AAV vectors resuits mainly in
gene transfer to photoreceptors and RPE celis, while intravitreal injection allows
infection of ceÏls in the ganglion celi layer. Unlike Ad, AAV appears to have a
preferential tropism for retinal neurons rather than glial cells. This is consistent with
studies in the brain showing AAV transduction of subsets of neurons rather than
astrocytes, oligodendrocytes or microglia (Kaplitt et al., 1994; Bartlett et al., 1998).
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Interestingly. genetic modification of capsid proteins has been shown to allow AAV
targeting ofcells normally resistant to infection (Girod et al., 1999).
1.8.3.3 Lentivirus (LV)
LV. a genus of retroviruses, consists of two identical single-stranded RNA
molecules and enzymes required for replication within a viral protein core. following
virus intemalization. the viral RNA is reverse transcribed into double-stranded DNA and
transported to the celi nucleus (Panganiban, 1990). Viral DNA is then permanently
integrated into the host genome to become a provirus. The retrovirus genome contains
gag, pol and env genes flanked by long-terminal repeats (LTRs). These genes encode
proteins essential for replication. encapsidation, intemalization and reverse transcription.
Replication-deficient recombinant retroviral vectors have been generated by substituting
ail viral genes for a transgene of interest with the exception of the cis-acting sequences
required for vector propagation, such as the reverse transcription initiation site and the
packaging site (Coffin, 1996). functional recombinant retrovirus particles can be
generated in culture when the gag. pol and env gene products are provided in trans.
Most retroviral vectors can only transfer genes into cells that are actively
proliferating (Roe et al., 1993). Thus, their use in neuroprotective strategies which
typically involve gene transfer into fully differentiated celis is rather limited. An
exception to this rule are LVs, such as the human immunodeficiency virus (HIV), which
can efficiently infect non-mitotic cells (Lewis and Emerman, 1994). This ability relies
on nuclear localization signals in the preintegration complex that allow entry into the
nucleus without the need for nuclear membrane fragmentation (Roe et al., 1993). Other
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advantages of the LV system are its relatively large cloning capacity. close to 10 kb, its
ability to mediate high levels of transgene expression in vivo and the lack of immune
response in the target tissues (Naldini et al.. 1996: Kafri et al., 1997). Recently,
recombinant LV was shown to efficiently infect hematopoietic stem ceils, extending its
potential use as a therapeutic vector (Miyoshi et al.. 1999).
The main concern with LV vector systems is the risk of generating replication
competent recombinant (RCR) virus during the production of viral stocks. Because HIV
is a human pathogen, considerable work lias been done to increase biosafety of LV
production systems. Other concems include low vector titers and the risks associated
with insertional mutagenesis as the vector integrates into the host genome. The issue of
transgene silencing stili requires further investigation. The lack of immune response
associated with LV recombinant infection and its ability to stably integrate into host
DNA are promising features for persistent gene expression. A systematic study of the
time-course of expression mediated by LV vectors in tlie retina should resolve this issue.
1.8.3.3.1 Cetlular Tropism ofLV Vectors
LV-mediated gene transfer and expression in the retina in vivo was first
characterized by subretinal injection of a vector carrying the green fluorescent protein
(GFP) gene (Miyoshi et al., 1997). Using tlie ubiquitous CMV promoter, the main
cellular targets of LV vectors were sliown to be photoreceptors and RPE ceils with some
bipolar and Mtiller ceils. When a rhodopsin-specific promoter was used, transgene
expression was restricted to the photoreceptor layer (Miyoshi et al., 1999; Takahashi et
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ai.. 1999). The infection pattern of LV vectors foliowing intravitreai injection remains to
be characterized.
An attractive feature of HIV-based vectors is their ability to efficiently infect
celis in vitro. For example. RPE primary cultures have been transduced with LV to
express GfP. Transgene expression persisted in the infected RPE celis foilowing their
transplantation into the subretinal space of a host (Lai et ai.. 1999). HIV-based vectors
have been shown to efficiently transduce human CD34 hematopoietic stem ceils that
were capable of long-term engrafiment in non-obese diabetic/severe combined
immunodeficient (NOD/SCID) mice (Miyoshi et al., 1999). Recentiy. fleurai stem ceils
have been isolated from the RPE in the ciliary margin of the aduit eye (Tropepe et al.,
2000). These celis can express retinai specific markers when they are differentiated in
vitro. Thus. ex vivo transduction of stem celis using HIV-based vectors foilowed by
retinal transplantation may be usefiul in the design of neuroprotective strategies.
1.9 GENE MODULATION FOR THE INJURED CNS, PART II: REMOVING A
GENE
In contrast to the gene supplementation approach described above, where a
given gene is added to obtain a beneficiai effect, certain gene products are detrimental to
the recovery of the lesioned CNS. For exampie, MAG promotes growth of immature
neurons (rat E1$ RGCs and DRGs younger then P4) but inhibits the growth of postnatal
RGCs and older DRGs (DeBellard et ai., 1996; Cai et al., 2001). In this regard, there are
strategies designed to counter these proteins in order to obtain a desired effect (e.g.
6$
neuronal survival or regeneration). In the following sections, J describe approaches that
are currently available to silence gene expression in vivo.
1.9.1 RNA Interference
RNA interference (RNAi). or RNA silencing. is a naturally occurring gene
silencing process first identified as a mechanism to light viral infections. It was initially
discovered in plants but is now known to occur in a wide scale of eukaryotes (Tijsterman
et al., 2002). RNAi is the cell’s endogenous response to double stranded (ds) RNAs.
Once the dsRNA enters the celi, it is converted by the enzyme Dicer into short
interfering (si) RNAs of —22 nucleotides in length. The siRNAs are subsequently
incorporated into a complex named RNA-induced silencing complex (RISC) which then
catalyzes the cleavage and degradation of mRNAs with sequence homology to the initial
dsRNA (fire et al., 199$). As an experimental tool and potential clinical strategy,
siRNAs are introduced into the cell by using mainstream transfection methods. In fact,
delivery of siRNAs by viral vectors such as AAVs is currently being developed and is
likely to yield a powerfifi tool for gene silencing in adult celis (Tomar et al., 2003).
With the completion of the sequencing of the human, rat and mouse genomes, a
wealth of gene targets is currently available. Entire siRNA libraries can be designed and
tested to identify the most effective inhibitors for a given gene. For example, a library of
14$ siRNAs was recently constructed and screened for genes that may influence Akt
phosphorylation (Hsieh et al., 2004).
Although a promising investigative and therapeutic tool, RNAi, as ail novel
approaches, has its current share of limitations. For example, it is complicated to design
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highiy specific RNAi triggers that have minimal homology with ail other sequences of
the genome. Consequently, non-specific gene silencing must be carefuliy screened for.
Also, introduction of foreign dsRNAs may trigger the host’s immune response. For
exampie. production of siRNAs using bacteriophage polymerases can readily stimulate
the ceiFs antiviral interferon pathways (Kim et ai., 2004). Moreover, as with ail
therapeutic approaches, effective strategies must be devised to ensure efficient
introduction of siRNAs into target celis.
Nevertheless, with a certain amount of fine tuning, RNAi based therapies are
likely to become a potent tool for the treatment of a vast scale of diseases from HIV to
amyotrophic lateral scierosis (ALS) (Jana et ai.. 2004). Already, the virtues of RNAi for
the treatment of retinai pathologies are starting to be seen, as it was successfully used to
reduce retinal neovascularization by reducing the expression of the VEGF gene (Reich
et al., 2003).
1.9.2 Antisense Oligonucleotides
Antisense oligonucleotides are single stranded DNA molecules that encode the
complementary sequence of a specific target mRNA. Once antisense oligos bind their
target mRNA, they inhibit its transcription and provoke its enzymatic degradation by
endogenous nucleases, ultimately blocking protein synthesis. In the retina, Bax-antisense
has been used to deiay RGC degeneration afier axotomy (Isenmann et al., 1 999a). A
disadvantage of this approach is that it yields, at best, rather limited transfection
efficacy. Other disadvantages include severe limitations in terms of relative instability in
situ, abiiity to cross the blood brain barrier or the blood retinal barrier and restricted
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ability to enter into ceils (Godfray and Estibeiro, 2003). For these reasons, this strategy
has seen only limited use in the retina.
1.9.3 Ribozymes
Ribozymes are catalytic RNAs which can be designed to cleave other RNAs in a
sequence-specific manrier. They can be packaged into viral vectors and delivered to a
target ceil population. They have been successfully used to reduce levels of pathological
mRNA species that encode deleterious proteins. such as mutant rhodopsin in diseases
such as retinitis pigmentosa (Hauswirth and Lewin, 2000; Shaw et al., 2001).
1.9.4 Small Mo]ecule Inhibitors
Small molecule inhibitors are the mainstay of the pharmacological industry.
Ihese molecules act by binding to a given protein (gene product) and thus rendering it
inactive. As with any exogenous molecule, their stability, cellular penetration and
general pharmacokinetics can be optimized in the lab and, as a result, they can become
highly effective inhibitors. The major limitation of this approach is the complexity of
designing and synthesizing these compounds. Because the proteins targeted by small
molecules may have radically different structures from one another, the synthesis of
each compound may require drastically different approaches. Consequently, there are
massive costs associated with the development of small molecules. Furthermore, the
specificity of these compounds may be limited by structural homology between the
target protein and other proteins, thereby causing undesirable side effects.
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1.9.5 Transgenic Knockout Animais
Although of limited therapeutic value, transgenic knockout (KO) animais offer
the most penetrant form of gene siiencing. They have become central to investigating
mammalian gene function. Because the gene is eliminated in ail cells. it mimics a
scenario where a given compound or gene silencing strategy attains perfect elimination
of its target gene.
Studies using KO mouse models have exposed numerous roles for genes that
were already thoroughly studied (Lee and Threadgill, 2004). for a non-essential gene.
viable homozygous KO animals can be generated. These animais provide usefui models
to assess the in vivo function of a gene or protein during development or post-natal life.
However, in conventional gene KO models, global gene deletions removes the
gene from alI celI in the organism. This may iead to developmental defects that may
later interfere with functionai studies. Therefore, it is ofien difficuit to exclude that the
observed phenotype in the aduit is flot a direct result of a deveiopmental defect. Also,
because ah celis are affected, it may be comphicated to attribute a given phenotype to a
particular ceil population in multi-cellular structures. Moreover, if the gene is vital for
embryonic development, the KO wiil be lethal and the knowledge gained on the gene’s
ftinction wiil be iimited to restricted periods of embryonic development. b counter this,
novel technologies have been developed that permit for the spatial and temporal KO of
candidate genes.
for example, one method to ensure tissue and ceil specific KO calis for the use
ofthe Cre/loxF system. The Cre recombinase is an integrase ofthe E. cou bacteriophage
PI. Whiie in its lytic state, the Pi bacteriophage bas linear double stranded DNA with
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two 34-bp Ïox P sites at the end of each strand. The principal function of the Cre
recombinase in the virus is to catalyze the site-specific recombination between the two
ÏoxP sites in order to circularize the DNA (Sauer and Henderson, 1988). b generate
transgenic mice, the ÏoxP sites can be inserted by homologous recombination into
embryonic stem celis such that they flank the desired gene (Jioxing the gene).
Subsequently, a homozygous mouse for the floxed gene is crossed with a mouse that has
the Ci-e transgene under the control of a celi or tissue specific promoter. Consequently.
in the homozygous progeny. the floxed gene will be eliminated by Cre/ÏoxP
recombination, specifically in the cells/tissue where the Cre gene associated promoter is
active(Branda and Dymecki. 2004).
The temporal restriction of gene expression is a valuable tool as it permits to
study the role of a given gene at a determined time point, while exciuding the possibility
that any abnormalities may be the result of developmental defects. These time-specific
inducible KOs can be achieved by introducing a gene that can be turned on or off with a
drug. First, the desired gene (e.g. a mutant construct) is introduced under the control of a
tet-O inducible promoter. Tet-O, originally found in bacteria, requires the transcriptional
regulator, tetracycline transactivator (tTA) to tum on transcription of its gene.
Therefore, another mouse une is generated with tTA placed under the control of a
tissue/cell specific promoter. In the homozygous progeny of these two unes, tTA binds
to the tet-O promoter and expression of the transgene (e.g. a mutant construct) occurs.
When the mouse is given the antibiotic doxycycline, the drug binds to tTA causing it to
fali of the promoter and transcription is stopped. Thus administering the drug tums the
gene off. Conversely, mice that express reverse tTA, (rtTA; a mutant form of tTA), can
_7 -,
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be generated. In this scenario, the mouse requires doxycycline for the rtTA
transactivator to activate transcription. Therefore. the transgene is only expressed when
the animal is given the drug.
Transgenic knockout animais are invaluable tools in elucidating the roles of
genes in mammais. With the application of new molecular technologies to the design of
transgenic animal models, new functions will be attributed to proteins and consequently
new therapeutic targets will arise.
1.10 OBJECTIVES 0F THE THESIS
In the past 100 years, since the days of Cajal, our vision of the CNS and its
propensity to survive and regenerate following injury has greatly evolved. With the
advent of modem biochemistry and molecular biology, we are now better able to
understand the causes and cellular mechanisms responsible for regenerative failure and
neuronal death within the lesioned CNS. This knowledge can be used to design novel
approaches geared at reversing the devastating consequences of CNS disease and injury.
In this thesis. we explore the hypothesis that genes involved in the orderiy
developrnent of the nervous system can be modulated in the aduit to achieve successful
survival and regeneration of mature lesioned CNS neurons. More specifically, we seek
to determine if either fGF-2 or RPTP-a, which are both abundantly expressed during
retinal development, participate in the regenerative process or the neuroprotection of
axotomized adult RGCs. Additionally, we investigate the signaling mechanisms
involved in these events.
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FIBROBLAST GROWTH FACTOR-2 GENE DELlVERY STIMULATES AXON
REGENERATION BY ADULT RETINAL GANGLION CELLS AFTER ACUTE
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2.1 ABSTRACT
Basic fibroblast growth factor (or FGF-2) has been shown to be a potent
stimulator of retinal ganglion celI (RGC) axonal growth during development. Here we
investigated if fGf-2 upregulation in adult RGCs promoted axon regeneration in vivo
alter acute optic nerve injury. Recombinant adeno-associated virus (AAV) was used to
deliver the fGF-2 gene to aduit RGCs providing a sustained source of this neurotrophic
factor. fGF-2 gene transfer led to an increase in the number and length of axons that
regenerated into the distal optic nerve. Detection of AAV-rnediated FGf-2 protein in
injured RGC axons correlated with growth distal to the lesion. The regenerative response
to fGF-2 upregulation was supported by our finding that FGF receptor-1 (FGFR-1) and
heparan sulfate (HS), known to be essential for FGf-2 signaling, were expressed by
adult rat RGCs. fGf-2 transgene expression led to only transient protection of injured
RGCs, thus the effect of this neurotrophic factor on axon extension could flot be solely
attributed to an increase in neuronal survival. Our data indicate that selective
upregulation of fGF-2 in adult RGCs stirnulates axon regrowth within the optic nerve,
an environment that is highly inhibitory for regeneration. These resuits support the
hypothesis that key factors involved in axon outgrowth during neural development may
prornote regeneration of adult injured neurons.
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2.2 INTRODUCTION
Adult retinal ganglion celis (RGCs), like other central nervous system (CNS)
neurons, fail to regenerate their axons after traumatic injury or disease. An appealing
hypothesis is that the molecular cues that direct axonal extension during development
may be used to stirnulate regeneration in the adult injured CNS. Diffusible neurotrophic
factors have a profound influence on neurite and axon growth during the maturation of
the nervous system (Barde, 1989; Davies, 2000; Huang and Reichardt, 2001; Sofroniew
et al., 2001). The fibroblast growth factor (FGF) family of neurotrophic factors play
multiple roles in the development of the brain (Eckenstein, 1994; Abe and Saito, 2001)
and the retina (Bamstable, 1991; Hicks, 1998). The biological activity of FGFs is
primarily rnediated through receptor tyrosine kinases (FGFRs), of which four distinct
families have been identified (FGfR-1-4) (Kiint and Claesson-Welsh, 1999a; Powers et
al., 2000). Members of the FGF and FGFR families are expressed in the developing and
adult retina of many species, including human (Gao and Hollyfield, 1992; Bugra et al.,
1993; Song and Slack, 1994; Kinkl et al., 2002).
FGf-2, a well-characterized member ofthe large FGF family, has been identified
as a potent stimulator of axon growth for developing RGCs (Dingwell et al., 2000). FGF
stimulates neurite outgrowth of ernbryonic and early post-natal RGCs in culture (Lipton
et al., 198$; Bahr et al., 1989; McFarlane et al., 1995). Importantly, in vivo expression of
a dominant negative FGFR in Xenopus RGC axons significantly impaired their ability to
grow along the developing optic tract (McFarlane et al., 1996). In the developing
mammalian retina, FGFR function has been shown to be required for the orderly
projection of RGC axons (Brittis et al., 1996). Astrocytes in the ganglion cell layer as
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well as ceils in the inrier and outer nuclear layers express endogenous FGF-2 (Gao and
Hollyfield, 1992; Kostyk et al., 1994; Ohsato et al., 1997). Interestingly, fGf-2 is
upregulated afler injury in cells of the inner nuclear layer and ganglion cell layer of the
adult retina (Wen et al., 1995; Cao et al., 1997; Wen et al., 199$), as well as in the optic
newe (Eckenstein et al., 1991b) and in the optic tract (Kostyk et al., 1994) suggesting
that this neurotrophic factor may be involved in neural repair.
FGFs have a high affinity for ceil surface heparan sulfate proteoglycans (HSPGs)
and require heparan sulfate (HS) to activate FGFRs in vitro and in vivo (Rapraeger et al.,
1991; Yayon et al., 1991; Omitz et al., 1992a; Lin et al., 1999). For example, in celis
that lack endogenous heparan sulfate, FGF fails to activate its high affinity receptor,
while fGf responsiveness is restored by addition of heparin or heparan sulfate (Yayon
et al., 1991). Previous studies showed expression of FGFR-1 and HSPGs in the rodent
inner retina including the ganglion ce!! layer (Blanquet and Jonet, 1996; Ozaki et al.,
2000; Inatani and Tanihara, 2002; Kinkl et al., 2002), but given that RGCs, displaced
amacrine cells and astrocytes populate this retinal layer, the specific cellular localization
of these proteins was flot established. Here we demonstrate that FGFR- 1 and HS are
expressed by aduit rat RGCs, a finding that supports the ability of these neurons to
respond to fGF-2.
A role for FGf-2 in the regeneration of adult injured RGCs in vivo has flot been
established. A previous study using intraocular administration of fGF-2 protein failed to
show RGC regeneration into a peripheral nerve grafi attached to the optic nen’e afler
intracranial axotomy (Cui et al., 1999). Lack of RGC axon regrowth in this study may
have been due to limited persistence of fGF-2 protein in the eye since FGFs have a short
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haif-life in vivo (Culajay et al., 2000; Unger et al., 2000). Here we used recombinant
adeno-associated virus (AAV) serotype 2 to evaluate the effect of sustained FGF-2
transgene expression on axon growth. We recently dernonstrated that AAV effectively
infects aduit RGCs upon injection of viral vectors into the vitreous chamber of the eye
(Cheng et al., 2002). AAV offers several advantages for in vivo gene delivery such as
minimal immune response in the host (Xiao et al., 1996; Xiao et al., 1997) and long-term
transgene expression that persists for over 1 year afier vector administration in the aduit
retina (Dudus et al., 1999; Guy et al., 1999a). The injury model used in our study was
micro-crush lesion of the optic nerve (Selles-Navarro et al., 2001), which bas clear
advantages over other procedures such as conventional optic nerve crush or peripheral
nerve grafis. Micro-crush lesion resuits in a well-defined lesion with a focal glial scar
and absence of optic nerve cavitation, facilitating accurate identification of the injury
site and quantification of axon growth. Because ail RGC axons are completely
transected afier micro-crusli lesion, there is no risk of confusing spared fibers, or axons
undergoing late secondary degeneration as in partially transected nerves, for
regenerating axons. Moreover, the proximal and distal portions of the optic nerve remain
aftached allowing us to test the effect of FGF-2 upregulation on axon regeneration
within the growth inhibitory optic nerve environment.
2.3 EXPERIMENTAL METHODS
2.3.1 Preparation ofRecombinant AAV Serotype 2 Vectors
A cDNA sequence encoding human fGf-2 was inserted downstream of the
cytomegalovirus immediate early promoter/enhancer in the plasrnid D10 (Wang et al.,
$0
1997). This plasrnid also contained a bovine growth hormone polyadenylation site and
AAV type 2 terminal repeat sequences. An AAV control vector carrying the green
fluorescent protein (GfP) gene, but lacking the fGF-2 gene, was generated in identical
fashion. Packaging of AAV particles was performed by triple transfection of low
passage human embryonic kidney 293 ceils. Celis were grown in a 10-layer celi factory
(Nalge Nunc, Naperville, IL) and cotransfected with the f0F-2 D10 vector, and helper
plasmids pKSrep/cap and pBHG1O. The virus was extracted by fteezing and thawing the
celis and the resulting suspension was then clarified by low speed centrifugation.
Packaged AAV was purified by heparin affinity chromatography and concentrated by
precipitation with polyethylene glycol. Viral titers were determined by DNA dot blot
analysis (Srivastava et al., 1990) and by infectious center assay (Clark et al., 1995a) and
were as follows: AAV.FGf-2 = 4 x 1012 infectious particies (i.p.)/ml; and AAV.GFP = 5
x 1012 i.p.Iml. The AAV stocks contained less than 1 wild-type genome per 1010
recombinant AÀV genornes. Bacterial endotoxin levels were assayed with Limulus
amebocyte lysate (Associates of Cape Cod, Inc., Woods Hole, MA) and were less than
70 U/ml.
2.3.2 Surgical Procedures
i,) Intravitreal injections
Ail surgical procedures were performed in aduit female Sprague-Dawley rats
(180-200 g) under general anesthesia (2% Isoflurane/oxygen mixture, 0.8 liters/min) and
in accordance with the guidelines for the use of experimental animals (Olfert et al.,
1993). Five tl of viral vectors, AAV.F0F-2 or AAV.GFP, or phosphate buffered saline
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(PBS) were injected into the vitreous chamber of the lefi eye using a 10-tl Harnilton
syringe with a 32-gauge needie. The contralateral, unoperated eyes or eyes from normal
unoperated animais served as controls. The sciera was exposed and the tip of the needie
was inserted at a 45° angle through the sciera and retina into the vitreous space.
Following slow withdrawal ofthe needle, the injection site was seaied with surgical glue
(Indermili, Tyco Health Care, Mansfield, IVIA). This rotite of administration avoided
injury to structures of the eye, such as the iris or lens, shown to promote RGC survival
and regeneration (Mansour-Robaey et al., 1994; Leon et ai., 2000).
ii) Axonal growth
The effect of AAV.FGF-2 on RGC axon growth in vivo was tested using the
experimentai protocol shown in Figure lA. We, and others, have observed that AAV
mediated transgene expression reaches a plateau between 3 and 4 weeks afier
administration ofthe vector into the rodent eye (Bennett et al., 1997; Ah et al., 1998b;
Bennet et al., 2000; Cheng et aï., 2002b) and persists thereafier (Guy et al., 1999a). This
delay in the onset of gene product expression in vivo may arise from the need to convert
single-stranded viral DNA to a double-stranded form prior to active transcription
(Ferrari et al., 1996). Because of the slow onset in transgene expression directed by
AAV, microcrush lesion of the optic nerve was performed 4 weeks after virus injection.
The optic nerve was exposed and a 10-0 suture was used to tie a knot to completely
constrict the nerve for 60 sec, afier which the suture was carefully released. Thirteen
days afier microcrush lesion, 5 il of 1% choiera toxin f3 subunit (CTf3, List Biologicai
Laboratories, Campbeil, CA) was injected into the vitreous chamber. Twenty-four hrs
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iater (2 weeks post-microcrush lesion), animais were sacrificed and the eyes were
processed for optic nerve immunostaining as described below. Groups included rats
injected with AAV.FGF-2 (n=4), controls injected with AAV.GFP (n=3) or saline (nr=4),
and non-injected animais with optic nerve lesion only (n=4).
iii,) Neuronal survival
RGC survival experiments were performed as foilows (fig. lB): 4 weeks afler
intraocular injection of viral vectors, the lefi optic nerve was transected at 1 mm from
the optic nerve head avoiding injury to the ophthaimic artery. One week prior to
axotomy, RGCs were labeled with 2% fluoroGoid (Fluorochrome, Englewood, CO) in
0.9% NaCI containing 10% dimethyi suifoxide (DMSO) by application of the tracer to
both superior colliculi. Retinas were examined histoiogically at 7 and 14 days afier optic
nerve transection to determine the density of surviving RGCs. Foilowing micro-crush
lesion or axotomy, the vasculature of the retina was aiways monitored by fundus
examination and animais showing signs of compromised blood supply were eliminated
from this study. Groups included: j) animais sacrificed at 1 week afier optic nerve lesion
that received AAV.FGF-2 (n=7), AAV.GFP (n=3) or no injection (axotomy oniy, n4,
or micro-crush lesion oniy, n4); and ii) animais sacrificed at 2 weeks afler injury that
received AAV.FGF-2 (n=2), AAV.GFP (n=4) or no injection (axotomy oniy, n=4, or
micro-crush lesion oniy, n=4)
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iv) Cellproltferation
The effect of FGF-2 gene delivery and optic nerve injury on retinal celi
proliferation was assessed foilowing the protocol illustrated in Figure 1 C. Briefly, 3
weeks afier intraocular injection of viral vectors, RGCs were iabeled and subsequently
axotomized. Rats received a daiiy intraperitoneal injection of BrdU (2.5 mg/100 g,
Sigma, Oakville, ON) for 1 week following transection of the optic nerve. Eyes were
then processed for immunocytochemistry as described below. Groups included animais
injected with AAV.FGF-2 (n=3) and controis injected with AAV.GFP (n=3).
2.3.3 Retinal immunocytochemistry
For co-localization studies, RGCs were retrogradely labeled with FluoroGold as
described above. One week later, animais (n=3-4/group) were perfused intracardially
with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB, pH 7.4) and the eyes
were immediately enucleated. The anterior part of the eye and the lens were removed
and the remaining eye cup was immersed in the same fixative for 2 hr at 4°C. Eye cups
were equilibrated in graded sucrose solutions (10-30% in PB) for severai hours at 4°C,
embedded in O.C.T. compound (Tissue-Tek, Miles Laboratories, Eikhart, iN) and frozen
in a 2-methylbutane/liquid nitrogen bath. Radial cryosections (16 jim) were coiiected
onto gelatin-coated siides and processed as foliows. Non-specific binding was blocked
by incubating sections for 1 hr in 3% bovine serum albumin (BSA, Sigma), 5% normal
goat serum (NGS) and 0.2% Triton X-100 (Sigma). Each primary antibody was added in
2% NGS, 0.2% Triton X-100 and incubated ovemight at 4°C. Sections were then
incubated with the appropriate secondary antibody, washed in PBS and mounted using
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an anti-fade reagent (SlowFade, Molecular Probes, Eugene, OR). Altematively, sections
were processed with a biotinylated secondary antibody foliowed by avidin-biotin
peroxidase reagent (ABC Elite Vector Labs, Burlingarne, CA) and incubation in a
solution containing 0.05% diaminobenzidine tetrahydrochioride (DAB) and 0.06%
hydrogen peroxide in PB (pH 7.4) for 5 min. Antibodies were: monoclonal anti-human
FGF-2 (Type I, clone bFM-1, 2 jig/ml, Upstate Biotechnology, Lake Placid, NY),
monoclonal anti-human FGF-2 (Type II, clone bFM-2, 10 tg/ml, Upstate
Biotechnology), polyclonal anti-FGFR-1 that recognizes an epitope in the carboxy
terminus of FGfR-1 (Fig C-15, 0.4 tg/ml, Santa Cruz Biotechnologies, Santa Cruz,
CA), polyclonal FGFR-1 against an epitope corresponding to arnino acids 22-97 within
the extracellular domain of FGFR-1 (Fig H-76, 2 tg/ml, Santa Cruz Biotechnologies),
monoclonal anti-heparan sulfate (HepSS- 1, 10 ig/ml, Seikagaku Corporation, Tokyo,
Japan), monoclonal anti-BrdU (6 tg/ml, Roche Diagnostics Canada, Lavai, QC), Alexa
594-conjugated goat anti-mouse IgG (14 .tg/mi, Molecuiar Probes), Cy3-conjugated
goat anti-rabbit (3 jig/ml, Jackson Irnrnunoresearch Laboratories, West Grove, PA) and
anti-mouse Fab fragment (Jackson Imrnunoresearch Labs). Fluorescence was visuaiized
with a Zeiss Axioskop 2 Plus microscope (Carl Zeiss Canada, Kirkiand, QC), images
were captured with a CCD camera (Retiga, Qimaging) and processed with Northem
Eciipse image analysis software (Empix Imaging, Mississauga, ON).
2.3.4 Optic nerve immunostaining and quantification of axonal growth
Animals were perfused intracardiaiiy with 4% PFA and the optic nerves
processed for irnrnunocytochemistry as described above. Longitudinal optic nerve
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cryosections (14 jim) were taken along the nasal-temporal plane and collected onto
gelatin-coated slides. Non-specific binding was blocked with 3% BSA, 5% normal
rabbit serum (Vector Laboratories, Burlingame CA) and 0.2% Triton X-100. Sections
were then incubated ovemight with goat CTf3 antibody (1:4,000 dilution, List Biological
Labs), followed by incubation with biotinylated rabbit anti-goat IgG (6 jtg/ml, Vector
Laboratories) and lastÏy, with DTAF-conjugated streptavidin (3.6 igIml, Jackson
Immunoresearch Labs). GAP-43 expression was detected using anti-rat GAP-43
antibody (1:4,000 dilution, kind gifi of Dr. L. Benowitz, Harvard Medical School)
followed by biotinylated anti-rat IgG (6 ig/ml, Vector Laboratories) and by streptavidin
coupled Alexa fluor 594 (2 jig/ml, Molecular Probes). Altematively, a monoclonal anti-
rat GAP-43 (2 tg/ml, Roche Diagnostics Canada) was used followed by incubation in
Alexa 594-conjugated anti-IgG (14 tg/ml, Molecular Probes).
The extent of axonal regeneration was evaluated by counting the number of CTI3-
positive axonal profiles that extended beyond the site of injury. Axons that crossed a
virtual line parallel to the lesion site at 50 im, 100 jim, 250 11m, 500 jim and 1 mm were
counted in three to four sections of optic nerve per animal. Sections were selected across
the entire width of the nerve to analyze axon growth in both central and peripheral
regions. The quantification of axons was carried out using two complementary methods:
i) axons were counted directly on each section using a 100X objective (Zeiss), and ii)
composite images of each nerve were generated at 60X magnification to verifi axon
counts with respect to the lesion site and for documentation. Both methods yielded
identical resuits. During quantification, the injury site was clearly identified in the same
optic nerve section by dark field rnicroscopy. In addition, the location of the lesion site
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was routinely confirmed in the same section or in an immediately adjacent section using
hematoxylinleosin staining. The thickness ofthe optic nerve was measured at each point
where axons were counted and this value was used to calculate the number of axons per
mm of nerve width. An estimate of the total number of axons (ra) extending over a
distance (d) was calculated by adding the number of axons in ail 14-tm thick (t) sections
of an entire nerve having a radius of r, according to the formula: = tr2 X [average
axons/mmJ/t (Leon et al., 2000a). The length of individual regenerating axons was
measured from the lesion site to the tip of the axon using Northem Eclipse image
analysis software (Empix Imaging Inc., Mississauga, ON). Data analysis was performed
using the GraphPad Instat program (GraphPad Software Inc., San Diego, CA) by a one
way analysis of variance (ANOVA) or an unpaired t test.
2.3.5 Quantification of Neuronal Survival
Rats were sacrificed by intracardial perfusion with 4% paraformaldehyde and
both the lefi (optic nerve lesion) and right (intact control) retinas were dissected, fixed
for an additional 30 min and flat-mounted vitreal side up on a glass slide. In addition,
backlabeled retinas from normal, unoperated animals were used as controls. The
ganglion cell layer was examined in whole-mounted retinas with fluorescence
microscopy and FluoroGold-labeled neurons were counted in 12 standard retinal areas as
described (Villegas-Perez et al., 1993). Data analysis and statistics were performed using
the GraphPad Instat program by a one-way ANOVA test.
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2.4 RESULTS
2.4.1 AAV-mediated FGF-2 protein is expressed by aduit RGCs
For gene transfer experiments, a recombinant AAV vector containing a human
FGF-2 cDNA was injected into the vitreous chamber of adult rat eyes (Fig. 1).
Endogenous and virally-mediated expression of FGf-2 protein was examined using
FGF-2 antibodies. Intact retinas or retinas infected with the control virus (Fig. 2A)
showed positive FGF-2 labeling in few celis in the ganglion celi layer, and widespread
staining of celis in the inner and outer nuclear layers. These resuits are consistent with
previous reports describing the endogenous localization of FGF-2 in the aduit retina
(Gao and Hollyfield, 1992; Kostyk et al., 1994b; Ohsato et al., 1997). Only astrocytes in
the ganglion cell layer, but flot aduit rat RGCs, have been shown to express endogenous
FGF-2 (Kostyk et al., 1994b). Four weeks aller single intravitreal injection of
AAV.FGF-2, we observed positive FGf-2 immunolabeling in RGCs (Fig. 2B), in
contrast to control retinas where FGF-2 staining was restricted to astrocytes. Consistent
with our previous study (Cheng et al., 2002b), -7O% of the total RGC population was
effectively infected with recombinant AAV. This is in agreement with a recent report
showing that intraocular injection of AAV.GFP led to transduction of 60-70% of aduit
RGCs (Harvey et al., 2002). Positive FGF-2 labeling was also observed in some RGC
dendritic processes (Fig. 2C) and processes in the nerve fiber layer (Fig. 2D). Identical
resuits were obtained with the two FGF-2 antibodies used in this study.
The ganglion ce!! layer of the aduit rat retina contains displaced amacrine ceils,
which account for j—40% of the total number of neurons in this layer (Perry, 1981), as
well as astrocytes. We sought to confirm that AAV directed FGF-2 protein expression in
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RGCs. For this purpose, we perforrned co-localization studies in retinas from eyes that
received an intravitreai injection of AAV.FGF-2 followed by retrograde labeling of
these neurons with FluoroGoid. Our resuits confirmed that RGCs produced AAV
mediated FGF-2 (Fig. 2E-G). We did not detect expression ofAAV.fGF-2 in other guai
celis, such as Millier cells, in any ofthe infected retinas, a finding in agreement with our
previous data showing that RGCs are the primary cellular target for AAV infection in
the inner retina (Cheng et al., 2002b).
2.4.2 RGCs express the high affinity fGf-2 receptor, fGFR-1, and heparan sulfate
To assess the capacity of RGCs to respond to FGF-2, we examined the
endogenous expression of FGFR- 1, a member of the FGF receptor family for which
FGF-2 shows high binding affinity (Omitz et al., 1996). Incubation of retinal sections
from normal, unoperated eyes with an antibody against the C-terminus of FGFR- 1 (Fig
C-15) dernonstrated positive immunostaining in the ganglion celi layer and the outer
nuclear layer, with faint labeling in the inner nuclear layer (Fig. 3A). An identical
labeling paftem was observed using a different antibody against an epitope in the
extracellular domain of FGFR- 1 (Fig H-76). Co-labeling experiments with anti-FGFR- 1
(Fig H-76) and FluoroGold confirmed FGFR-1 localization in RGC somata and
processes in the nerve fiber layer (Fig. 3B-D) as weil as in some displaced amacrine
celis. Our resuits are consistent with a previous study showing FGFR-1
imrnunoreactivity in RGCs in the ferret retina (Quan et al., 1999).
We also investigated the localization ofheparan sulfate (HS), typicaliy associated
with ceil surface H$PGs, in the aduit uninjured rat retina. Using an HS antibody, we
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observed robust positive immunolabeling in the ganglion celi layer (fig. 3E). Strong,
positive HS labeling couid be clearly visualized in many fleurons. In contrast, diffuse HS
staining was observed in the outer and inner nuclear layers suggesting the association of
HS with extraceilular matrix components. HS immunostaining of retinas labeied with
fluoroGold showed co-localization of HS on RGC bodies and in processes in the nerve
fiber layer (Fig. 3F-H). No staining was observed in control retinai sections in which the
prirnary antibodies were omitted (flot shown). These data indicate that key molecules
involved in fGf-2 binding and activity, FGFR-1 and HS, are expressed by aduit RGCs.
2.4.3 AAV.FGF-2 promotes regeneration of injured RGC axons
The effect of AAV.FGF-2 on axonal growth was tested after rnicro-crush lesion
of the adult rat optic nerve (Fig. lA). While ail RGC axons are cornpletely transected in
this injury paradigm, the lesion site rernains well-defined and the extent ofthe guai scar
is rninirnized (Lehrnann et ai., 1999; Seiles-Navarro et al., 2001a). Application of
fluoroGold to the superior coiiicuii afier the lesion resulted in absence of fluorescence
in the retina, confirming that the optic nerve was completely transected and vaiidating
our technique (Figs. 4A and 4B). The lesion site was accurately identffied during
quantification of RGC axons by visuaiization of the optic nerve in dark field (Fig. 4C).
In addition, we routineiy confirrned the iocaiization of the injury zone in the same
section or in an immediately adjacent section using hernatoxylinleosin staining (Fig.
4D).
Extensive growth of RGC axons, visualized with CTB, was observed in ail the
eyes treated with AAV.FGF-2 (Figs. 5 A-C). In contrast, AAV.GfP-treated eyes showed
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RGC axons that retracted from the lesion site and few crossed over the guai scar (Fig.
5D and 5E). Quantitative analysis ofaxon growth demonstrated that FGF-2 gene transfer
increased the number of regenerating axons at ail distances examined from the injury
site (fig. 6A), particularly between 50 im and 500 tm from the lesion. For example, the
number of growing axons per mm of optic nerve at 50 im, 250 jim and 500 j.tm was
76.8 ± 11 (mean ± SEM), 25.4 ± 12 and 7.3 + 1.6, respectively. In addition, we
estimated that the total number of axons per nerve that extended past 50 jim, 250 tm
and 500 tm were: 668 ±35, 254 ± 30, and 61.5 ± 7, respectively. There was a 8.5-fold
and 10-fold increase in the number of axons growing at 250 jim and 500 im ftom the
lesion, respectiveÏy, after AAV.FGF-2 injection compared to optic nerves from eyes
treated with AAV.GFP. While individual axons could be visualized using CTÏ3 staining
in optic nerve longitudinal sections, we cannot exciude the possibility that some fine
axon fascicles, rather than single axons, were counted. This quantification error may
resuit in an underestimation of the total number of growing axons in ail experimental
groups, but the overail fold-increase between AAV.FGF-2-treated and control groups
would remain unchanged.
b evaluate if fGF-2 gene transfer had an effect on the length of the growing
axons, we identified the longest axons in the experimental and controt groups and
measured their mean distance of growth from the lesion site. Our analysis showed that
the average length of the longest axons in AAV.FGF-2-treated eyes at 2 weeks post
axotomy was 909 + 55 im (mean ± S.E.M.), whereas in eyes treated with the control
virus it was 387 ± 20 jtm (Fig. 6B). The short distance regeneration in AAV.GFP- and
saline-treated eyes compared to injured control eyes that did flot receive any intraocular
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injection (Fig. 6A), couid be attributed to retinal injury during injection which has been
shown to increase FGF-2, FGFR-l and ciiiary neurotrophic factor (CNTF) mRNA leveis
in the retina (Wen et ai., 1995; Cao et ai., 1997; Cao et ai., 2001). Duriiig ail surgicai
procedures, we avoided injury to the lens and anterior structures of the eye shown to
promote RGC regeneration and survival (Mansour-Robaey et al., 1994; Leon et ai.,
2000a), but injury to the retina itself is unavoidable upon insertion of the tip of the
needie into the vitreous space. We observed a smail, but flot statisticaliy significant (p>
0.05), increase in axon growth between AAV.GfP- and saline-injected eyes (Fig. 6A).
Under these conditions, however, we aiways found enhanced axon growth hduced by
AAV.FGF-2 with respect to control eyes.
The growth-associated protein 43 (GAP-43) has been shown to be expressed in
RGCs during axonai growth (Doster et al., 1991; Schaden et al., 1994; Berry et ai.,
1996). We used two different GAP-43 antibodies to confirm that AAV.FGF-2 induced
axon growth afier micro-crush iesion of the optic nerve. Robust GAP-43 staining was
observed in axons growing past the injury site in eyes treated with AAV.fGF-2 (Fig.
6C). The pallem of GAP-43 immunostaining ciosely resembled that of CTI3 labeling
(Fig. 6D). Double-labeling experiments demonstrated that ail regenerating axons were
immunopositive for both C113 and GAP-43 (Fig. 6E). Identicai resuits were obtained
with two different GAP-43 antibodies used in this study. Taken together, our data
indicate that AAV-mediated gene transfer of FGF-2 increases the number and length of
RGC axons that grow past the lesion the site in the injured rat optic nerve.
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2.4.4 Selective upregulation of FGF-2 in RGCs, but flot in optic nerve glia, is
required for axonal growth
In intact, non-lesioned optic nerves, endogenous FGF-2 expression was detected
in guai ceil bodies organized in linear anays along the anterior-posterior axis of the
nerve (Fig. 7A). Following micro-crush lesion alone, in the absence of viral vector
injection, we detected an increase in the number of FGF-2 immunoreactive guai cells
(fig. 7B). In addition, the linear organization of FGF-2 positive glial ceils was disrupted
with accumulation of celis around the lesion site. Importantly, endogenous FGF-2 was
neyer detected in RGC axons in intact or injured, non-treated optic nerves. We then
exarnined the correlation between axonal growth and fGF-2 transgene expression. At 2
weeks afler rnicro-crush lesion, positive FGF-2 staining was ciearly visualized in ail
CTI3-labeied RGC axons growing into the distal optic nerve (Figs. 7C-E). Figs. 7F-H
iliustrate an individuai RGC axon between 200 tm and 350 jim from the lesion site, co
labeled with C113 and FGf-2 antibodies. In contrast, FGF-2 expression was neyer
detected in RGC axons of injured eyes injected with the control vector AAV.GFP (Fig.
71-K). As expected, both AAV.FGF-2-treated and AAV.GFP-treated injured optic
nerves showed endogenous positive FGF-2 immunoreactivity in guai celis. These resuits
indicate that although rnicro-crush lesion alters the pattem of endogenous FGf-2
expression in the optic nerve, endogenous FGf-2 expression is neyer detected in RGC
axons. More importantly, our data indicate that selective upregulation of FGF-2 in
RGCs, but flot in optic nerve glia, correlates with axon extension up to 1 mm from the
lesion site.
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2.4.5 FGf-2 gene delivery confers transient protection to axotomized RGCs.
To determine whether axonal growth produced by AAV.FGF-2 was due to an
increase in the number of surviving RGCs, we investigated the neuroprotective effect of
fGf-2 gene delivery afier optic nerve axotomy (Fig. lB). We first cornpared the time
course of RGC death induced by either axotomy or rnicro-crush lesion of the optic
nerve. Our quantitative analysis demonstrated that both injury modalities led to a similar
loss of RGCs within the first 2 weeks of injury (Fig. sA), thus allowing us to compare
AAV.FGF-2-mediated survival and regeneration. Flat-mounted retinas were examined at
7 and 14 days afier optic nerve transection to determine the density of surviving RGCs
identified by their FluoroGold label (Fig. $A and Table 1). Macrophages and microglia
that may have incorporated FluoroGold afier phagocytosis of dying RGCs were
excluded ftom our quantitative analysis based on their morphology and the presence of
microglia specific markers as described (Cheng et al., 2002). A single intraocular
injection of AAV.FGF-2 resulted in increased RGC survival at 1 week afier axotomy:
74% of RGCs remained alive compared to only 49% neuronal survival induced by
AAV.GFP. At 2 weeks after axotorny, however, treatment with AAV.FGF-2 protected
only 13% of ah RGCs, a survival rate that was not significantly different from that
produced by the control virus (Fig. SA).
FGf-2 is a potent mitogenic factor for retinal neurons during early development
and for neural progenitor cehhs in the retinal cihiary margin (Hicks, 1998; Ahmad et al.,
2000; Patel and McFarlane, 2000; Tropepe et al., 2000). To rule out that the increase in
RGC density observed with AAV.FGF-2 at 1 week post-axotomy was due to cell
prohiferation, we first evaluated the number of FluoroGold-labeled neurons afler
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AAV.FGF-2 or AAV.GFP injection in the normal, intact retina. Our analysis
demonstrated that the total number of RGCs aller infection with either AAV.FGF-2
(2,056 ± 107, n=4, mean ± S.E.M.) or AAV.GFP (2,169 ± 153, n=3) was not statistically
different (unpaired t test, P=0.62$) (Fig. sA). In addition, we evaluated retinal ceil
proliferation visualized by BrdU incorporation aller AAV.FGF-2 or AAV.GFP injection
and axotomy of the optic nerve (Fig. 1 C). The pattern of BrdU-positive ceits was similar
in both AAV.FGF-2- and AAV.GFP-treated eyes at 1 week aller nerve injury: while few
BrdU-labeled ceils were detected in the retinal fiber layer (Fig. $B), a larger number of
proliferating ceils was observed at the optic nerve beaU (Fig. 8C). Double labeling
experiments using a BrdU antibody in combination with FluoroGold dernonstrated that
the BrdU-positive celis were not RGCs (Figs. 8B and $C). The location of BrdU
positive celis suggests that they may be retinal astrocytes, known to proliferate aller
retinal injury (MacLaren, 1996). These data indicate that AAV.FGF-2 prornotes only
transient survival, but flot proliferation, ofaxotomized RGCs.
2.5 DISCUSSION
The idea has been put forward that factors that promote axon growth during
development may facilitate axon regeneration by aduit neurons in the injured CNS. In
the adult visual system, injured RGCs re-express markers typically found during
developrnent, such as cytoskeletal proteins (McKerracher et al., 1993; Dieterich et al.,
2002), growth associated proteins (Meiri et al., 19$6; Moya et al., 19$$; Doster et al.,
1991), neurotrophic factors (Eckenstein et al., 199 lb; Gao et al., 1997), adhesion and
guidance molecules (Petrausch et al., 2000; Ellezam et al., 2001; Knoll et al., 2001;
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Lang et al., 2001), metabolic substrates (Allen et al., 2001) and transcription factors
(Ziman et al., 2001), suggesting that these neurons revert to a developmental growth
mode when attempting to regenerate. In this study we tested the hypothesis that FGF-2,
a potent stimulator of RGC axon growth iii the developing visual system (McFarlane et
al., 1995; Brillis et al., 1996; McFarlane et al., 1996; Dingwell et al., 2000), promotes
regeneration of aduit rat RGCs.
Using a gene transfer approach, we demonstrate that selective upregulation of
FGF-2 in RGCs stimulated axonal extension distal to the lesion afier acute optic nerve
injury. Other neurotrophic factors, such as brain-derived neurotrophic factor (BDNF),
nerve growth factor (NGF), neurotrophin (NT)-3 or NT-4, failed to promote RGC axon
growth into a peripheral nerve grafi attached to the severed optic nerve (Cui et al.,
1999). Intraocular injection of CNTF was shown to stimulate some RGC regeneration
into a grafi (Cui et al., 1999), but failed to enhance RGC axon growth into the optic
nerve afier crush injury (Leon et al., 2000). Thus, our study provides the first evidence
that upregulation of a single trophic factor, FGF-2, can stimulate RGC axon extension
within the growth inhibitory environment of the aduit optic nerve perhaps by
recapitulating the expression of some developmental genes associated with axonal
growth. This idea is supported by our observation that GAP-43 was localized in ah
growing axons of AAV.fGF-2-treated eyes. GAP-43 is typically expressed by
developing RGCs during axon growth and synaptogenesis, but it is downregulated in
mature RGCs (Skene and Willard, 1981; Meiri et al., 1986). The level of GAP-43 is
transiently upregulated afier optic nerve injury (Doster et al., 1991; Fournier et al.,
1997), but remains expressed at high levels only during active regeneration ($kene and
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Willard, 1981; Benowitz and Lewis, 1983; Doster et al., 1991; $chaden et al., 1994;
Berry et al., 1996).
Importantly, we found that aIl regenerating axons also expressed virally
rnediated FGF-2 protein. Our data showed that endogenous FGF-2 was not present in
mature RGC bodies or axons but only in guai celis of the ganglion celi layer and optic
nerve. Although injury to the optic nerve increased the number of FGF-2-positive guai
celis, particularly around the injury site, endogenous expression of this neurotrophic
factor remained restricted to nerve glia. Optic nerve crush has been shown to increase
endogenous FGF-2 expression within the retina in the outer nuclear layer, but flot in
RGCs (Kostyk et al., 1994). Our data indicate that injury-induced upregulation of
endogenous FGF-2 was not sufficient to prornote axon growth. In contrast, selective
expression of FGF-2 in retinai ganglion neurons stimulated axonal extension distal to the
lesion. 0f interest, FGFR-1 rnRNA and protein are known to increase in photoreceptor
celis of the aduit retina afier focal mechanical injury (Ozaki et al., 2000; Cao et al.,
2001). We can not rule out the possibility that endogenous FGFR-1 upregulation
restricts RGC axon growth and survival by increasing the ability of neighboring celis to
bind FGF-2, thus reducing the amount of neurotrophic factor available to RGCs. Our
resuits suggest, however, that within the first two weeks of injury a sufficient quantity of
viraily-delivered FGF-2 is available to elicit RGC axon growth, perhaps overcorning the
potentiai effect of increased retinai FGFR- 1 as an FGF-2 sink.
FGF-2 lacks a classical signal sequence for secretion (Abraham et al., 1986), yet
this neurotrophic factor is secreted into the extracellular milieu presumably via a non
conventional secretory pathway (Powers et al., 2000). Although the mechanism of action
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of AAV-mediated FGF-2 is stiil undefmed, it is possible that infected RGCs secrete
F6F-2 into the extracellular space where it binds ceil surface FGFRs and HS, in an
autocrine manner, stimulating axon growth. The observation that AAV-mediated FGF-2
is found in growing axons suggests that this neurotrophic factor is anterogradely
transported, thus it is also possible that local FGF-2 release from axon tenriinals can
influence growth. Our observation that both FGFR-1 and HS, key molecules involved in
FGF-2 binding and signaling, are Iocalized in aduit rat RGC bodies and axons support
these possible rnechanisms of FGF-2 action. Other fGFRs have been shown to be
present in the rat hmer retina (Blanquet and Jonet, 1996; Kinkl et al., 2002) and although
unequivocal localization of these FGFRs on RGCs has yet to be established, we can flot
exciude their potential role in FGF-2-induced RGC regeneration. There is substantial
evidence supporting roles for FGFR signaling in RGC axon extension, guidance and
targeting during development (Mcfarlane et al., 1995; Brittis et al., 1996; McFarlane et
al., 1996; Lom et al., 1998). Similarly, HSs are important regulators of axon growth and
targeting in the developing visual system (Walz et al., 1997; Irie et al., 2002). For
example, heparitinase removal of native HSs during formation of the Xenoptts optic tract
retarded retinal axon elongation (Walz et al., 1997). Thus, it is likely that FGFR-1 and
H$ play a role during RGC axon regrowth in the aduit injured visual system.
Although f6F-2 gene delivery stimulated significant axon growth, this effect
was restricted to within 1 mm from the lesion site. Other strategies using angiotensin II
(Lucius et al., 1998), the Rho-A inhibitor C3 (Lebmann et al., 1999), antibodies against
myelin (Papadopoulos et al., 2002), or lens injuly (Leon et al., 2000) have also resulted
in short distance RGC axon regrowth. The limited ability of RGC axons to regenerate
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has been partly attributed to the growth inhibitory environnient ofthe optic nerve, rich in
proteins such as Nogo-A (Caroni and Schwab, 19$8a; Caroni and Schwab, 198$b),
myelin-associated glycoprotein (MAG) (McKerracher et al., 1994; Mukhopadhyay et al.,
1994) and oligodendrocyte-myelin glycoprotein (OMgp) (Kottis et al., 2002) that restrict
the extension of axons on myelin by interacting with the Nogo receptor (Foumier et al.,
2001a; Liu et al., 2002; Wang et al., 2002b). When the optic nerve was replaced for the
permissive environment of a peripheral nerve grafi, RGC axons regenerated long
distances and re-established functional synaptic connections with their targets (Vidai
Sanz et al., 1987; Keirstead et al., 1989). Nevertheless, only a small number of ail
RGCs, an average of 3% (Vidal-Sanz et al., 1987), were able to regenerate into the
favorable grafi environnient. We estimated that afier AAV.FGf-2 injection, 2% of
surviving RGCs were able to regrow an axon 250 jim past the lesion site within the
growth inhibitory environment of the optic nerve. The limited regenerative capacity
displayed by aduit RGCs is further illustrated by the observation that strategies that
promote long distance regeneration in the injured spinal cord produce only short
distance axon growth in the optic nerve. For example, a myelin-based vaccine stimulated
regeneration for distances up to 11 mm past the lesion site in the aduit mouse spinal cord
(Huang et al., 1999), while the same treatment produced a few hundred microns of
regenerative axon growth in the optic nerve (Ellezam et al., 2003). Several studies
indicate that a given treatment can lead to axon regeneration in spinal cord that is almost
an order of magnitude larger than that produced in optic nerve (Bartsch et al., 1995;
Lehmann et al., 1999; Dergham et al., 2002). It is apparent that other factors participate
in the control of the regenerative capacity of RGCs, including inhibitory components of
99
the guai scar and/or changes in the neuronal expression of key molecules involved iii
axon growth.
Regeneration in the optic nerve is also likely to be limited by the death of large
numbers of RGCs soon afier injury: >90% of these neurons are lost at 2 weeks afler
axotorny. Our data indicate that FGF-2 upregulation produced transient survival, but not
proliferation, of injured RGCs. The absence offGF-2-induced survival at 2 weeks afier
lesion could flot be attributed to loss of FGF-2 gene expression since here, and in
previous studies (Dudus et al., 1999; Guy et al., 1999; Cheng et al., 2002), sustained
AAV-rnediated transgene expression was observed for several months afler vector
administration. Strategies involving other neurotrophic factors have proved to be more
effective at promoting long-terrn survival of injured rat RGCs. For exampie, we
previously demonstrated that TrkB gene delivery, in combination with exogenous BDNF
supported the survival of 76% of RGCs at 2 weeks after axotomy (Cheng et al., 2002).
The present study indicates that in spite of low RGC survival, FGF-2 upregulation
enhanced RGC axon growth. The early increase in neuronal survival that we observed at
1 week afler injury may have translated into more RGCs being capable of responding to
FGF-2 with subsequent activation of their growth signaling pathways. Recent studies
clearly show that RGC survival alone is not sufficient to promote axon regeneration. for
example, upregulation of Bd-2 in RGCs was sufficient to keep neurons alive, but faiied
to prornote axon extension in culture (Goldberg et al., 2002), within the optic nerve
(Lodovichi et al., 2002) or into a peripheral nerve grafi (moue et al., 2002). These resuits
suggest that signais that induce ROC survival or axon growth utilize different
intraceilular pathways. Future studies are required to establish if axon regeneration can
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be enhanced when strategies that resuit in long-term RGC survival are combined with
FGF-2 upregulation.
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2.7 FIGURES
Figure 1. Experimental protocols used to test the effect of AAV.FGF-2 on RGC
axon growth, survival or proliferation.
(A) Micro-crush lesion (MC) ofthe optic nerve was perforrned 4 weeks afier intraocular
(10) injection of AAV.FGF-2, the time required for AAV-mediated transgene
expression to reach a plateau in the adult rat retina. Thirteen days afier injury, RGC
axons were anterogradely labeled by 10 injection of CTand 24 hrs later (2 weeks post
rnicrocrush lesion), animais were sacrificed and the optic nerves were processed for
analysis of axon growth. Control groups included animais that received a single
intravitreal injection of AAV.GFP, saline or no injection. (B) For neuronal survival
assays, RGCs were retrogradely Iabeied with FiuoroGold and subsequently axotomized
at 4 weeks afier 10 injection of AAV vectors. RGC survival was assessed by
quantification of fluorescent neurons in whole-mounted retinas at 1 week (Group A) or 2
weeks (Group B) after optic nerve lesion. Control groups inciuded animais that received
a singie injection of AAV.GFP or no injection. (C) For in vivo cell proliferation assays,
AAV.FGF-2 or AAVGFP (control) were injected intravitreally and, 4 weeks later, the
optic nerve was transected. RGCs were retrogradeiy labeled prior to axotomy. Foiiowing
optic nerve lesion, rats received daiiy intraperitoneal injections of BrdU for 1 week afier
which animais were sacrificed and their retinas were processed for BrdU
imrnunocytochemistry.
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figure 2. AAV mediates fGF-2 transgene expression in aduit RGCs.
(A) FGF-2 protein expression in retinal sections from eyes injected with control
AAV.GFP (n=3) was visualized by fluorescent rnicroscopy using fGf-2 antibodies.
FGF-2 immunostaining was detected in sorne astrocytes in the ganglion celi layer
(GCL), and ceils in the limer and outer nuclear layers (INL, ONL), but flot in RGCs. An
identical labeling pattem was found in normal, unoperated retinas (not shown). (B) Four
weeks after single intraocular injection of AAV.FGf-2 (n=4), FGF-2 labeling was
observed in 7O% of ail RGCs. (C-D) Expression of AAV-rnediated FGF-2 was also
visualized in dendrites (C) and processes in the nerve fiber layer (D) of some of the
virally transduced RGCs. In contrast, endogenous levels of FGF-2 in the 1NL and ONL
remained unchanged afier intraocular injection of AAV.FGF-2. (E-G) Expression of
AAV-mediated FGF-2 in RGCs was confirmed by double-labeling using FluoroGoÏd
(E), and a FGF-2 antibody (F). Superimposition of the images shown in (E) and (F)
demonstrated that RGCs expressed AAV-mediated FGF-2 (G). Identical resuits were
obtained using two different FGF-2 antibodies. ONL: Outer Nuclear Layer, OPL: Outer
Plexiform Layer, INL: Inner Nuclear Layer, IPL: Inner Plexiform Layer, GCL: Ganglion
Celi Layer. Scale bars: 100 im (A, B), 10 tm (C-D), 25 tm (E-G).
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Figure 3. FGFR-1 and heparan suiphate (HS) are expressed by aduit RGCs.
Expression of endogenous FGFR-1 and HS by RGCs was investigated by
immunohistochemistry in adult retinas from normal, unoperated eyes. (A) Incubation of
retinal sections (nz=3) with an antibody against the C-terminus of FGFR-1 (Fig C-15)
demonstrated strong positive immunostaining in the ganglion ceil layer (GCL) and outer
nuclear layer (ONL), with somewhat fainter !abeling in the inner nticlear layer (TNL).
(B-D) Expression of FGFR-1 protein in the GCL was confirmed using a different
antibody against an epitope within the extracellular domain of FGFR-1 (Fig H-76). Co
labeling experiments with FGFR-1 antibody and FiuoroGoid detected FGFR1 in RGC
ce!! bodies. (E) HS, typically associated with HSPGs, was examined using an HS
antibody (HepSS-1). Positive HS labeling (n=3) was found associated with neurons in
the GCL. In contrast, diffuse HS staining was obseiwed in the ONL and INL. (F-H) HS
immunostaining of retinas labeied with F!uoroGoid detected HS irnmunoreactivity in
RGC sornata and in axon bundies of the nerve fiber layer. IPL: Inner Plexiforrn Layer,
OPL: Outer Plexiform Layer, PS: Photoreceptor Segments, RPE: Retinal Pigment
Epitheiium. Scale bars: 100 jim (A, E), 25 jtm (B-D and F-H).
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figure 4. Micro-crusli lesion resuits in complete transection of the optic nerve and
a welI-defined injury site.
(A) Whole-mounted retina visualized after application of the tracer FluoroGold to the
superior colliculus that labeled the entire RGC population. (B) Micro-crush lesion of the
optic nerve preceded application of FluoroGold, thus absence of fluorescence in the
retina confirrned that the optic nerve was cornpletely transected. (C-D) Micro-crush
lesion typically resulted in a well-defined injury site in which the extent of the glial scar
was minirnized. The lesion site (white arrowheads) was accurately identified at 2 weeks
post-injury by visualization of the optic nerve section in dark field during RGC axon
quantification (C). The location of the injury site (black arrowheads) was routinely
confirrned in the same section or in an imrnediately adjacent section by staining with
hematoxylin!eosin (D). Scale bars: 200 iim (A, B), 150 tm (C, D).
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figure 5. FGF-2 gene transfer promotes RGC axon growth after micro-crush lesion
of the optic nerve.
(A) Optic nerve section irnrnunostained with a CTB antibody showed extensive RGC
axon growth following intravitreal injection of AAV.FGf-2. A large number of CTB
positive axons regenerated into the distal optic nerve past the lesion site (asterisks). (B)
The same section shown in (A) was visualized with dark field, which allowed the clear
identification of the injury site (asterisks). (C) Higher magnification image of an
AAV.FGf-2-treated optic nerve showing nurnerous RGC axons growing between 100
j.irn and 350 tm from the lesion site. (D) Intravitreal injection of the control vector
AAV.GFP resulted ii lack of RGC axon growth. Many axons retracted from the lesion
site (asterisks). (E) Sarne section shown in (D) visualized in dark field to locate the
injury site (asterisks). Scale bars: 100 tm (A, B), 25 im (C), 50 tm (D, E).
FIGURE 5.
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Q Figure 6. AAV.FGF-2-induced RGC axon regeneration within the injured optic
nerve: quantitative and immunocytochemical analysis of growing axons.
(A) Number of RGC axons (mean ± S.E.M.) regenerating afier a single intravitreai
injection of AAV.fGF-2 (black bars, n=4), AAV.GFP (hatched bars, n=3) or saline
(gray bars, n=4) at 2 weeks afier optic nerve injury. Lesion only controls are shown with
white bars (n4). RGC axon growth in the AAV.FGf-2-treated group was significantiy
larger (asterisk) than in the AAV.GFP control group (ANOVA, p < 0.05), saline-treated
group (p < 0.01) or lesion only group (p < 0.001). The difference in axon growth
between AAV.GFP and saline control groups at 50 jim and 100 tm from the lesion site
was not significant (p > 0.05). (B) The length of the longest regenerating axons in ail
optic nerve sections analyzed was rneasured and averaged. AAV.FGF-2 treatrnent ied to
a significant increase in the distance of growth (n=4) cornpared to AAV.GfP- treated
eyes (n3) (student t test, p < 0.001). (C-E) Fluorescent microscopy images of optic
nerve sections following AAV.FGF-2 administration showed that ail regenerating RGC
axons, identified by their CTI3-positive staining (D), also expressed the growth
associated protein GAP-43 (n=4) (C). (E) Superimposition of (C) and (D). Scale bars: 50
tm.
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Figure 7. Selective upregulation of FGF-2 in RGCs, but not in optic nerve glia, is
required for axonal regeneration.
(A) FGF-2 immunostaining of longitudinal sections of intact, non-injured aduit rat optic
nerve (n3). Linear arrays of optic nerve glia expressed endogenous FGF-2. (B) Soon
afier micro-crush (MC) lesion, in the absence of viral infection, increased numbers of
fGF-2 positive guai ceils were detected in optic nerves (n=3). This pattem of staining
persisted for at least 2 weeks after injury. Endogenous fGF-2 staining was neyer
detected in RGC axons. (C-E) Immunofluorescence of optic nerve sections (w=3)
following AAV.fGF-2 injection showed co-localization of fGF-2 and CTI3 staining in
ail axons distal to the lesion at 2 weeks aller injury. Axons shown are between 100 tm
and 250 j.tm from the lesion site. (f-H) Micrograph of a single RGC axon, between 200
.im and 350 im from the lesion site, shows clear CTB and fGf-2 co-labeling. (I-K)
Control eyes injected with AAV.GFP showed only endogenous fGF-2 expression in
optic nerve gila but not in RGC axons. Scale bars: 200 irn (A, B); 40 irn (C-E), 20 tm
(F-H), 50 .im (I-K).
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Figure 8. fGF-2 gene transfer promotes transient survival ofaxotomized RGCs.
(A) The density of RGCs in retinas from normai, unoperated animais (light gray bar,
n=8) was sirnilar to that found in retinas from eyes contralateral to axotomized eyes
(stippled bar, n1 5), indicating that optic nerve injury does flot alter the total number of
RGCs in the contralateral, unoperated retinas. The RGC density in normal retinas
remained unchanged afier injection of AAV.FGf-2 (solid bar, n=4) or AAV.GFP
(hatched bar, n=4), which indicates that FGF-2 expression or viral infection by itself do
flot change the total number of ganglion neurons in intact retinas. Quantitative analysis
of RGC survival following optic nerve axotomy showed that the neuroprotective effect
of AAV.FGF-2 (solid bars, n=7) was significantly higher than that of AAV.GFP
(hatched bars, n=3) or injury alone (white bars, n=3) at 1 week after axotomy (ANOVA,
p < 0.00 1), but was not significantly different from that found in control retinas at 2
weeks post-injury. The time-course of RGC death was identical following either
axotorny (white bars, n4) or micro-crush lesion (dark gray bars, n=4) of the optic
nerve. (B-C) To rule out that the increase in RGC density observed with FGF-2 gene
transfer at 1 week afier axotomy was due to celi proliferation, we examined BrdU
incorporation after AAV.FGF-2 injection (n=3) and axotomy of the optic nerve. While
few BrdU-labeled celis were detected in the retinal fiber layer (B), a larger number of
proliferating celis was observed at the optic nerve head (ONH) (C). Double labeling
experiments using a BrdU antibody in combination with fluoroGold demonstrated that
the BrdU-positive celis in the retina (B) and ONH (C) were not RGCs. Scale bars: 25
jim (B), 50 tm (C).
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Table 1. Survival ofAxotomized RGCs Following FGF-2 In Vivo Gene Transfer
RGCsImm2 ± S.E.M.
Treatment Time After Axotomy
Intact Retina
Viral Vector 1 week 2 weeks
2,056±107 1,695±154 293±24AAV.FGf-2
11=4 (74%),n=7 (13%),n=2
2,169±153 1,131±53 220±77AAV.GFP
n = 4 (49%), n = 3 (10%), n = 4
Contralateral:
2,291 ± 185
n = 15 1,062 ± 100 193±77None (46%), n = 5 (8.4%), n = 4Normal:
2,285 ± 162
n=8
* Numbers in parentheses represent % of intact, contralateral retinas (100%).
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3.1 ABSTRACT
The intracellular signaling mechanisms used by neurotrophic factors to promote
axon growth in the mature, injured CNS are flot well understood. We recently
demonstrated that basic fibroblast growth factor (or FGF-2) stimulates aduit retinal
ganglion ce!! (RGC) axon regeneration within the injured optic nerve. Here we
investigated the signa!ing cascades that control FGF-2-mediated RGC axon extension in
vivo. For this purpose, recombinant adeno-associated virus (AAV) was used to deliver
the FGF-2 gene to RGCs providing a sustained source ofthis neurotrophic factor. fGf-2
gene transfer led to a —10-fo1d increase in the number of axons that extended past the
lesion site compared to contro! nerves. Axon growth correlated with FGF-2-induced
activation of the extracellular signal-regulated kinases 1/2 (Erkl/2), but not other
signaling pathways including phosphoinositide 3-kinase, phospholipase 01’ or protein
kinase C. Pharmacological inhibition of Erkl/2 activation resulted in $0% decrease in
the number of axons that regenerated at 0.5 and 1.0 mm from the site of injury. Our data
demonstrate that the Erkl/2 pathway is a key signaling component in FGF-2-mediated
axon regeneration in the mature, injured visual system.
134
3.2 INTRODUCTION
The fibroblast growth factor (FGF) family of neurotrophic factors play critical
foies in the development of the central nervous system (CNS) (Bamstable, 1991;
Eckenstein, 1994; Hicks, 1998; Abe and Saito, 2001). FGf-2 is the best characterized
member of this large family, with well-documented roTes in neurogenesis, survival and
synaptic plasticity (Reuss and von Bohien und Halbach, 2003). In the visual system,
FGf-2 has been identified as a potent stimulator of axon growth for developing retinal
ganglion cells (RGCs) (Brittis et al., 1996; McFarlane et al., 1996; Dingwell et al.,
2000). Importantly, we recently demonstrated that FGF-2 gene transfer promotes
regrowth of aduit rat RGC axons in the irijured optic nerve in vivo (Sapieha et al., 2003).
The regenerative response to FGF-2 upregulation was supported by our fmding that FGF
receptor- 1 (FGFR- 1) and heparan sulfate, known to be essential for FGF-2 signaling, are
expressed by aduit RGCs (Sapieha et al., 2003).
Understanding the signal transduction events responsible for switching a CNS
neuron to an axonal growth mode is a fundamental question in neurobiology. Much of
our knowledge of the pathways that mediate fGf signaling is derived ftom biochemical
studies using fGfR-1 as the prototypical fGf receptor (FGFR). The signaling pathways
elicited by different FGFRs, however, are quite similar owing to the high degree of
homology between the various receptor types (Johnson and Wiliiams, 1993; Raffioni et
al., 1999). Ligand binding leads to fGFR dimerization, tyrosine autophosphorylation
(Ullrich and Schiessinger, 1990) and subsequent activation of FGFR substrate 2 (FRS2)
(Klint et al., 1995), which recruits growth factor receptor-bound protein 2 (Grb2), son of
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sevenless nucleotide exchange factor (SOS), and Src homology 2 phosphatase 2 (SHP2)
(Hadari et al., 199$). These initial events promote the stimulation of the extracellular
signal-regulated kinases 1/2 (Erkl/2) pathway (Schlessinger, 2004). In addition, FGFs
stimulate phosphoinositide 3-kinase (PI3K) and the protein Akt by an indirect
mechanism that involves phosphorylation of the docking protein Gabi (Lamothe et al.,
2004). fGfR-1 has also been shown to activate phospholipase Cy (PLCy) (Mohammadi
et al., 1991; Peters et al., 1992), which catalyzes the conversion of phosphatidylinositol
4,5 biphosphate (PIP2) to inositol 1,4,5 triphosphate (1P3) and diacylglycerol (DAG). 1P3
releases Ca2 from intemal stores acting in concert with DAG to transiocate protein
kinase C (PKC) to the ceil membrane and stimulate its activity (Schiessinger, 2004).
Here we used recombinant adeno-associated virus (AAV) serotype 2 carrying a
human fGF-2 gene to investigate the signaling pathways that promote RGC axon
growth. The injury model used in our study was micro-crush lesion of the optic nerve,
which has clear advantages over other procedures such as conventional optic nerve crush
or peripheral nerve grafis. Micro-crush lesion results in a well-defined injury site with a
focal guai scar and absence of optic nerve cavitation, facilitating accurate identification
of the injury site and quantification of axon growth ($apieha et al., 2003). We
demonstrate that in vivo FGF-2 upregulation leads to strong activation of retinal Erkl/2,
but not PI3K, PLCy or PKC. Furthermore, pharmacological inhibition of MEK, the
obiigate upstream activator of Erkl/2, markedly inhibited FGF-2 mediated RGC axon
growth. This study identifies Erkl/2 as a key intermediary in the signaling pathway
responsible for fGf-2-induced axon regeneration in the adult CNS.
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3.3 EXPERIMENTAL PROCEDURES
3.3.1 Preparation of Recombinant AAV Serotype 2 Vectors
The human FGF-2 cDNA (provided by K. Rendahi, Chiron Corporation,
Erneryville, CA) was inserted downstream of the hybrid cytomegalovirus (CMV)
enhancer/ chicken B-actin promoter in the plasmid pXX-UF12, a derivative ofpTR-UF5
(Zolotukhin et al., 1996), containing the AAV terminal repeat sequences and a sirnian
virus 40 polyadenyiation sequence. The helper piasrnid pDG (Grimm et al., 199$) that
contains both the AAV genes (rep and cap) and heiper genes required for AAV
propagation was used to generate recombinant AAV. Vectors were packaged,
concentrated and titered as previously described (Hauswirth et al., 2000). The number
of infectious particles/ml (ip/ml) was deterrnined by infectious center assay as described
(McLaughlin et al., 198$) and was: 1.4 x 1012 ip/ml for AAV.FGF-2 and 2.9 x 1011 ip/ml
for the control AAV containing green fluorescent protein, AAV.GFP. No heiper
adenovirus or wild-type AAV contamination was detected in these preparations.
3.3.2 Intravitreal injection of viral vectors
Ail surgical procedures were performed in adult female Sprague-Dawley rats
(180-200 g) under general anesthesia (2% Isoflurane/oxygen mixture, 0.8 liters/min) and
in accordance with the guidelines of the Canadian Council on Animal Care
(www.ccac.ca). Injections into the vitreous chamber were performed on the left eye
using a lO-jil Hamilton syringe adapted with a glass-pulled needle (—40 im extemal
diameter). The contralateral, unoperated eyes served as controls. The sciera was exposed
and the tip of the needle inserted at a 45° angle through the sciera and retina into the
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vitreous space. foliowing slow withdrawal of the needie, the injection site was sealed
with surgical glue (Indermiil, Tyco Heaith Care, Mansfieid, MA). This route of
administration avoided injury to structures of the eye, such as the iris or lens, shown to
promote RGC survival and regeneration (Mansour-Robaey et al., 1994; Leon et ai.,
2000). AAV-mediated transgene expression reaches a plateau between 3-4 weeks afier
intravitreal administration ofthe vector (Bennett et al., 1997; Ah et al., 199$; Beimet et
al., 2000; Cheng et al., 2002), thus subsequent surgical procedures were performed 3-4
weeks afier AAV administration.
3.3.3 Retrograde RGC labeling and retinal immunohistochemistry
For co-iocalization studies of AAV-mediated FGF-2 in the inner retina, RGCs
were retrogradeiy labeled 3 weeks afler intravitreai injection of viral vectors. For this
purpose, the fluorescent tracer FluoroGold (2%, Fluorochrorne, Englewood, CO) was
apphied to both superior colliculi. One week later, animais were perfused intracardiaiiy
with 4% paraformaldehyde (PFA) and the eyes and optic nerves were irnmediately
enucleated and the anterior structures and the lens rernoved. Eye cups and nerves were
incubated in 4% PFA for 2 ht at 4°C, foiiowed by immersion in a 20% sucrose solution
for 6 hrs at 4°C. Tissue was embedded in optimal cutting temperature (O.C.T.)
compound (Tissue-Tek, Mues Laboratories, Elkhart, iN, USA) and frozen in a 2-
rnethylbutane/liquid nitrogen bath. Radial retinal cryosections (16 .im) were coliected
onto gelatin-coated siides. Non-specific binding was biocked by incubating sections for
1 hr in 3% bovine serum albumin (BSA, Sigma, Oakville, Ontario), 5% normal goat
serum (NG$) and 0.2% Triton X-100 (Sigma). Hurnan FGF-2 monoclonal antibody (10
13$
jig/rnl, Upstate Biotechnology, Lake Placid, NY, USA) was added in 2% NGS, 0.2%
Triton X-100 and incubated ovemight at 4°C. Sections were then incubated with Alexa
594-conjugated goat anti-mouse (14 jig/rnl, Molecular Probes, Eugene, OR), washed in
PBS and mounted using an anti-fade reagent (SlowFade, Molecular Probes). Fluorescent
staining was examined using a Zeiss Axioskop 2 Plus microscope (Carl Zeiss Canada,
Kirkland, QC), pictures captured with a CCD video camera (Retiga, Qimaging,
Burnaby, British Columbia) and analysed with Northem Eclipse software (Empix
Imaging, Mississauga, ON).
3.3.4 Micro-crush lesion of the optic nerve and anterograde axon labeling
Axonal regrowth was investigated following optic nerve microcrush lesion. In
this paradigm, ail RGC axons are completely transected while leaving the proxirnal and
distai nerve segments aftached (Selles-Navarro et al., 2001; Sapieha et al., 2003).
Briefly, the lefi optic nerve was exposed and a 10-0 suture used to tie a knot to
completely constrict the nerve for 10 sec, afier which the suture was careftully released.
During this procedure, care was taken to avoid injury of the ophthalmic artery. The
vasculature of the retina was aiways monitored by fundus examination and animais
showing signs of compromised blood supply were eliminated from the study. Thirteen
days afier microcrush lesion, 5 pi of 1% choiera toxin f3 subunit (CTJ3, List Biological
Laboratories, Campbeii, CA) was administered by intravitreai injection. Eighteen hrs
afier CTJ3 injection, two weeks post-microcrush lesion, animais were sacrificed and the
eyes were processed for optic nerve immunostaining and axon quantification as
described below. Animais received a single injection of AAV.FGF-2 (n$), AAV.GFP
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(n=3) or control PB$ (n=4); or were lefi uninjected (n=4). At the time of lesion, a group
of rats treated with AAV.FGF-2 received a single injection of the IVIEK inhibitor
PD98059 (200 iM, Ceil Signaling, Beverly, MA; n=3) or vehicle control (n=5).
3.3.5 Optic nerve immunohistochemistry and quantification of axon growth
Longitudinal optic nerve cryosections (14 gm) were taken along the nasal-
temporal plane and collected onto gelatin-coated slides. Non-specific binding was
blocked with 3% BSA, 5% normal rabbit serum (Vector Laboratories, Burlingame CA)
and 0.2% Triton X-100. Sections were then incubated ovemight with goat CTE3 antibody
(1:4,000 dilution, List Biological Labs), followed by incubation with biotinylated rabbit
anti-goat IgG (6 jig/ml, Vector Laboratories) and lastly, with DTAF-conjugated
streptavidin (3.6 jig/ml, Jackson Imrnunoresearch Labs, West Grove, PA). For co
labeling experiments, sections were simultaneously incubated overnight with a
monoclonal anti-f3111 tubulin antibody (21 jig/ml, Sigma) and anti-CTI3 antibody
followed by incubation with secondary antibodies.
The extent of axonal growth was evaluated by counting the number of CTÏ3-
positive axons that extended beyond the site of injury. Axons that crossed a virtual line
parallel to the lesion site at 500 tm and 1 mm were counted in four sections of optic
nerve per animal. Sections were selected across the entire width of the nerve to analyze
axon growth in both central and peripheral regions. The quantification of axons was
carried out using two complementary methods: j) axons were counted directly on each
section using a 100X objective (Zeiss), and ii) composite images of each nerve were
generated at 60X magnification to verify axon counts with respect to the lesion site and
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for documentation. During quantification, the injury site was identified in the same optic
nerve section by dark field rnicroscopy. In addition, the location of the lesion site was
routinely confirmed in the same section or in an immediately adjacent section using
hematoxylinleosin staining. The thickness of the optic nerve was rneasured at each point
where axons were counted and this value was used to calculate the number of axons per
mm of nerve width. Data analysis and statistics were performed using GraphPad Instat
software (GraphPad Software Inc., San Diego, CA) by a one-way analysis of variance
(ANOVA) test.
3.3.6 Western Blot Analysis
freshly disected retinas were hornogenized with an electric pestie (Kontes,
Vineland, NI) in ice-cold lysis buffer (20 mM Tris, pH 8.0, 135 mM NaCI, 1% NP-40,
0.1% SDS and 10% glycerol supplemented with protease inhibitors). following a 15-
min incubation on ice, samples were centrifuged at 13,000 rpm for 5 min at 4°C and the
supematants containing solubilized protein extracts were collected. Retinal samples (50-
150 jig) were resolved on 10% SDS polyacrylamide gel electrophoresis and transferred
to nitrocellulose membranes (Bio-Rad Life Science, Mississauga, ON). Non-specific
binding was eliminated by incubating blots for 1 hr at room temperature in a solution of
3% bovine serum albumin in TBST (10 mM Tris, 150 mM NaC1, 0.2% Tween-20).
Blots were then incubated ovemight at 4°C with either of the following primary
antibodies: polyclonal phospho-Erkl/2 that specifically recognizes Erkl/2
phosphorylated on Thr202/1$5 and Tyr204/187 residues (0.2 tg/m1, BioSource,
International, Camarillo, CA), polyclonal pan Erkl/2 (2.3 jig/ml, BioSource
141
International), polyclonal phospho-Akt that recognizes Akt phosphorylated on Thr3O$
(0.6 tg/ml, Celi Signaling), polyclonal Akt (0.1 ig/ml, Celi Signaling), polyclonal
phospho-PKC-Œ that recognizes PKCa phosphorylated on Ser657 (1.3 rgJml, Upstate
Biotech, NY) polyclonal phospho-PLC-yÏ that recognizes PLC-yl phosphorylated on
1yr783 (1:750, CelI Signaling), or monoclonal -actin (0.5 tg/ml Sigma). Membranes
were subsequently washed in TBST and incubated with anti-mouse or anti-rabbit
peroxidase-linked secondary antibody (0.5 tg/ml, Amersham Pharmacia, Baie d’Urfé,
QC) in 5% non-fat milk in TBST for 1 hr at room temperature. Blots were treated with a
chemiluminescent reagent (ECL, Arnersham Pharmacia) and exposed to X-OMAT
(Kodak) imaging film. Densitornetric analysis was performed using BioDoc Analyze 1.0
software (Biornetra, Giittingen, Germany) on scanned autoradiographic films obtained
from a series of 3 independent western blots each carried out using retinal samples from
distinct experimental groups: i) AAV.fGF-2 (n=5), ii) AAV.GFP (n=5) and iii) intact,
non-injected (n=5). The densitornetric values obtained for the phosphorylated (active)
proteins were normalized with respect to their loading controls (non-phosphorylated
proteins) in the same blot to obtain the final phosphorylated/total protein ratios. Data
analysis and statistics were performed using GraphPad Instat software (GraphPad
Software Inc.) by a Student’s t-test.
3.4 RESULTS
3.4.1 AAV serotype 2 directs FGf-2 transgene expression in aduit RGCs
We prepared recombinant AAV serotype 2 containing a hurnan FGF-2 cDNA
under the control of the hybrid CMV immediate early enhancer/chicken beta actin
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(Cf3A) promoter (AAV.fGF-2). This enhancer/promoter combination has been shown to
direct more efficient transgene expression than with CMV alone (Acland et al., 2001).
AAV.fGF-2 virus was injected into the vitreous chamber and retinas were examined at
four weeks following vector administration, the time required for transgene expression
to reach a plateau in the rodent retina (Bennett et al., 2000; Cheng et al., 2002). Adult
RGCs do flot express endogenous FGF-2 (Kostyk et al., 1994), thus AAV-mediated
expression of this neurotrophic factor in the inner retina was examined by
imnrnnohistochemistry using an antibody against FGF-2. four weeks after a single
intravitreal injection of AAV.FGF-2, we observed positive FGF-2 iminunolabeling in
most cells ofthe ganglion cell layer (GCL) (fig. lA), whereas control eyes that received
an injection ofAAV.GFP lacked FGF-2 positive immunoreactivity (fig. lB).
We, and others, have shown that >70% of RGCs can be effectively infected
when recombinant AAVs are adrninistered into the vitreous chamber (Cheng et al.,
2002; Harvey et al., 2002; Martin et al., 2002; Fischer et al., 2004). b confirm that
AAV.FGF-2 mediated fGF-2 expression in RGCs, we performed co-localization studies
in retinas from eyes that received a single intravitreal injection of the viral vector
followed by retrograde labeling of RGCs using fluoroGold applied to the superior
colliculus. Double-labeling experiments demonstrated that the vast majority of RGCs,
visualized with fluoroGold (Fig. 1 C), produced virally-mediated FGF-2 protein (Figs.
lE). This finding is in agreement with our previous data showing that RGCs are the
primaly cellular target for AAV infection in the inner retina (Cheng et aÏ., 2002; Sapieha
et al., 2003; Pemet et al., 2005). No signs of inflammation, cytotoxicity, abnormal
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growth or immune reaction were detected in any of the eyes following administration of
AAVs.
3.4.2 FGF-2 gene transfer promotes regrowth of RGC axons after acute optic nerve
injury
The effect of AAV.FGf-2 on RGC axon growth in vivo was tested using the
experimental protocol outlined in Figure 2. We, and others, have observed that AAV
mediated transgene expression reaches a plateau between 3 and 4 weeks after
administration of the vector into the rodent eye (Benneft et al., 1997; Ah et ai., 199$;
Bennet et al., 2000; Cheng et al., 2002) and persists thereafier (Guy et al., 1999). This
delay in the onset of gene product expression in vivo may arise from the need to convert
single-stranded viral DNA to a double-stranded form prior to active transcription
(Ferrari et ai., 1996). Because of the slow onset in transgene expression directed by
AAV, microcrush lesion ofthe optic neiwe was perforrned 4 weeks afler virus injection
(Fig. 2). The anterograde tracer choiera toxin beta-subunit (CTB), which lias been shown
to be highly sensitive for reveahing fme axonal morphology in the visual system
(Mikkelsen, 1992; Angelucci et al., 1996; Matteau et al., 2003), was used to examine
regenerating axons at 2 weeks post-injury.
Fohlowing a single injection of AAV.FGF-2, growing axons, visuahized with
CTr3, were observed up to several millimeters past the guai scar (Fig. 3A, B). Figure 3A
shows a representative example of axonal growth up to 2.5 mm from the site of injury.
In contrast, eyes treated with a control virus containing the reporter gene GFP showed
absence of RGC axons that successfuiiy crossed over the ghial scar (Fig. 3C, D). AAV
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predorninantly targets aduit RGCs (Cheng et al., 2002; Martin et al., 2003; Fischer et al.,
2004), thus no other neurons or guai celis are likely to contribute significantly to this
regenerative response. Growing RGC axons were immunopositive for f3111 tubulin (Fig.
3E), an isoform that is selectively expressed by RGCs (Cui et al., 2003; Yin et al., 2003)
and upregulated during regeneration (Fournier and McKerracher, 1997). Co-iocalization
of f3111 tubulin with the anterograde tracer CTf3 (Fig. 3F) confirrned that these axons
were from regenerating RGCs (Fig. 3G). Moreover, growth cone-like structures were
present at the tips of the axons further suggesting that these neurons were in an active
growth state (f ig 3E-G, arrows).
3.4.3 AAV.FGF-2 stimulates retinal Erkl/2 activation
To elucidate the pathway(s) involved in AAV.FGF-2-mediated axonal
outgrowth, we investigated the activation of known FGF-2 signaling effectors. For this
purpose, we performed Western blot analyses of whole-retina homogenates using
antibodies that specificaily recognize the phosphorylated (active) forms of Erkl/2, Akt,
PLCy 1 or PKCa. Retinal samples were obtained from three independent experirnental
conditions: j) eyes that received a single, intravitreal AAV.FGF-2 injection (n=5); ii)
eyes that received a single, control AAV.GFP injection (n5); or iii) intact, unoperated
control eyes (n5). Retinal tissue was rapidly dissected out; ail samples were processed
identically and analyzed in triplicate. Because mostly RGCs are infected by AAV
(Cheng et al., 2002; Martin et al., 2003; Fischer et al., 2004), changes in protein
phosphorylation reflect changes that occur in these neurons.
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Treatment with AAV.FGF-2 induced a marked increase in phosphorylated
Erkl/2, detectable at 4 weeks after vector administration, compared with control retinas
that displayed low, basal levels of phospho-Erkl/2 (Fig. 4A). Densitometric analysis
confirmed that a single AAV.FGF-2 injection led to a 2-fold increase in phospho-Erkl
(Student’s t-test, p < 0.05) and a 2.3-fold increase in phospho-Erk2 (Student’s t-test, p <
0.05) with respect to control retinas (Fig. 4B). In contrast, we did flot detect AAV.FGF
2-induced phosphorylation of Akt, PKCŒ or PLC-yl (Figs. 4C-G). Quantitative analysis
of densitometric signals confirmed that there were no significant differences in the levels
ofphospho-Akt (Fig. 4D, Student’s t-test,p = 0.3) or phospho-PKCŒ (Fig. 4E, Student’s
t-test, p = 0.3) between AAV.FGF-2-treated and control retinas. We were flot able to
detect phospho-PLCyÏ in any of the retinal samples (fig. 4G). A protein sample from
human carcinoma (A43 1) celis stimulated with epidermal growth factor (EGF) was used
as positive control for PLCyY activation (Fig. 4G). Taken together, these data indicate
that AAV-rnediated FGF-2 leads to selective activation ofErkl/2 in adult RGCs in vivo.
3.4.4 Erkl/2 mediate RGC axon growth induced by FGF-2
To determine whether Erkl/2 signaling was involved in FGF-2-mediated growth
of transected RGC axons, we used the pharmacological inhibitor PD9$059 that has been
shown to selectively inhibit MEK1 (Dudley et al., 1995), the obligate upstream activator
of Erkl/2. Eyes were injected with AAV.FGf-2 and, 4 weeks later, received a single
intraocular injection of PD9$059 or vehicle control at the time of micro-crush lesion of
the optic nerve. First, the extent of Erkl/2 inhibition was investigated by Western blot
analysis ofwhole retinal hornogenates collected at 4$ hrs or 14 days following PD9$059
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treatment. We previously established that a single intravitreal injection of 200 jiM
PD9$059 (final intravitreal concentration: 17 iM) effectively inhibited retinal Erkl/2
activation in vivo (Cheng et al., 2002), therefore this concentration was also used here.
Our results show that a single intravitreal injection of PD9$059 markedly blocked FGF
2-induced Erkl/2 phosphorylation at 4$ hrs after administration of the inhibitor (Fig.
5A). As expected, the levels of phospho-Erkl/2 increased again at 14 days afler
administration of PD9$059. The transient inhibitory effect of PD9$059 is consistent
with the short half-life of this drug that resuits in only temporary inhibition of Erkl/2
activation promoted by sustained FGF-2 upregulation. To verify the specificity of
PD9$059, we examined the phosphorylation levels of Akt following administration of
this inhibitor. We found that the levels ofphospho-Akt (Fig. 5B) were flot altered in the
presence of PD98059. These results confirmed the specificity of the inhibitory effect of
this compound in vivo. Examination of histological sections and whole-mount
preparations ofthe treated retinas did not show any inherent cytotoxic effect ofPD98O59
(flot shown).
To investigate if Erkl/2 activation was responsible for FGF-2 induced RGC axon
growth, we performed in vivo axon growth assays in the presence of PD9$059 injected
at the time of optic nerve lesion (Fig. 6). Administration of PD9$059 (200 jiM) resulted
in striking inhibition of the regenerative effect produced by FGF-2 gene transfer.
Quantitative analysis revealed that a single injection of PD9$059 caused a
reduction in the number of axons growing at 500 jim (ANOVA,p < 0.00 1) and 1 mm
(ANOVA,p < 0.0001) from the lesion site. These data indicate that Erkl/2 are key
signaling components that regulate AAV.FGF-2-mediated RGC axon growth.
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3.5 DISCUSSION
Much research has focused on the guai inhibitory proteins that block
regeneration in the CNS (He and Koprivica, 2004; McKerracher and David, 2004;
Schwab, 2004), however, considerably less attention has been paid to identifying
intracellular signaling pathways that promote axon regeneration. Although some data is
beginning to emerge from in vitro studies (Goldberg, 2003), virtually nothirig is known
about the intracellular events that direct axonal growth in vivo. A study using early post
natal RGC cultures convincingly demonstrated that these neurons do flot extend axons
by default unless signaled to do so by growth factors (Goldberg et al., 2002b). This
finding necessarily implicates components of the neurotrophic factor-signaling cascade
in the ability of RGCs to regenerate axons. We recently demonstrated that gene transfer
of FGf-2, a potent stimulator of axon outgrowth for developing RGCs (Mcfarlane et al.,
1995; Brittis et al., 1996; McFarlane et al., 1996; Dingwell et al., 2000), promotes robust
growth of aduit RGC axons within the lesioned optic nerve (Sapieha et al., 2003). In the
present study, we identified the Erkl/2 signaling cascade as an essential molecular
component ofFGf-2-mediated RGC axon growth in vivo.
Genetic studies in mice, ftogs, flues and nematodes, along with studies in vitro
have demonstrated that receptor-mediated induction of the Erkl/2 pathway is a central,
evolutionarily conserved mechanism used by FGFs to elicit a broad spectrum of
biological activities including ceil growth, differentiation, and morphogenesis (Tang et
al., 1995; Umbhauer et al., 1995; Sundaram et al., 1996; Saxton et al., 1997; $zebenyi et
al., 2001). 0f interest, in vitro studies have shown that Erkl/2 activation mediates
neurite outgrowth in PC12 celis (Pang et al., 1995), retinal neurons (Perron and Bixby,
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1999; Bonnet et al., 2004), sympathetic neurons (Atwal et al., 2000) and dorsal root
ganglion neurons (Sjogreen et al., 2000; Wiklund et al., 2002). Our data is consistent
with these reports and provides the first in vivo evidence for the involvement of Erk 1/2
in neurotrophic factor-induced regeneration of aduit, injured RGCs. We show that even
transient inhibition of Erkl/2 activation using PD9$0590 was sufficient to markedly
block regenerative growth iriduced by FGF-2. This suggests that Erk 1/2 activation is
essential soon afier injury to successfully stimulate axon regeneration. It is well
documented that injured CNS neurons undergo short-distance abortive sprouting shortly
afier injury (Ramon y Cajal, 192$; Schwab, 2002). It is likely that RGCs in this early
growth-mode are stimulated to regenerate axons by increased levels of active Erkl/2.
Our finding that administration of PD9$059 led to substantial ($0%) but
incomplete blockade of axon growth may be a consequence of its transient inhibitory
effect on Erkl/2 activation. In addition, other, yet undefined, signaling molecules may
participate in the RGC response to FGF-2. In support of the model that Erkl/2 does flot
act alone to prornote RGC regeneration, recent data from our laboratory demonstrated
that gene transfer of a constitutively active forrn of the obligate Erkl/2 activator, MEK1,
by itself was not sufficient to promote axon outgrowth (Pemet et al., 2005). It is likely
that FGf-2, signaling through its receptor, activates other intracellular cues that switch
RGCs to an axon growth mode. Perhaps the clearest example of a rapid change in the
ability of RGCs to extend axons is the drarnatic switch that occurs at birth. RGCs
cultured one day before birth can extend their axons up to 1 0-times faster than RGCs
cultured one day after birth (Goldberg et al., 2002). The molecular mechanisms leading
to this change of growth ability remain largely unknown. 0f interest, it has been recently
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demonstrated that exposure to neurotrophins primes cerebellar neurons for growth on
inhibitory myelin substrates by elevating internai cAMP (Cai et al., 1999). Moreover,
endogenous cAMP levels drop sharply after birth, which coincides temporaiiy with loss
of regenerative growth (Cai et al., 2001). These experiments demonstrate that
neurotrophic factors can stimulation the intrinsic growth state of CNS neurons. Thus, we
propose a model in which fGF-2 activates an intrinsic growth program in aduit RGCs in
which Erkl/2 act as key regulators of axon regeneration by modulation of downstream
effectors.
The downstream targets of Erkl/2 involved in axon outgrowth are currently
unknown. Molecules that stimulate fGfR-dependent axon growth such as laminin and
N-cadherin (Doherty and Walsh, 1996; Lom et al., 199$) have been shown to cause the
redistribution of active Erk 1/2 to the plasma membrane in ernbiyonic retinal neurons
(Perron and Bixby, 1999). This suggests that non-nuclear targets, such as cytoskeletal
proteins, are candidate substrates used by Erkl/2 to promote growth. for example,
microtubule-associated proteins, which influence the stabiiity of the microtubule
network and are invoived in axon outgrowth, are known to be phosphorylated by Erkl/2
(Roder H. M. et al., 1993; Garcia Rocha and Avila, 1995). furthermore, Erkl/2
phosphorylate neurofilament proteins and inhibition of this phosphoiylation leads to a
reduction of neurite length in hippocampal cultures (Veeranna et al., 199$). It is also
likely that successful axon regrowth depends on the ability of Erkl/2 to modulate gene
expression by activating transcription factors and consequent protein synthesis
(Sonenberg and Gingras, 1998; Grewal et al., 1999). A recent study dernonstrated that
the cAMP-response element binding (CREB) protein, a downstream target of Erkl/2,
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contributes to CNS axon regeneration by overcorning myelin inhibition (Gao et al.,
2004). Future studies will elucidate the downstream molecular rnechanisms by which
Erk 1/2 regulates RGC axon regrowth in the mature, inj ured visual system.
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3.7 FIGURES
Figure 1. AAV serotype 2 directs FGF-2 transgene expression in aduit RGCs.
fGF-2 protein expression was examined in retinal sections at 4 weeks aller intraocular
injection of AAV.FGF-2 (A) or control AAV.GFP (B). Aduit RGCs do flot express
endogenous FGF-2, thus AAV-mediated fGF-2 was visualized by fluorescent
rnicroscopy following immunostaining with an FGf-2 antibody. Expression of AAV
rnediated FGf-2 in RGCs was confirmed using the retrograde tracer FluoroGold (C).
Superimposition ofthe images shown in (A) and (C) demonstrated that RGCs expressed
AAV-mediated FGF-2 (E). Scale bars: 50 jim (A-E).
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Figure 2. Experimental protocol used to investigate the effect of AAV.FGF-2 on
RGC axon growth.
Micro-crush lesion (MC) of the optic nerve was performed 4 weeks afier intraocular
(10) injection of AAV.fGf-2, the tirne required for AAV-rnediated transgene
expression to reach a plateau in the aduit rat retina. Thirteen days afier nerve injury,
RGC axons were anterogradely Iabeled by 10 injection of CTf3 and, 24 hrs later (2
weeks post-rnicrocrush lesion), animais were sacrificed and the optic nerves were
processed for analysis of axon growth.
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Figure 3. FGF-2 gene transfer promotes regrowth of RGC axons after acute optic
nerve injury.
A) Representative optic nerve section irnmunostained with an antibody against the
anterograde tracer choiera toxin B (CTB) shows RGC axon growth foiiowing intravitreal
injection ofAAV.fGf-2. Iwo weeks after injury, a large number of CTB-positive axons
(arrows) extended into the distal optic nerve past the lesion site (asterisks). (B) The same
section shown in (A) was visualized with dark field, which aiiowed the unequivocal
identification ofthe injury site (asterisks). (C) Intravitreal injection of control AAV.GFP
did flot provoke axonal regrowth past the site of lesion (D). (E-G) Higher magnification
images of an AAV.FGF-2-treated injured optic nerve taken at 1 mm from the site of
lesion show RGC axons co-stained with 3-III tubulin and CTB. f3-III tubuiin is an RGC
specific isoform that is upregulated during regenerative axon growth. The white arrows
indicate structures at the tip of axons that appear to be growth cones. Scale bars: 250 tm
(A-D), 25 tm (E-G).
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Figure 4. AAV.FGF-2 stimulates retina] Erkl/2 activation
Activation of FGF-2 candidate signaling pathways was investigated using Western blots
of total retinal extracts (75-150 tg) probed with antibodies that selectiveiy recognized
phosphoryiated (active) Erkl/2, Akt, PLCy1 or PKCa. Protein samples were collected at
4 weeks following intraocular injection of AAV.FGF-2 (n=5) or control AAV.GFP
(n=5). In addition, retinas from uninjected, intact eyes served as controls (n5). (A)
AAV.FGF-2 markedly increased phosphorylation of Erkl/2 compared with control
retinas that displayed iow, basal levels of phospho-Erkl/2. (B) Densitometric analysis
confirmed that a single AAV.FGF-2 injection ied to a 2-fold increase in phospho-Erkl
(Student’s t-test, p < 0.05) and a 2.3-fold increase in phospho-Erk2 (Student’s t-test, p <
0.05) with respect to control retinas. In contrast, we did not detect changes in the leveis
of phospho-Akt (C and D, Student’s t-test, p = 0.3) or phospho- PKCŒ (E and F,
Student’s t-test, p = 0.3) with respect to control retinas. (G) Phospho-PLCy1 remained at
iow basal levels in ail sampies. Protein extracts from human carcinoma A43 1 ceils
stimulated with epidermal growth factor (EGF) was used as positive control for PLC71
activation. In ail cases, lower panels represent the same blot as in the upper panels but
probed with an antibody that recognizes total protein or f3-actin used to confirm equal
protein loading in each lane.
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figure 5. Selective in vivo inhibition of AAV.fGF-2-induced activation of retinal
Erkl/2
Inhibition of Erkl/2 phosphorylation was examined at 4$ hrs and 14 days fo11owhg
intraocular injection of 200 iM of PD98059. The intravitreal concentration of this
compound was —16.7 1iM based on the estimated volume ofthe vitreous chamber in the
adult rat eye (—60 tl). (A) Phosphorylated Erkl and Erk2 were visualized with an
antibody against phospho-Erkl/2 (Thr202/Tyr204 residues, top panel) and total Erk
protein was visualized in the same blot reprobed with p44!42 MAP kinase antibody
(bollom panel). In vivo Erkl/2 activation was effectively inhibited at 48 hrs afier
PD98059 administration. (B) Intraocular injection of 200 jiM of PD9$059, which
effectively inhibited Erkl/2 activation, did flot block Akt phosphorylation. This resuit
confirrns the biochemical specificity ofthe pharmacological inhibitor PD9$059
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Figure 6. Erkl/2 mediate RGC axon growth induced by FGf-2
The density of RGC axons that regenerated following FGF-2 gene transfer was
significantly reduced by specific inhibition of the Erkl/2 pathway with a single
intraocular injection of PD9$059 (200 .iM) administered at the tirne of nerve lesion.
Quantitative analysis of axon growth at 2 weeks post-injury dernonstrated that PD98059
caused ‘80% reduction in the number of axons extending at 500 tm (ANOVA, *: p <
0.001) and 1.0 mm (ANOVA, **:p <0.0001) in the presence ofAAV.FGF-2 (gray bars,
n=3). Control groups included: i) animais treated with AAV.FGF-2 that received a
single injection ofvehicie at the time ofnerve injury (solid bars, n=4), ii) animais treated
with control AAV.GFP (open bars, n=3) or PBS (hatched bars, n4), and iii) animais
without any injection but that received rnicro-crush lesion ofthe nerve (grid bars, n=3).
AAV.FGF-2 + Vehicle
AAV.FGF-2 + PD98059
AAV.GFP
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Non injected
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4.1 ABSTRACT
Recentiy, receptor protein tyrosine phosphatase-G (RPTPa) has been shown to
inhibit axon regeneration in injured peripheral nerves. Unlike the peripheral nervous
system (PNS), central nervous system (CNS) neurons fail to regenerate their axons afler
injury or in disease. In order to assess the role of RPTPa in CNS regeneration, we used
the retinocollicular system of adult mice lacking RPTPG to evaluate retinal ganglion ceil
(RGC) axon regrowth afier optic nerve lesion. Quantitative analysis demonstrated a
significant increase in the number of RGC axons that crossed the guai scar and extended
distally in optic nerves from RPTPa (-I-) mice compared to wild-type liffermate
controls. Although we found that RPTPG is expressed by adult RGCs in wild-type mice,
the retinas and optic nerves of aduit RPTPa (-I-) mice showed no histologicai defects.
furthermore, the time-course of RGC death afier nerve lesion was flot different between
knockout and wild-type animais. Thus, enhanced axon regrowth in the absence of
RPTPG couid not be attributed to developmental defects or increased neuronal survival.
Finally, we show constitutively elevated activity of mitogen activated protein kinase
(MAPK) and Akt kinase in adult RPTPG (-I-) mice retinas, suggesting that these
signaling pathways may contribute to promoting RGC axon regrowth foliowing
traumatic nerve injury. Our resuits support a model in which RPTPG inhibits axon
regeneration in the adult injured CNS.
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4.2 INTRODUCTION
During development and regeneration of the nervous system, the growth cone
responds to multiple guidance eues to direct axon extension and establish synaptic
connections with appropriate targets. The ability of the growth cone to react to
extracellular signais is largely regulated by celi surface receptors linked to a complex
transduction machinery (Huber et al., 2003). Although protein tyrosine kinases are key
components of these signaling pathways, it is now clear that receptor protein tyrosine
phosphatases (RPTPs) are equally essential for growth cone ftinction (Hunter, 1989;
Stoker, 2001; Johnson and Van Vactor, 2003).
Type lia RPTPs, a weÏÏ-characterized group of the large RPTP family, have been
shown to influence axon outgrowth and guidance during neural development (Jolrnson
and Van Vactor, 2003). Members ofthis subfamily ofRPTPs: RPTPG, RPTP and LAR,
are composed of two cytoplasmic phosphatase dornains and extracellular
imrnunoglobulin domains followed by fibronectin type III (FNIII) repeats, similar to the
NCAM family of celi adhesion molecules. Mutations in Drosophila type lia RPTPs
DLAR and DPTP69D cause errors in axon guidance ofmotoneurons (Desai et al., 1996;
Krueger et al., 1996), photoreceptors (Garrity et al., 1999; Newsome et al., 2000) and
commissural neurons (Sun et al., 2000). HrnLAR, a DLAR homolog in Ieech, is required
for appropriate axon guidance and extension (Gershon et al., 1998; Baker and Macagno,
2000). In the developing Xenopits visual system, RPTP and RPTP control the rate of
axon extension of retinal ganglion cdl (RGC) axons (Johnson et al., 2001) while in the
developing chick retina, RPTPa regulates intraretinal RGC axon growth (Ledig et al.,
1 999a).
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The participation of type lia RPTPs in axon growth during development
suggested that these proteins rnight also influence axon regeneration following traurnatic
injury in aduit mice. It has been shown that RPTPG, which is highiy expressed in the
developing and aduit nervous system (Yan et al., 1993; Wang et al., 1995; Schaapveld et
al., 199$), inhibits axon regeneration afier peripheral nerve injury (McLean et al., 2002;
Thompson et al., 2003). for example, enhanced axon regeneration in the sciatic nerve
was observed in the absence ofRPTPG (McLean et al., 2002). More recently, Thompson
et ai. (2003) showed that mice deficient in RPTPG displayed accelerated regeneration of
axotomized facial nerve motoneurons, and that absence of RPTPc increased the rate of
axon outgrowth.
In contrast to their PNS counterparts, CNS neurons have a limited capacity to
regenerate following injury or disease. A role for RPTPY in post-traumatic axon growth
in the aduit CNS has flot been established. Here we used the retinocollicular system of
aduit transgenic mice Jacking RPTPG to investigate the regenerative capacity of RGCs
aller rnicrocrush ofthe optic nerve. This injury paradigm was chosen because it resuits
in a focal glial scar and absence of optic nerve cavitation, facilitating accurate
identification of the injury site and quantification of axon growth (Selles-Navarro et al.,
2001; Sapieha et ai., 2003). Furthermore, because ail RGC axons are cornpletely
transected aller microcrush lesion, there is no risk of confusing spared fibers with
regenerating axons.
Littie is known about the molecular components that mediate signaling triggered
by RPTP family members. Nevertheless, a few candidate intracellular effectors of RPTP
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signaling pathways have been identified, such as ableson tyrosine kinase (Abi), enabled
(Ena), liprin-a and guanine-nucleotide exchange factor Trio (Johnson and Van Vactor,
2003). Interestingly, the type II RPTP Clr-1 in C. etegans has been shown to be an
antagonist ofthe fibroblast growth factor receptor (FGFR) ortholog egl-15 (Kokel et al.,
199$). In this study, the mutant Clr-1 phenotype was suppressed by loss of egl-15 and
could be mimicked by overexpression of egl-15, suggesting that Clr-1 likely acts as a
negative regulator of FGFR signaling pathways. Stimulation of receptor tyrosine
kinases, such as FGFR, resuits in the activation of downstream signaling components,
including the mitogen activated protein kinase (MAPK), phosphatidylinositol 3-kinase
(PI3K) and Akt kinase, and phospholipase Cy (PLCy) (Huang and Reichardt, 2003;
Segal, 2003). Thus, it is likely that RPTPs influence cellular function by regulating the
activity of receptor tyrosine kinases (Jallal et al., 1992; Sorby and Ostman, 1996) or
downstream signaling components.
Here we report that injured optic nerves from aduit RPTPa (-I-) mice showed
increased numbers of RGC axons growing past the lesion site into the distal nerve. Lack
of RPTPY did not alter the time-course of RGC death, thus its effect on axon growth
could not be attributed to increased neuronal survival. Moreover, histological analysis of
retinas and optic nerves revealed no major structural differences between RPTPG (-I-)
and RPTPa (+1+) mice. Finally, we show that the MAP kinases Erkl/2 and Akt kinase
are activated in adult RPTPG (-I-) mice retinas, suggesting that stimulation of these
signaling pathways may increase axon growth by injured RGCs in vivo.
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4.3 EXPERIMENTAL METHODS
4.3.1 Animais
RPTP knockout mice used in this study were generated and bred on a BALB/c
background as previously described (Elchebiy et ai., 1999). Ail procedures were carried
out using 4- to 6-month old female RPTPY (-I-) or control wild-type littermates in
accordance with the Canadian Council on Animal Care guidelines for the use of
experimental animais in research (Olfert et ai., 1993).
4.3.2 In situ hybridization
Sense and antisense cRNA probes corresponding to 47$ bases (nucleotides 3461-3939)
of the mouse Ftprs gene were generated. Probes were synthesized from cDNA tempiates
with T3 (sense) (Roche, Lavai, QC, Canada) or T7 (anti-sense) (Gibco BRL, Burlington,
ON, Canada) RNA polymerases and digoxygenin (DIG) RNA labeling mix (Roche,
Lavai, QC, Canada). Mice were perfused intracardialiy with ice cold 0.1 M phosphate
buffered saline (PBS, pH 7.4) containing 0.1% Diethyl Pyrocarbonate (DEPC) (Sigma,
Oakville, ON, Canada). Eyes were immediately enucleated and the anterior structures
and the lens were removed. The remaining eye cups were incubated in 4%
paraformaldehyde (PfA) containing 0.1% DEPC for 2 hr at 4°C, foliowed by immersion
in a sucrose solution (20% in PB) for 6 hrs at 4°C. Eye cups were embedded in optimal
cutting temperature (O.C.T.) compound (Tissue-Tek, Miles Laboratories, Elkhart, IN,
USA) and frozen in a 2-methylbutane/liquid nitrogen bath. Retinal cryosections (7 p.m)
were collected onto siides (Superfrost Plus; Fisher Scientific, Whitby, ON, Canada) and
processed as follows. Endogenous peroxidase activity was quenched with 0.3%
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hydrogen peroxide (Fisher Scientific) in methanol. Sections were pre-hybridized for 20
min at room temperature in 5X saline sodium citrate (SCC), 50% dimethyl-formamide,
5X Denhardt’s solution, 1% SDS and 40 ig/ml single stranded salmon sperm.
Hybridization was performed ovemight at 56°C with 50 ng/ml of probe in 5X SSC, 50%
dimethyl-formamide and 40 tg/ml single stranded salmon sperm. Sections were washed
and incubated with a peroxidase conjugated anti-DIG antibody (Roche), followed by
Tyramide Signal Amplification (TSA, Perkin Elmer Life Sciences, MA, USA) and
3,3N-Diaminobenzidine Tetrahydrochioride (DAB) Liquid Substrate (Sigma). Retinas
were visualized with a Zeiss Axioskop 2 Plus microscope (CarI Zeiss Canada, Kirkland,
QC, Canada). Images were captured with a CCD camera (Retiga, Qimaging, ON,
Canada) and processed with Northem Eclipse image analysis software (Empix Imaging,
Mississauga, ON, Canada)
4.3.3 Retinal and optic nerve histology
Mice were perfused intracardially with 3.6% glutaraldehyde in Sorensen’s Buffer and
eyes with optic nerves were immediately dissected out. The anterior structures ofthe eye
as well as the lens were removed and the remaining tissue was incubated ovemight in
the same fixative. Samples were then incubated in 2% osmium tetroxide, dehydrated in
graded alcohol baths and embedded in Epon resin (Marivac, Montreal, Canada).
Sections of the retina (1-jim thick) were prepared along the dorsal-ventral plane of the
eye and serial sections that passed through the optic nerve head, used as reference, were
analyzed. The thiclmess of the outer nuclear layer (ONL), the inner nuclear layer (1NL)
and inner plexiform layer (IPL) was measured in the superior central retina in wild type
180
(n=5) and RPTPG knockout (n=5) mice using Northem Eciipse image analysis software.
In addition, RGC axons were counted in 1-jim thick transverse sections in wild-type
(n=3) and RPTPG knockout (n=3) optic nerves. Axons in five areas of each optic nerve
section, encompassing a total area of 2,700 J1m2 per nerve, were quantified. The five
optic nerve areas analyzed included one in the center ofthe nerve, two peripheral dorsal
and two peripheral ventral regions. The total surface area per optic nerve cross section
was rneasured using the Northem Eclipse image analysis software, and this value was
used to estimate the total number of axons in each optic nerve.
4.3.4 Surgical procedures
Axonat growth
The microcrush lesion injury paradigm previously used in the rat optic nerve
(Sapieha et al., 2003) was adapted for the smaiier mouse eye. Briefly, the lefi optic nerve
was exposed and a 10-0 suture was used to tie a knot to completely constrict the nerve
for 10 sec afier which the suture was careftilly reieased. During this procedure, care was
taken to avoid injury to the ophthalmic artery. The vasculature ofthe retina was aiways
monitored by fundus exarnination and animais showing signs of cornpromised biood
supply were eliminated from the study. Thirteen days aller microcrush lesion, 2 j.ti of 1%
choiera toxin [3 subunit (CT[3, List Bioiogical Laboratories, Campbell, CA) was injected
into the vitreous chamber using a 1 0-t1 Hamilton syringe with a glass-puiled needle
(-40 jim extemai diameter). Anterograde axonal tracing with CTB has been shown to be
highiy sensitive for revealing fine axonal morphoiogy in the visual system (Mikkeisen,
1992; Angelucci et al., 1996; Matteau et al., 2003).
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For injection ofthe CTB tracer, the sciera was exposed and the tip ofthe needte
inserted at a 450 angle through the sciera and retina into the vitreous space. Following
slow withdrawal of the needie, the injection site was sealed with surgical giue
(Indermiil, Tyco Health Care, Mansfield, MA). This route of administration avoided
injury to the iris or the Yens which lias been shown to promote RGC survival and
regeneration (Mansour-Robaey et al., 1994; Leon et al., 2000). Eighteen hrs aller CT
injection, two weeks post-microcrush lesion, animais were sacrificed and the eyes were
processed for optic nerve immunostaining and axon quantification as described below.
ii) Neuronal sttrvival
One week prior to optic nerve axotomy, RGCs were Iabeied with 2% FiuoroGold
(Fluorochrome, Engiewood, CO) in 0.9% NaCl containing 10% dimethyl sulfoxide
(DMSO) by application of the tracer to both superior collicuii. Retinas were exarnined
histologicaily at 7 and 14 days aller microcrusli lesion to determine the density of
surviving RGCs. Groups inciuded: i) RPTPG knockout mice (n=4) and wild type mice
(n=4) sacrificed at 1 week aller optic nerve lesion, and ii) RPTP knockout mice (n=3)
and wiid type mice (n=2) sacrificed at 2 weeks aller injury.
4.3.5 Quantification of axonat growth and neuronal survival
For quantification of axonai growth, animais were perfused intracardialiy with
4% PFA in 0.1 M phosphate buffer (PB, pH 7.4) and the eyes with optic nerves were
immediateiy disected and processed as described for in sitti hybridization. Longitudinal
nerve cryosections (14 im) were taken along the nasal-temporal plane and collected
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onto gelatin-coated siides. Non-specific binding was blocked with 3% BSA, 5% normal
rabbit serum (Vector Laboratories, Burlingame CA) and 0.2% Triton X-100. Sections
were then incubated ovemight with goat CT antibody (1:4,000 dilution, List Biological
Labs), followed by incubation with biotinylated rabbit anti-goat IgG (6 tg/ml, Vector
Laboratories) and lastly, with DTAF-conjugated streptavidin (3.6 tgIml, Jackson
Immunoresearch Labs). Fluorescence was visualized using a Zeiss Axioskop 2 Plus
microscope (Cari Zeiss). The extent of axonal growth was evaluated by counting the
number of CTJ3-positive axons that extended beyond the site of injury. Axons that
crossed a virtual line parallel to the lesion site at 50 Jlm, 75 tm, 100 trn and 200 .im
were counted in four sections of optic nerve per animal. Sections were selected across
the entire width of the nerve to analyze axon growth in both central and peripheral
regions. The quantification of axons was carried out using two complementary methods:
i) axons were counted directly on each section using a 100X objective (Zeiss), and ii)
composite images of each nerve were generated at 60X magnification to verifS’ axon
counts with respect to the lesion site and for documentation. Both methods yielded
identical results. The location of the lesion site was routinely confirmed in the same
section or in an immediately adjacent section using an antibody against chondroitin
sulfate proteoglycan (CSPG) (1:200, Sigma) followed by Alexa 594-conjugated goat
anti-mouse IgG (14 ig/ml, Molecular Probes) or hematoxylinleosin staining. The
thickness of the optic nerve was measured at each point where axons were counted and
this value was used to calculate the number of axons per mm of nerve width as described
(Sapieha et al., 2003). Data analysis was performed using the GraphPad Instat program
(GraphPad Software Inc., San Diego, CA) by an unpaired t test.
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For quantification of neuronal survival, mice were sacrificed by intracardial
perfusion with 4% PFA and both the lefi (optic nerve lesioned) and right (intact control)
retinas were dissected, fixed for an additional 30 min and flat-mounted vitreal side up on
a glass siide. The ganglion ceil layer was examined by fluorescence microscopy and
fluoroGold-labeled neurons were counted in a total of 12 retinal zones corresponding to
a total area of 0.5 mm2. The retinal zones analyzed included three areas in each of the
eye quadrants at 0.5 mm, 1.0 mm and 1.5 mm from the optic nerve head. Data analysis
and statistics were performed using the GraphPad Instat program by unpaired t test.
4.3.6 Western blot analysis and immunocytochemistry
for protein analysis, fresh retinas were rapidly dissected and homogenized with
an electric pestie (Kontes, Vineland, Ni) in ice-cold lysis buffer: 20 mM Tris, 135 mlvi
NaC1, 1% NP-40, 0.1% SDS, 10% glycerol containing Complete-Mini Protease Inhibitor
Cocktail (Roche). Following a 15-min incubation on ice, samples were centrifuged at
13,000 rpm for 5 min at 4°C and the supematants containing solubilized protein extracts
were collected. Retinal extracts (150 jig) were resolved on 10% SDS polyacrylamide gel
electrophoresis and transferred to nitrocellulose membranes (Bio-Rad Life Science,
Mississauga, ON). Non-specific binding was eliminated by incubating blots for 1 hr at
room temperature in a solution of 5% non-fat milk in TBST (10 mM Tris, 150 mlvi
NaCÏ, 0.2% Tween-20). Blots were then incubated ovemight at 4°C with either of the
following primary antibodies: RPTPa (17G7.2, 1:200) (Thompson et al., 2003),
monoclonal phospho-Erkl/2 that specifically recognizes Erk 1/2 phosphorylated on
Thr202/Tyr204 residues (0.8 tg/ml, Celi Signaling, Beverly, MA), polyclonal pan
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Erkl/2 (2.3 jig/ml, BioSource International, Camarillo, CA), polyclonal phospho-Akt
that recognizes Akt phosphorylated on Thr308 (0.6 jig/ml, Ceil Signaling), polyclonai
Akt (0.1 ig/rn1, Celi Signaling), polyclonal phospho-PLCy1 that recognizes PLCy1
phosphorylated on Tyr783 (1:750, Celi Signaiing), or monoclonal f3-actin (0.5 ig/ml
Sigma). Membranes were subsequently washed in TB$T and incubated with anti-mouse
or anti-rabbit peroxidase-linked secondary antibody (0.5 jig/ml, Amersham Pharmacia,
Baie d’Urfé, QC) for 1 hr at room temperature. Blots were treated with a
chemiluminescent reagent (ECL, Amersham Pharmacia) and exposed to X-OMAT
(Kodak) imaging film.
For retinal immunocytochemistry, animais were perftised intracardially with 4%
PFA and the eyes dissected and processed as described for in situ hybridization. Radial
cryosections (16 tm) were collected onto gelatin-coated siides. Non-specific binding
was blocked by incubating sections for 1 1w in 3% bovine serum albumin (BSA, Sigma),
5% normal goat serum (NGS) and 0.2% Triton X-100 (Sigma). Primary antibody,
phospho-Erkl/2 (2 ig/ml, BioSource) or phospho-Akt (1:20, Ce!! Signaling) was added
in 2% NGS, 0.2% Triton X-100 and incubated ovemiglit at 4°C. Sections were then
incubated with Cy3-conjugated goat anti-rabbit (3 .ig/m1, Jackson Immunoresearch
Laboratories, West Grove, PA), washed in PBS and mounted using an anti-fade reagent
(Slowfade, Molecular Probes, Eugene, OR). Fluorescence was visualized with a Zeiss
Axioskop 2 Plus microscope (Car! Zeiss).
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4.4 RESULTS
4.4.1 RPTPa mRNA is expressed by aduit mouse RGCs
Endogenous expression of RPTPG mRNA in the adult mouse retina and optic
nerve was investigated by in situ hybridization usirig a digoxigenin (DIG)-labeled RNA
antisense probe specific for murine RPTPa. Robust DIG labeling was detected in most
cells in the ganglion cell layer (GCL) of RPTPG (+1+) mice (Fig. lA) indicating that
RGCs, and possibly displaced amacrine celis found in the GCL (Perry, 1981), express
this phosphatase. Many celis in the inner nuclear layer (INL), which contains ceil bodies
of bipolar, horizontal, arnacrine neurons and Millier glia, were aiso DIG-positive. In
contrast, we did not detect staining in retinal sections from RPTPa (-I-) mice (Fig. 1 B)
or wild-type mice incubated with control sense probe (Fig. 1C). These findings are
consistent with other studies showing that RGCs express the RPTPa homologue, CRYP
u, in the developing chick and Xenopus retina (Ledig et al., 1 999b; Johnson and Hoit,
2000). RPTPr mRNA was also detected in the optic nerves of aduit RPTPu (+1+) mice
(Fig. 1D) but flot in RPTPc (-I-) mice (Fig. lE) or in sections from RPTPr (+1+) mice
treated with sense probe (1F). DIG labeling was confined to guai celis organized in
linear arrays along the antero-posterior axis of the nerve (Fig. 1G), a pattem typical of
oligondendrocytes. These resuits dernonstrate that RPTPG is constitutiveiy expressed in
the retina and optic nerve throughout aduit life.
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4.4.2 Lack of RPTPa does not alter retinal or optic nerve histology
To determine if lack of RPTPa disrupted cellular migration or organization of
the rodent visual system, we performed histological analysis of retinas and optic nerves
from RPTPa (-I-) mice and wild-type littermates at post-natal day (P) 6 and in
adulthood. The outer plexiform layer (OPL) in the mouse retina begins to form at P4-
P5. Photoreceptor precursors migrate through the OPL and reach their final destination
in the outer nuclear layer (ONL), a process that is completed at —-P 10 in the central retina
(Rohrer et al.. 1999). The position ofthe OPL during these stages ofretinal development
serves as an indication of precursor celi migration within the retina. At P6, both RPTPG
(+1+) and RPTPa (-f-) mice retinas showed typical layered structures with sirnilar
cellular densities (Figs. 2A and 2B). Absence of RPTPc did flot alter the formation or
location of the OPL, visualized as a gap between the photoreceptor nuclei, suggesting
that the rate ofphotoreceptor migration was preserved.
Analysis of aduit RPTPa (-I-) mouse retinas revealed that the layered
organization was identical to that found in wild-type control retinas (Figs. 2C and 2D).
All retinal celis reached their final destination and photoreceptor inner and outer
segments were fully elongated. The cellular density of each layer appeared normal in
RPTPY (-I-) retinas. To confirm this, the thickness of the limer plexiform layer (IPL),
inner nuclear layer (1NL) and ONt were measured and no significant differences
between knockout (n=5) and wild-type (n=5) littermates were found (Fig. 2E). In
addition, RGCs were retrogradely labeled by application of the fluorescent tracer
FluoroGold to the superior colliculus and quantified on retinal whole-mounts (Fig. 2F).
The number of neurons in wild-type retinas (4,447 ± 99 RGCs/rnm2, mean + S.E.M,
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n=4) was flot significantly different from that found in RPTPa (-I-) retinas (4,472 ± 151
RGCs/rnrn2, n=4).
The histology of knockout and wild-type optic nerves was analyzed using light
rnicroscopy (Fig. 3) and no morphological difference was detected between the two
groups (Figs. 3A and 3B). Furthermore, quantification of axons in five standard areas of
knockout and wild-type optic nerves, corresponding to a total area of 2,700 j.tm2 per
nerve, revealed an equal number of axons (Fig. 3C). The total number of axons per
nerve was calculated based on the total surface area per optic nerve cross section
rneasured using image analysis software. We estimated a total of 55,757 ± 1,454 axons
(mean ± S.E.M. n=3) and 59,467 ± 1,42 1 axons (n3) in RPTPG (-I-) and RPTPY (+1+)
optic nerves, respectively. These values, which are not significantly different from each
other (P>0.05), are consistent with a previous report quantifiing the total number of
RGC axons in the BALB/c mouse retina (Williarns et al., 1996). To determine if the lack
of RPTPa favored the development of axons of a particular diameter, we analyzed the
distribution of axonal size in optic nerve cross-sections. No significant difference was
found in the distribution of axonal size between RPTPG (-I-) and RPTPG (+1+) neiwes
(Fig. 3D). Together, these data indicate that absence of RPTPa does not alter retinal or
optic nerve structures.
4.4.3 Absence of RPTPa does not influence RGC survival after optic nerve
transection
First, we investigated if axotomy induced a change in the expression of RPTPG
in the wild-type retina. Western blot analysis was performed using protein samples from
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retinas collected at 3, 5 and 7 days aller microcrush lesion of the optic nerve. RPTPa
was detected using a monoclonal antibody specific for the intracellular subunit of this
phosphatase (Thornpson et al., 2003). Our resuits indicate that optic nerve lesion did flot
alter RPTPG proteii levels in the retina (Figure 4A). Consistent with this, the paftem of
retinal RPTPG inRNA expression examined by in situ hybridization with a DIG-labeled
RPTPG probe rernained unchanged at 3 and 5 days aller nerve lesion (data flot shown).
To determine if RPTPG played a functional role in RGC survival, we examined
the time-course of celi death in RPTPG (-I-) and wild-type mice following optic nerve
transection. FluoroGold-labeled RGCs were counted on retinal flat-mounts at 7 and 14
days aller microcrush lesion to assess the density of surviving RGCs (Fig. 4A). Both
knockout and wild-type mice showed a sirnilar paftem of axotomy-induced RGC death.
At 7 days aller optic nerve transection, 2,033 ± 358 RGCs/mm2 (mean ± S.EM.) or
2,020 ± 232 RGCs/rnrn2 remained alive in RPTPY (-1-) (n=4) or RPTPc (+1+) (n=4)
mice, respectively. While at 14 days, only 1,174 ± $1 RGCs/rnm2 or 984 + $6
RGCs/mm2 survived in knockout (n=3) or wild-type (n=2) retinas, respectivey. No
significant difference was found in the number of RGCs between RPTPG (-I-) and
RPTPG (+1+) retinas at one week (t test, P0.97,) or two weeks (t test, P0.22) aller
injury. Macrophages and microglia that may have incorporated FluoroGold aller
phagocytosis of dying RGCs were excluded from our quantitative analysis based on
their morphology and the presence of microglia specific rnarkers as described (Cheng et
al., 2002).
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4.4.4 RPTPG (-I-) mice display enhanced RGC axon regrowth after acute optic
nerve lesion
The functional influence of RPTPY on the ability of RGCs to regrow an axon
was tested two weeks afier microcrush lesion ofthe aduit mouse optic nerve. To validate
the microcrush lesion model in the mouse visual system, FluoroGold was applied to the
superior colliculi afier transection of the lefi optic nerve and retinas from both the
operated and the contralateral, intact, eyes were examined. Lack of fluorescent labeling
in the injured retina confirrned that RGC axons in the optic newe were fuily transected
(Fig. 5A and 5B). While ail RGC axons are completely severed in this injury paradigm,
the lesion site rernains well-defmed and the extent of the guai scar is minirnized
(Lehmann et al., 1999; Selles-Navarro et al., 2001). The lesion site was identified by
immunostaining with an antibody against chondroitin sulfate proteoglycan (CSPG), an
extracellular matrix protein that accumulates following lesion (Selles-Navarro et al.,
2001) (Fig. 5C). In addition, we routinely confirmed the localization of the injury zone
in the sarne section or in an irnrnediately adjacent section using hernatoxylinleosin
staining (flot shown).
Increased axonal extension past the lesion site, visualized with the anterograde
tracer choiera toxin 13 subunit (CTf3), was observed in ail RPTPG (-I-) eyes (F ig. 6A and
6B), while considerably fewer axons crossed the guai scar in wild-type nerves (Fig. 6C).
Quantitative analysis of axon growth demonstrated that absence of RPTPY significantly
increased the number of axons that extended into the distal optic nerve (Fig. 6D). This
effect was apparent at ail distances examined from the injury site, producing an increase
in the number of growing axons between 46% and 73% with respect to wild-type optic
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nerves. These data suggest that RPTPY inhibits aduit RGC axon extension in the injured
mammalian visual system.
4.4.5 Retinal MAPK and Akt are activated in adutt RPTPa (-I-) mice
b investigate putative signaling rnechanisms involved in enhanced RGC axon
growth detected in the absence of RPTPG, we performed western blot analysis of retinal
proteins using antibodies that specifically recognize the phosphorylated forms of
MAPK, Akt and PLCyY. Robust activation of the MAP kinases, Erkl and Erk2, was
observed in intact aduit RPTPY (-I-) retinas compared to basal levels of Erkl/2
phosphorylation found in wild-type retinas (Fig. 7A). A moderate increase in
phosphorylated Akt was also detected in the absence of RPTPG (Fig. 7B). In contrast,
low levels of phosphorylated PLCyY remained unchanged in both knockout and wild
type retinas (fig. 7C). To identify the ceils within the retina that upregulated expression
of active MAPK and Akt in the absence of RPTPO, we examined the expression of these
molecules by immunocytochemistry using phospho-specific antibodies. For this
purpose, RPTPa (-I-) and RPTPa (+1+) retinal sections were mounted on the same siide,
processed simultaneously for immunofluorescence and microscope images were
captured using identical conditions. Our data showed an increase in phospho-Erkl/2
staining in RPTPG (-I-) retinal ceils, particularly in celis ofthe GCL and TNL, compared
to the basal levels found in RPTPG (+1+) retinas (Figs. 7D, 7E). Interestingly, staining
with a phospho-Akt antibody revealed staining only in celis in the GCL and fiber layer
of RPTPa knockout retinas compared to basal levels found in wild-type retinas (f igs.
191
7F, 7G). These resuits indicate that lack of RPTPY resuits in activation of the MAPK
and Akt kinase signaling pathways in aduit RGCs.
4.5 DISCUSSION
The identification of RPTPG as a key regulator of axon extension and guidance
during development has sparked interest in its potential role in the control of axon
growth following injury (Haworth et al., 199$; Xie et al., 2001). Recent studies
demonstrated that absence of RPTPG increased axonal regeneration in peripheral nerves
following crush injury (McLean et al., 2002; Thornpson et al., 2003). It is well
established that injured PNS neurons have the ability to extend an axon toward
peripheral targets with subsequent restoration of sensory and motor function. In contrast,
aduit mammalian CNS neurons fail to regenerate an axon afier injury. The inabulity of
CNS neurons to regenerate an axon has been generally attributed to an inhibitory guai
environment (Yiu and He, 2003; Raisman, 2004; Silver and Miller, 2004) however,
emerging data indicate that signais intrinsic to neurons play a significant role in the
control of axon growth (Cai et al., 1999; Lehmaim et al., 1999; Cai et al., 2002;
Goldberg et al., 2002).
Here we used the retinocollicular system of RPTPG knockout mice to investigate
the role of this protein phosphatase in the regulation of axon growth by aduit injured
RGCs, a prototypicai CNS neuronal population. Our in situ hybridization analysis
demonstrated that RPTPa mRNA is expressed by aduit mouse RGCs. This finding
agrees with previous reports that RPTPG homologs are expressed by RGCs in
developing chick (Ledig et al., 1999b) and Xenopus (Johnson and Hoit, 2000). In
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addition, we found that guai celis within the optic nerve express RPTPG, consistent with
the observation that Schwann ceils in the aduit mouse sciatic nerve produce RPTPa
(McLean et al., 2002). Nerve injury ofien leads to rnarked changes in neuronal gene
expression (Plunet et al., 2002). Thus, we examined whether optic nerve transection
affected RPTPa expression by RGCs. We demonstrate that expression of RPTP-a
mRNA and protein by RGCs remained unaltered after optic nerve transection suggesting
that this protein is present in lesioned RGCs and therefore able to play an active roTe in
inhibiting axon regrowth. Similarly, aitered RPTPG gene and protein expression was not
detected in facial motoneurons after facial nerve crush (Thornpson et al., 2003). In
contrast, RPTPa mRNA increased in aduit dorsal root ganglia and in injured sciatic
nerve during regeneration (Haworth et al., 1998; McLean et al., 2002). Taken together,
these resuits suggest that injury-induced changes in RPTPa gene expression may be
differentially regulated among celi populations.
Transgenic mice lacking RPTPa exhibit growth retardation, delayed peripheral
neiwe development and altered development of the olfactory bulb, pituitary gland and
hypothalamus (Eichebly et al., 1999; Wallace et al., 1999). Our morphological analysis
identified no phenotypic difference between RPTP (-I-) and RPTPG (+1+) retinas
during developrnent and in aduit mice. In addition, the structure of the optic nerve was
unaltered in RPTPG (-I-) mice. These resuits are consistent with a study in which
expression of dominant negative CRYP-Œ, an RPTPG homoÏog, did flot affect celi fate
determination or population size in Xenopus retina, yet it enhanced RGC neurite
outgrowth in vitro (Johnson et al., 2001). 0f interest, mice expressing a mutant RPTP6,
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another type lia RPTP, have a CNS that appears histologically normal but exhibit
impaired leaming and enhanced iong-term potentiation (Uetani et al., 2000). The
preservation of retinal and optic nerve structure in RPTPG knockout mice could be
attributed to functional redundancy as other type lia RPTPs are expressed in vertebrate
RGCs (Fuchs et al., 1998b; Ledig et al., 1999b; Johnson and Hoit, 2000).
Here we demonstrate that absence of RPTPa stimulates RGC axon outgrowth
afier acute optic nerve injury. Quantitative analysis showed a significant increase in the
number of injured axons that successftully extended past the lesion site in RPTPG
knockouts with respect to wiid-type littermate controls. This effect could flot be
attributed to a larger number of RGCs, and therefore axons, in RPTPG (-I-) mice because
the time-course of axotomy-induced RGC death was similar in knockout and wild-type
animais. Our data is supported by previous studies in the deveioping visuai system. For
example, expression of dominant negative RPTPG increased the length of RGC neurites
in developing Xenopus retinai explants (Johnson et al., 2001). Together, these findings
suggest that RPTPa activity is detrirnental for RGC axon growth. Importantly, RPTPG
has been postuiated to slow the rate of axon extension during regeneration of injured
PNS neurons. For exampie, absence of RPTPG stimulated axon regeneration and
recovery afier crush injury in adult sciatic (McLean et al., 2002) and facial (Thompson
et al., 2003) nerves. Our study, however, provides the first demonstration that RPTPa
negativeiy regulates axon growth in the aduit CNS following traumatic injuty.
The mechanisrn by which RPTPG regulates growth cone motility and axon
extension remains iargely unknown. Genetic analysis of DLAR function in D.
Melanogaster suggests that type lia RPTPs regulate cytoskeletal organization through
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proteins that include the guanine-nucleotide exchange factor Trio (Debant et al., 1996;
Awasaki et al., 2000; Bateman et al., 2000), the tyrosine kinase Abi (Wills et al., 1999a;
Wills et al., 1999b) and the AbI substrate Enabled (Wills et al., 1999a). However, at
present, there is no evidence that these proteins act as downstream effectors for any type
lia RPTP family member in mammals. An alternative approach to identify mediators of
RPTPc action is to investigate pathways already known to be involved in axon growth.
Although liffle is known about the signaling pathways that direct axon growth by aduit
neurons in vivo, work using primary neuronal cultures have identified components
involved in neurotrophic factor-induced axon extension (Brann et al., 1999; Perron and
Bixby, 1999; Atwal et al., 2000; Liu and Snider, 2001; Goldberg et al., 2002; Markus et
al., 2002; Edstr6m and Ekstrôm, 2003). For example, the neurotrophin receptor TrkB
has been shown to modulate both MAPK and PI3KJAkt pathways to promote axon
growth by cultured neonatal sympathetic neurons (Atwal et al., 2000), Another study
demonstrated that inhibition of the MAPK pathway, blocked FGF-induced neurite
outgrowth in embryonic chick retinal neurons (Perron and Bixby, 1999). More recently,
the PI3K!Akt kinase pathway was implicated in axonal outgrowth from explants of aduit
mouse dorsal root ganglia (Edstrôm and Ekstrôm, 2003). Thus, RPTPa may regulate
axon growth by interacting with signaling components downstream of receptor tyrosine
kinases. This idea is supported by our resuits indicating that both MAPK and Akt kinase
are constitutively active in adult RPTPG (-I-) retinas, notably in RGCs. Thus, MAPK
and PI3K!Akt kinase are candidate signaling mechanisms by which RPTPG may
promote RGC axon outgrowth.
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RGC axon growth in RPTPG (-I-) mice was restricted to short distances from the
lesion cornpared to other recent studies that report axon growth as far as 1 mm from the
injury site afier intravitreal injection of cAMP (Monsul et al., 2004) or lens injury (Yin
et al., 2003; fischer et al., 2004). A number of factors may contribute to these
differences, including the use of rats in these latter studies, compared to the use of mice
by us. Furtherrnore, these other studies each induced some form of retinal injury shown
to upregulate expression of endogenous growth factors (Wen et a]., 1995; Cao et al.,
1997; Cao et al., 2001), which may contribute to promoting axon regeneration in the
optic nerve.
The ability ofRGC axons to regenerate is limited in part by the growth inhibitory
environment of the optic nerve, rich in proteins such as Nogo-A (Caroni and Schwab,
198$a; Caroni and Schwab, 198$b), myelin-associated glycoprotein (MAG)
(McKerracher et al., 1994; Mukhopadhyay et al., 1994) and oligodendrocyte-myelin
glycoprotein (OMgp) (Kottis et al., 2002) that restrict the extension of axons on myelin
by interacting with the Nogo receptor (Fournier et al., 2001; Liu et al., 2002; Wang et
al., 2002b). This iimited regenerative capacity by aduit RGCs is ftirther illustrated by the
observation that strategies that promote long distance regeneration in the injured spinal
cord produce only short distance axon growth in the optic nerve (Bartsch et al. 1995;
Lehmann et al. 1999; Huang et al. 1999; Dergham et al. 2002; Ellezam et aI. 2003).
Irnportantly, emerging data suggest that overcoming inhibitory signais is not sufficient
to promote axon growth but that activation of an intrinsic growth program in neurons is
also required for axon regeneration in the CNS. For example, during retinal maturation,
a signal from amacrine celis triggered an irreversible loss of the intrinsic axon growth
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ability of RGCs (Goidberg et al., 2002). Moreover, suppression of Nogo receptor
activity was flot sufficient to prornote extensive RGC regeneration unless these neurons
were stimulated with macrophage-derived factors (Fischer et al., 2004). Future studies
will establish if RPTPG inhibition combined with strategies that overcome growth
inhibitory signais or stimuiate active growth wili promote long-distance axon
regeneration.
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4.7 FIGURES
Figure 1. RPTPa is expressed by aduit RGCs and optic nerve g]ia.
Expression of endogenous RPTPa was investigated by in situ hybridization of aduit
wild-type retinas and optic nerves. Incubation of retinal sections with a digoxigenin
(DIG)-labeled RNA anti-sense probe specific for mouse RPTPG revealed strong positive
staining in the ganglion ceil layer (GCL) and inner nuclear layer (1NL) (A), as well as in
guai celis of the optic nerve (D). A higher magnification of an optic nerve section
showed that DIG-positive guaI ceils forrned linear arrays along the antero-posterior
plane, a pattem typical of oligodendrocytes (G). Incubation of retinal (B) or optic nerve
(E) sections from RPTPa (-I-) mice with the anti-sense probe confirmed absence of
RPTPY expression. Sections from wild-type animais incubated with control sense probe
did flot show staining, thus confirming the specificity of our assay (C, F). IPL: Inner
Plexifonn Layer. Scale bars: 50 iim (A-C, G), 100 tm (D-F).
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Figure. 2. RPTPa deficiency does not alter retinal structure.
Epon embeded sections (1-im-thick) stained with toluidine blue show normal retinal
developrnent in RPTPa (-I-) mice as compared to wild-type liffermate controls (A, B).
Note the matching position of the outer plexiforrn layer (OPL) in both knockout and
control retinas suggesting that cellular migration was not affected by RPTPG removal.
The retinal structure was identical in aduit wild-type and RPTPa knockout mice (C-D).
Quantitative analysis of the thickness of retinal layers revealed no significant difference
between RPTPG (+1+) (n=5) and RPTPY (-I-) (n5) mice (unpaired t-test; confidence
interval 95%; ONL: p=O.3472; INL: pO.$196; IPL: pO.5633) (E). Moreover, the
density of FluoroGold-labeled RGCs was sirnilar in control (n=4) and RPTPa (-I-) (n4)
animals suggesting that RPTPa is not essential for normal RGC development (F). GCL:
Ganglion CelI Layer, IPL: Inner Plexiform Layer, ONL: Outer Nuclear Layer, RPE:
Retinal Pigment Epithelium. Scale bars: 50 tm (A-D).
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Figure 3. Lack of RPTPa does not affect optic nerve structure.
Epon ernbeded sections of optic nerve stained with toluidine blue revealed a sirnilar
morphology between RPTPO (-I-) and RPTPG (+1+) mice (A, B). Quantification of the
total number of axons in transverse optic nerve sections confirrned a comparable axon
density in wild-type (n=3) and knockout (n=3) nerves (C). Furthermore, analysis of
axonal calibre, measured as the area of the axon in an optic nerve cross section,
demonstrated a sirnilar distribution of axon size between RPTPa (+1+) (n=3) and RPTPG
(-I-) (n=3) (D). $cale bars: 25 tm.
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Q Figure 4. Retinal RPTPa protein continues to be expressed after optic nerve injurybut does flot regulate RGC survival.
Whole retinal homogenates were obtained from wild-type intact or operated mice at 3, 5
or 7 days afier nerve transection. The level of retinal RPTPa was examined by
immunoblot (150 ig per lane) using a monoclonal antibody raised against the
intracellular domain of RPTPŒ (A). The uniform intensity of the immunoreactive bands
corresponding to RPTPa suggests that the protein level of this phosphatase is flot
affected by injury. Bottom panel: same blot was re-probed with an antibody against 13-
actrn to visualize total protein. (B) RGC densities in retinas from intact wild-type mice
(white bars, n=4) were similar to those found in intact RPTPG knockouts (solid bars,
n=4) suggesting that RPTPÇY is not involved in the developmental regulation ofthe RGC
population size. The time-course of RGC death afier micro-crush lesion was virtually
identical between wild-type (white bars) or knockout (black bars) mice. A similar
number of RGCs survived at I week (wild-type: n=4, knockout: n=4) or two weeks
(wild-type: n2, knockout: n=3) after injury. These data indicate that RPTPCY does flot
influence the survival of axotornized RGCs.
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Figure 5. Micro-crush (MC) lesion of the mouse optic nerve resuits in complete
transection of RGC axons.
(A) Whole-rnounted mouse retina visualized afler application ofthe tracer FluoroGold to
the superior colliculus to label the entire RGC population. (B) MC lesion of the optic
nerve preceded application of FluoroGold, thus absence of fluorescence in the retina
confirrned that the optic nerve was completely transected. (C) Optic nerve MC typically
resulted in a welI-defined injury site in which the extent ofthe guai scar was rninimized.
The lesion site (asterisks) was accurately identified at 14 days post-crush by
immunostaining against chondroitin sulfate proteoglycan (CSPG), an extraceilular
matrix protein that accurnulates foilowing injury. Scale bars: 250 tm (A, B) and 100 irn
(C).
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Figure 6. RPTPa (-I-) mice show enhanced regrowth of transected RGC axons.
(A) Optic nerve longitudinal section from a RPTPG (-I-) mouse immunostained with a
CTI3 antibody showing regrowth of fully transected RGC axons. A significant number of
CTfI-positive axons extended into the distal optic nerve past the lesion site (asterisks).
(B) Higher magnification image of a RPTPc (-I-) optic nerve showing numerous RGC
axons growing between 50 jtrn and 100 tm ftom the lesion site. (C) Minimal RGC axon
outgrowth was obseiwed in nerve sections from wild-type control mice. (D) Number of
RGC axons (mean ± S.E.M.) extending past the lesion site in RPTPG (+1+) (white bars:
n=6) or RPTPa (-I-) (solid bars: n7) mice at two weeks after optic nerve transection.
RGC axon growth in the RPTPG (-I-) group was significantly larger than in the RPTPY
(+1+) control group (unpaired-t-test, p < 0.05). Scale bars: 100 im (A, C) and 50 jtm
(B).
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figure 7. MAPK and Akt kinase pathways are constitutively active in RPTPa (-I-)
mice retinas.
(A)Robust activation of Erkl/2 kinases was detected in RPTPG (-I-) mice retinal
homogenates analyzed by western blots. (B) A modest stimulation of Akt kinase was
detected in RPTPa (-I-) retinal homogenates. (C) The levels of phosphorylated PLCy1
were very low and remained unchanged between RPTPa knockout and wild-type
retinas. A protein sample from human carcinoma (A43 1) cells stimulated with epidermal
growth factor (EGF) was used as positive control for PLCy1 activation. Lower panels in
(A), (B) and (C) show the same blot re-probed with antibodies that recognize non
phosphorylated Erkl/2, Akt or PLC-yL to verify equal protein loading. The endogenous
activity ofErkl/2 kinases and Akt kinase detected in RPTPG (-I-) retinas was confirmed
by immunofluorescence. Upregulation of phospho-Erkl/2 was observed in ceils of the
ganglion celi layer (GCL) and inner nuclear layer (INL) of RPTPG (-I-) retinas (E)
compared to RPTPG (+1+) controls (D). Increased phospho-Akt staining in RPTPG (-I-)
mice (G) with respect to wild-type controls (F) was confined to the ganglion ceil and
fiber layer. Scale bars: 50 jim (C, D).
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Chapter V
GENERAL DISCUSSION
5. GENERAL DISCUSSION
It is well established that, as CNS neurons mature, they lose the ability to
regenerate their axon afier acute injury. This disparity between embryonic and aduit
neurons stems from intrinsic properties (Cai et al.. 1999; Cai et al.. 2001; Goldberg et
al.. 2002a) as well as from changes in their environment.
The studies presented in this thesis focused on the modulation of genes that are
robustly expressed in the developing visual system, as a strategy to reactivate the
neurons intrinsic growth program and as a means to promote neuronal survival. In
addition, we explored the possible signaling pathways involved in enhancing
regenerative growth in the aduit CNS.
5.1 SEARCHING FOR GENES INVOLVED IN REGENERATION
The identification of genes that can either stimulate or inhibit CNS regeneration
is a challenging task. One approach cails for the comparative analysis of gene expression
within the CNS at periods when axons are growing (immature fleurons) versus when
they become senescent (mature neurons). Using subtractive differential analysis or DNA
micro-array teclmology. there are stili far too many candidates from the —30. 000 genes
expressed in neurons (Hahn and Laird. 1971; Grouse et al.. 1972) to test individually.
furthermore, the quest is complicated by the likelihood that more than one gene may
need to be modulated to promote adequate axon regrowth. To make matters worse, a
single ceil in the CNS expresses 20, 000 to 30, 000 distinct mRNAs and 99% ofthese
mRNA transcripts are rare. In fact, -99% of the mRNA transcripts make up less than
30% ofthe total mass of mENA (Hahn and Laird, 1971; Grouse et al.. 1972; Hahn et al.,
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197$). This signifies that the vast majority of genes are expressed at very low levels,
making it considerably more difficuit to detect them. It is therefore possible that
regeneration associated genes (RAGs) could fali into this category of low abundance
mRNAs. Moreover, because of the massive transcriptional activity observed in
developing tissues, the hunt for RAGs is further convoluted by the abundance of genes
that regulate processes other than axonal growth and regeneration. Although it would be
simpler to assume that there are marked differences in RAG expression between
developing and mature tissues, there is evidence that certain genes that influence axon
growth do not show dynamic changes in their expression. For example, it is well
documented that the myelin associated protein Nogo, is highly inhibitory towards axon
growth (reviewed in David and Lacroix, 2003). Nevertheless, Nogo mRNA is highly
expressed in both the developing and mature CNS (Josephson et al., 2001) and does flot
vary afier spinal cord or cortical lesion (Huber and Schwab, 2000). The same pattem
was found with RPTP-G described in chapter 4 ofthis thesis.
Following the identification of a candidate gene, whether it be by differential
screen or by analyzing the biochemical properties of the protein, it is necessary to
conduct tests in vivo to ascertain its role. It is logical to predict that, certain genes, such
as those coding for the transcription factor c-j un and the growth cone transduction
proteins GAP-43 and CAP-23 (Herdegen et al., 1997; Frey et al., 2000; Bomze et al.,
2001), should be upregulated to enhance regeneration, while other genes, such as myelin
inhibitor NogoA/B and p75”1T’, should be downregulated (Hannila and Kawaja, 1999;
Walsh et al., 1999; Kim et al., 2003). In this thesis, both strategies were described. First
we investigated the ability of FGF-2 to promote survival and regeneration by
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upregulating the fGF-2 gene in aduit transected ROCs. Second, we investigated the
effect of RPTP-cy gene removal from the mouse genome and studied its impact on RGC
survival and regeneration.
5.2 SUSTAINED UPREGULATION 0F fGF-2 IN INJURED ADULT RGCS
In the first two articles presented in this thesis (Chapters 2 & 3), we upregulated
f0f-2 protein in mature ROCs using an AAV containing the f0f-2 transgene. fGf-2 is
typically associated with developing RGCs during periods of axon extension and growth
in the embryonic retina (de Iongh and McAvoy, 1993) and is absent altogether from
aduit RGCs (Kostyk et al., 1994; Sapieha et al., 2003). By increasing its levels in the
aduit, we were able to test if FGf-2 was capable of influencing the aduit ROC injury
response. following AAV mediated gene transfer. elevated levels of fGf-2 persisted in
mature ROCs for at least 2 months afier injection, spam-ling the entire duration of the
experiment. We found that this treatment promoted enhanced regeneration of injured
ROCs, while having a robust yet transient effect on ceil survival.
Due to the 4-week incubation period required to achieve optimal transgene
expression with AAVs, the dosing protocol was designed so that the plateau of FOf-2
expression coincided with the initial protracted phase of ROC death (day O to day 5 after
axotomy) (Berkelaar et al., 1994). During this period, untreated neurons unsuccessfttlly
attempt to sprout new axons in what is known as “frustrated regenerative acts” (Ramon
y Cajal, 192$). This suggests that during this phase of abortive growth, ROCs mount a
response to counteract the effects of injury. Consequently, the neurons may be more
responsive to survival and growth promoting treatments.
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5.3 NEUROPROTECTION AND FGFS
5.3.1 FGF-2, FGF-5 and FGF-18 Promote Transient Survival of Axotomized
RGCs
In addition to fGf-2, we also investigated the neuroprotective qualities of two
other members of the FGF family: fGF-5 and fGf-18 (Appendix C). As with fGf-2.
we employed AAVs to attain sustained. ]ong term expression ofthese proteins in RGCs.
These factors were of interest as both AAV.FGf-5 and AAV.fGF-18 had been shown to
slow photoreceptor degeneration in transgenic models of light damage (Lau et al., 2000;
Green et al., 2001). Using the optic nerve axotomy injury paradigm, we observed that
one week afier lesion, retinas treated with AAV.F6f-5 or AAV.F6f-1 $ showed 68%
and 67% RGC survival respectively. This survival was of a comparable magnitude to the
74% obtained with AAV.f6f-2 and significantly higher than control AAV-GFP
injected eyes, which showed 49% survival. Nevertheless, as with AAV.f6f-2, the
neuroprotection was transient and declined to 12% survival two weeks after injury
(control AAV.GFP injected retinas dropped to 10% survival).
5.3.2 FGFR1 Expression in the Injured Retina
We had previously demonstrated that the survival effect prornoted by BDNF
afier TrkB gene transfer was considerabÏy larger than that observed with AAV.f6f-2
(Cheng et al. 2002; Sapieha et al. 2003). One of the principal theories explaining the
lack of long term survival following axotomy suggests that RGCs lose responsiveness to
trophic factors after injury (Shen et al., 1999) (Goldberg and Barres, 2000). This can be
explained by the fact that lesioned CNS neurons downregulate certain neurotrophic
226
receptors, such as Trks afier injury (Venero et al., 1994; Kobayashi et al.. 1997; Liebi et
al.. 2001; Cheng et al.. 2002) and fhereby become less apt to activate pro-survival
signaling cascades.
In order to explain the short-lived survival effect of FGF s. we investigated the
post-axotomy behavior ofthe fGF receptor. fGfR1. that binds fGf-2. FGf-5 and fGF
18. Interestingly, following RGC axotomy, Western blot analysis showed a persistent
increase in fGfR1 protein expression within the retina (Appendix D). This data is
consistent with a previous study demonstrating that retinal FGfR1 mRNA is upregulated
after focal mechanical injury to the retina (Wen et al., 1995). Immunohistochemical
analysis of axotomized retinas, revealed a pronounced increase in fGfR1 protein
predominantly in photoreceptor celis, but flot in RGCs (figure 1. B, Appendix D).
SimilarÏy. fGf-2 protein was reported to be upregulated in photoreceptor celis following
an optic nerve crush (Kostyk et al., 1994). In fact. photoreceptor celis are thought to
have an a2 adrenergic receptor-coupled mechanism which induces fGf-2 upregulation
and can consequently attenuate light damage (Wen et al.. 1996). Taken together, these
data may explain the peculiar finding by Bush and Williams (1991) that optic nerve
transection protects photoreceptor neurons against light damage (Bush and Williams,
1991).
The observed increase in fGfR1, however, does not confer a survival advantage
to axotomized RGCs. fGf-2 and fGf-18 are secreted, thus it is possible that FGFRI
upregulation in neighboring photoreceptors acts as an fGf sink, consequently depriving
RGCs ofthese factors.
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5.4 SOMATIC EXPRESSION 0F FGF-2 IS REOUIRED TO STIMULATE
REGENERATION
The location of a growth promoting stimulus is key to activating axonal growth.
Should the treatment be delivered to the cell body or to the distal end of the transected
axon? This question has been addressed in detail in studies on neurotrophin-induced
axon growth using Campenot chambers (Campenot, 1994). In this culture system,
neurons have their ceil bodies and their distal axons in separate physical compartments.
Early studies on PNS neuronal cultures revealed a dissociation between cell survival and
axonal growth, depending on where the stimulus was applied. for example, NGF
promoted survival when added to the soma. However, when NGF was added to the
axonal terminal, it stimulated both axonal growth and survival (Campenot, 1994). It was
later demonstrated that neurotrophin stimulation of the distal axon provoked
phosphorylation of axonal Trks and the consequent activation of Ras/MAPK pathways
(Riccio et al., 1997; Senger and Campenot, 1997). Moreover, when Erkl/2 was inhibited
within axons, there was a significant decrease in axonal outgrowth (Atwal et al., 2000).
In developing RGCs, it was shown that BDNF stimulation of axonal terminals enhanced
dendritic arborization, while stimulation of dendrites reduced arborization (Lom and
Cohen-Cory, 1999). These data are examples of the increasing evidence suggesting that
the location of stimulation determines the neuron’s response to a given molecule.
The retino-collicular system resembles an in vivo Campenot chamber in that the
cell bodies are within the retina, in the eye, and the axon terminal in the brain. It is
known that shortly afier CNS injury, macrophages and other cells infiltrate the lesion
site and secrete, amongst other factors, fGf-2 (Finklestein et al., 198$; Logan et al.,
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1992). Increased FGF levels attract oligodendrocyte precursors and fibroblasts which
enter the lesion site and form dense ramifications. contributing to the growth inhibitoiy
guai scar (fawcett and Asher, 1999). It is therefore established that fGF-2 levels are
elevated at the site of a CNS lesion.
In our study, we demonstrated that, following optic nerve micro-crush, there is a
reorganization and buiid-up of fGf-2 positive ceils around the site of lesion. Because
fGf-2 is secreted. it is likelv that local concentrations of fGf-2 are elevated in the
proximity of transected axons. Nevertheless, this presence of fGf-2 at the lesion site is
flot sufficient to promote either axonal regrowth or RGC survival. In fact, we showed
that fGf-2 needs to be upregulated in RGC ceil bodies to promote survivaÏ or
regenerative axon growth. Although anterograde transport of fGF-2 was observed in
regenerating RGCs. the protein itself is newly synthesized in the soma. Moreover. in
Chapter 3, we showed a substantial reduction in axonal regeneration when MEK was
inhibited upon application of a pharmacologicai blocker to the RGC body. This is in
contrast with the MEK mediated growth of cultured developing sympathetic neurons,
xhich is exclusively controlled locally at the axon (Atwal et ai.. 2000). Taken together.
these data provide evidence that fGF-2 stimulation is required at the cell body and not at
axon terminals in order to promote survival and regeneration and survival of aduit
iesioned RGCs in vivo (figure 5-1, p231).
5.5 RPTP-a HINDERS RGC REGENERATION
In Chapter 4 of this thesis, we provide the first in vivo evidence that expression
of the type lia phosphatase, RPTP-a, impedes the regrowth of injured aduit mammalian
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CNS neurons. Although RPTP-a bas been identified as a crucial protein for nervous
system development, its role in the aduh CNS was unknown (Elchebly et al., 1999;
Wallace et al., 1999). Using the optic nerve micro-crusli lesion paradigm, we
investigated RPTP-cf s involvement in the regeneration and survival of aduit RGCs
following acute injury. We report that axonal regrowth of transected RGCs was
significantly enbanced in adult RPTP-c (-I-) mice while the rate of survival remained
unchanged. Furthermore, we showed that even if aduit mouse RGCs express RPTP-a, a
lack of this protein does flot affect their phenotype or population density. The exact
mechanjsm of action of RPTP-a remains to be elucidated, but our data indicate that it
plays an important role in the regulation of axon outgrowth. The following sections
speculate on the possible modes of actions of RPTPs in the context of axon regeneration.
figure 5-1. The working model and genera] summary.
This figure depicts the major conclusions presented in this thesis as well as data relevant
to our findings. (A) AAV.FGf-2 readily infects and expresses its transgene in aduit
RGCs (Chapter 2). We identified on mature RGCs, fGfR and heparan sulfate
proteoglycan (HSPG), two surface molecules required for AAV integration. The
expression of these proteins likely contributes to the high rates of infection. (B) FGf-2
binds to HSPGs with high affinity and requires this surface glycoprotein for efficient
signaling through FGFR. (C) Upon stimulation of FGFR by FGF-2, signaling cascade(s)
that ultimately result in axonal regeneration are activated (Chapters 2 & 3). We have
identified Erkl/2 as an important player in the signaling events leading to FGF-2-
induced RGC re-growth (Chapter 3). Nevertheless, another, yet to be identified signaling
effector is likely to be required to achieve growth, as activating Erkl/2 by itself is
insufficient to promote RGC regeneration (Pemet et al.).
(D) We demonstrated that RPTP-a impedes RGC regeneration following acute injury
(Chapter 4). Moreover, removal of RPTP-a resuits in both the activation of Erkl/2 and
Akt and provokes axonal regrowth afler acute injury (described in greater detail in
Figure 5-2). (E) The ligand induced inactivation hypothesis stipulates that RPTP-a is
catalytically active until it binds its ligand. Once the ligand bound, RPTP-a subunits
dimerize and cause its inactivation. In this scenario, a RPTP-G knockout animal would
mimic continuous ligand binding.
(F) A theoretical mode! of RPTP action at the growth cone. The actin modulating
proteins Ableson (Abi) and Enabled (Ena) can bind directly to RPTP. Ena, a common
substrate for both Abi and RPTP, can promote axon elongation by binding directly to
actin and interfering with actin-capping proteins or by recruiting the protein Profihin
which can promote actin assembly. Altematively, RPTP interacts with the Rho guanine
exchange factor Trio. Through its Dl domain, Trio can activate Rac 1 and consequently
promote actin assembly.
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5.6 RPTP-a SIGNALING
5.6.1 How Does Ligand Binding Influence RPTP-a Signaling?
The interactions between RPTP-a and its ligands and effectors remain largely
unknown. Putative ligands for cPTP-a (chick RPTP-a) have been identified along the
developing avian retinotectal pathway (Haj et al., 1999) and, more precisely, the heparan
sulfate proteoglycans agrin and collagen XVIII have been identified as ligands for
RPTP-a (Aricescu et al., 2002). Agrin is present in the optic nerve and the tectobulbar
pathway (Halfier et al., 1997) of the developing chick, indicating that RPTP-a may
interact with this substrate during embryogenesis. Site-directed mutagenesis of the
extracellular domain of RPTP-a revealed that binding interactions are mediated by a
group of amino acids in the first 1g domain. This motif is highly conserved and therefore
suggests that other species are likely to show similar receptor-ligand interactions
(Aricescu et al., 2002). It remains to be determined what ligand-receptor interplay occurs
in aduh lesioned nerves and whether this interaction (or lack of) could ultimately
contribute to regeneration failure.
5.6.2 Ligand-induced Inactivation ofRPTPs
As with RPTP’s substrates, the mechanisms triggered afier RPTP ligand binding
have yet to be defined. Several examples exist of a ligand-induced inactivation of RPTP
catalytic activity. For instance, structural studies of the type IV RPTP-a, a distant
relative of RPTP-a, show that following ligand binding, a dimerization event occurs
where the phosphatase domain of one subunit inserts its amino-terminal helix-tum-helix
into the catalytic domain ofthe other and renders it inactive (Biiwes et al., 1996). In this
scenario, ligand-mediated dimerization mayiiiock the access of the phosphatase to its
substrate and prevent dephosphorylation. Further evidence from the type V RPTP-f3 and
the type I CD45, support the idea that ligan&induced dimerization may reduce
phosphatase catalytic activity (Desai et al.. 1993; Majeti et al., 1998; Majeti et al.. 2000).
Moreover, in the chick, RPTP-a iigand/receptor interaction reduces the rate of retinal
axon outgrowth (Ledig et al. 1 999a), while transfecting Xenopus RGCs with a kinase
deficient RPTP-a, increases the rate of axonal outgrowth (Jolmson et al. 2001). These
data provide evidence that ligand binding to RPTP-G promotes outgrowth by
inactivating its catalytic activity.
The previous examples propose that a signaling response is initiated once
phosphatase activity is blocked. This most likely occurs by the modification in levels of
key phospho-tyrosine residues (either negative or positive regulatory phospho-tyrosine
residues) on adaptor and effector signaling proteins with specialized phospho-tyrosine
binding domains (e.g. Src homology 2 (SH2) and phospho-tyrosine binding (PTB)). De
phosphorylation of these residues influences their ability to bind and to activate their
substrates and therefore affects cellular signaling (Tonks and Neel, 2001).
In accordance with the ligand-induced inactivation model, knockout animais for
the phosphatases would simulate perpetual ligand binding and therefore produce
continuous catalytic inactivation. In this context, the following scenario may explain the
axonal regeneration that we report. The ligands for RPTP-c are present along the
developing retino-collicular path, thus leading to catalytic inactivation during
embryogenesis. These ligands may later be developmentally downregulated or
completely absent from the aduit. Therefore, afier ROC transection, when the distal axon
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is once again within the optic nerve, the original substrates could be absent and
consequently, the catalytic activity of the phosphatase turned on; a scenario that is
exactly the opposite of what occurs during development.
RPTP-a would flot be the first protein that is permissive during development and
later becomes inhibitory in mature life. For exampÏe, another member of the 1g-
superfamily, MAG, is permissive to axonal growth during embryonic development. yet
is highly inhibitory in the adult. For example. growth of embryonic E 1$ RGCs or DRGs
younger than P4 is stimulated when plated on MAG substrate, whereas older RGCs or
DRGs are stunted when grown on this same substrate (DeBellard et al., 1996; Cai et al.,
2001). This suggests that. as with RPTP-a, there is a developmental switch that changes
MAG from being growth promoting to growth inhibitory. It will therefore be interesting
to compare the rates of axonal extension of RPTP-a (-I-) and wild-type RGC cultures at
various developmental stages (embryonic versus postnatal).
Nevertheless, not ail RPTPs bare the same quaternary structures and therefore the
mechanisms of action observed in the aforementioned RPTPs cannot be extrapoiated to
ail RPTPs. For example, the crystal structure ofthe type II RPTP-i and LAR reveal that
in these RPTPs. the helix-tum-helix dornain that blocks phosphatase activity in RPTP-a
would flot be able to interact with the opposing monomer because of steric hindrance
(Hoffmann et al.. 1997; Nam et al., 1999). Therefore, a model reconciling all RPTPs
cannot yet be built.
5.6.3 Separate Functions for the Extracellular and Intracellular Domains
Another possibility is that ligand binding does flot influence phosphatase activity.
It is possible that the extracellular domains of RPTPs merely act as celi adhesion
molecules or as part of a receptor complex, independent of their cytoplasmic activity.
The extracellular domains might contribute to localizing the RPTPs to defined regions of
the plasma membrane where their catalytic activity is required. such as at focal adhesion
sites (fAs) (Serra-Pages et al., 1995). while the intracellular domains would be entirely
controlled by cytoplasmic effector proteins.
Several studies in which RPTP loss of function mutants are rescued demonstrate
that the catalytic activity of the phosphatase is essential for proper function. for
example. the phenotype of mutant Drosophila phosphatase. DPTP69D. cannot be
rescued with catalytically inactive DPTP69D (Garrity et al., 1999). Furthermore,
removing the phosphatase activity of PTP-p. simulates its loss of function phenotype
with regards to axonal outgrowth on N-cadherin (Burden-Gulley and Brady-Kalnay,
1999). while the rescue of the mutant phosphatase Clr-1 phenotype in C. elegans also
requires PTP catalytic activity (Kokel et al., 1998). Although these studies demonstrate
the need for phosphatase activity, they do not indicate that the catalytic fiinction is
modulated by ligand binding and therefore we do flot rule out a mechanism in which the
extracellular and intracellular constituents function independently.
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5.7 RPTPS AND GROWTH DYNAMICS
5.7.1 Cytosolic Effectors of RPTP Signaling
Contrariiy to RTKs which add phosphate groups to their substrates. RPTPs
remove phosphate groups, thereby making the identification and detection of substrates
more difficuit. An efficient strategy to detect the downstream targets of RPTP activity
has yet to be devised even if a few candidate moiecuies have been identified, using
substrate-trapping mutants and yeast interaction assays. for exampie, Abieson (Ahi), a
non-receptor protein tyrosine kinase, was shown in Drosophila to be antagonistic
towards the DLAR (a DrosophiÏa type lia phosphatase) signaling pathway (Wiiis et ai.,
1 999a). Overexpression of Ahi yieids a DLAR (-I-) phenotype whiie co-expressing wiid
type Ahi and DLAR, rescues this effect. Moreover, suppressing the Abi gene reverses
the DLAR mutant phenotype. Aithough a direct in vivo interaction has yet to be shown,
in vitro studies have demonstrated that the cytopiasmic domain of DLAR binds to,
recruits and dephosphorylates the Ahi kinase. These resuits strongly suggest, that DLAR
and Ahi mediate opposite effects on the same substrates (Wiiis et ai., 1 999h) (Figure 5-
1, f,p.231).
To further eiucidate the downstream events in this pathway, genetic screens to
determine potentiai substrates for Ahi have identified Enabie (Ena) as a likeiy candidate.
This actin binding protein. binds the phosphatase domains of DLAR (and DPTP69D) in
vitro and can itseif be phosphoryiated by Abi and dephosphoiyiated by DLAR (Wiiis et
ai., 1 999a). In addition phosphoryiation ievels of Ena are severaily reduced in Ahi
mutants, further suggesting that Abi is a substrate for Ena (Gertier et ai., 1995).
The role of Ena on axonai elongation is likely to be mediated through its actin
binding domain which associates with the barbed end of actin filaments and promotes
growth by interfering with actin-capping proteins (Bear et al., 2002). Ena lias also been
shown to interact with profilin (Reinhard et al., 1995). Although the exact flinction of
profilin in the Abi pathway remains unclear. it plays an important role in motor axon
outgrowth by regulating the growth cone actin cytoskeieton (Wiiis et al., 1999b). The
involvement of Abi and Ena in the signaling of a type lia phosphatase offers a direct iink
between this phosphatase signaling and the actin cytoskeleton (Figure 5-l, F, p.23 1).
5.7.2 RPTPs and Rho GlPases
AÏthough a clear picture of RPTP signaling remains to be elucidated. certain data
suggest that RPTPs are regulators of the Rho famiiy of GTPases. The Rho guanine
exchange factor (GEF), Trio, was shown to physically associate with the cytoplasmic
domain of mammalian LAR (Debant et ai., 1 996a) and chick-PTP-a (Johnson et al.,
2003) (figure 5-1, F, p.23l). Trio consists ofthree domains: two GEF domains (GEf
Dl and GEf-D2) and a protein kinase domain (Debant et al., 1996). In vitro, the GEF
Dl domain lias Rad activity and GEf-D2 RhoA GEF activity. Interestingly,
overexpression of dominant negative Rad yields a DLAR (-/-)-like axon guidance
phenotype (Kaufmaim et al., 1998), supporting that Trio is acting on Rad, downstream
of DLAR. Concurrently, in vivo, Trio was found to enhance Ahi and interact with Ena
(Liebi et ai., 2000). Nevertheless, whiie Trio is cleariy involved in a variety of
cytoskeletai remodeiing events (Seipel et al., 1999; Biangy et ai., 2000), its function
downstream of type lia RPTPs remains to be defined.
5.8 ERK1/2 ACTIVATION AND RGC REGENERATION
In this thesis, we showed two in vivo examples in which an increase in axon
regeneration correlated with an increase in Erkl/2 phosphorylation. In the first case, we
demonstrated that FGF-2 upregulation increased the leveis of activated Erk 172 and that
this rise was essential for regenerative growth. In the second scenario, we showed that
removal of the gene coding for RPTP-a significantly enhanced axonal regrowth afier
injury and promoted constitutive activation of Erkl/2. Whiie both studies indicated that
Erkl/2 activation correlates with axonal growth, the downstream targets of Erkl/2
remain to be determined. Several prospective substrates for Erkl/2 phosphorylation can
influence axon growth. For example, Erkl/2 can activate nuclear transcription factors
sucli as CREB that participate in gene expression and soma! protein synthesis (Grewal et
ai., 1999 ) an influence axonal growth. Other attractive substrates inciude microtubule
associated proteins (MAPs) such as Tau and MAP2 (Roder et ai., 1993; Garcia Rocha
and Avila, 1995) and neurofliament proteins (Veeraima et ai., 1998) which are ah
involved in the process of axonal growth. Lastiy, the translational repressor eIF-4EB 1
and transiational activator eIF-4E at axonal terminais (Campbeil and Holt, 2001; Ming et
al., 2002) have been shown to be stimuiated by Erk 1/2 with implications on local
protein synthesis and axonal guidance, but may be aiso be an interesting target to
consider for axonai growth.
Interestingiy, recent work from our laboratory has shown that robust activation of
the Erkl/2 pathway, although beneficial for neuronal survivai, is in itself insufficient to
promote regrowth (Pemet et ai. 2005). In this study, a constitutively activated MEK1
(MEK.CA) construct was delivered to RGCs by means of an AAV, but was compietely
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incapable of enhancing growth after injury. There are at least two possible explanations
to reconcile these findings with my observations: either 1) a separate pathway must be
co-activated in order to obtain growth (figure 5-l. C. p.23 1) or. 2) over-activation of the
Erkl/2 pathway may have adverse affects on axonal integrity.
5.8.1 MAPKIErk1/2 may Require a Co-signaJ to Promote Axon Growth
We dernonstrated in Chapter 3 that Erkl/2 is required for RGC re-growth, yet
Erkl/2 alone does flot promote RGC regeneration (Pemet et al., 2005). These data
suggest that Erkl/2 is permissive towards growth, but another independent signal is
simultaneously or subsequentiy required to trigger growth. This mode] wouid reconcile
why Erk 1/2 is needed to promote growth, but incapable of stimulating it when
upreguiated by itself. Evidence for this cornes from in vivo experiments. where the
MAPK cascade is required for the differentiation of naive PC 12 celis to a neuronal like
state (Pang et al., 1995) and yet. once they take on a neuron-like phenotype. the MAPK
pathway is no longer required for neurite outgrowth (Sano and Kitajirna, 1998). In this
situation, MAPK is permissive but not instructive in the process leading to axonal
growth. Similarly, in Chapter 3, we found that transiently blocking MAPK during the
initial response to injury severely compromised the ability of RGCs to regenerate. This
suggests that Erk 1/2 is an essential signai in the initial phase of growth. We also
examined the involvement of PKCŒ, PLCy and AKT; ail downstream effectors of fGfR
and ail having documented roies in axonal growth (Huang and Reichardt. 2003: Segal.
2003; Doherty and Walsh, 1996; Boilly et al., 2000). These pathways, were flot activated
after AAV.fGf-2 injection, however. Thus it is likeiy that other yet to be identified
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cascades must be activated concurrently with MAPK to achieve CNS axonal
regeneration.
5.8.2 Adequate Levels of Erkl/2 are Required for Axonal Growth
Paradoxically, over activation of Erkl/2 may be detrimental to the neuron (Pei et
al.. 2002; ferrer et al., 2003). Point mutations in the catalytic domain ofMEK1 (as those
in MEK1 .CA) resuit in a four to five-hundred fold increase in activity. This level of
activation may deviate from physiologically relevant level s and have detrimental effects
on the stability of certain secondary substrates of MEK1, such as the microtubule and
neurofflament networks. These could be consequently severely destabilized as a resuit of
over-phosphorylation and hence be unable to adequately elongate (Roder et al., 1993;
Garcia Rocha and Avila. 1995; Veeranna et al., 199$). for example, elevated levels of
phospho-MEK1 and phospho-Erkl/2 have been associated with the progression of
neurofibrillary degeneration in Alzheimef s disease (Pei et al., 2002). Similarly, elevated
levels ofphospho-Erkl/2 have been detected in neurofibrillary tangles and pre-tangles in
familial tauopathies (ferrer et al., 2003).
5.8.3 fGF-2 and Erkl/2 Activation
If Erkl/2 requires a specific window of activation intensity to promote growth,
how would fGf-2 induce adequate stimulation of this pathway? Interestingly. fGf
receptors have a built in “capacitor” that permits them to modulate the intensity of their
cascades. Studies have shown that regardless of the stimulus, the signaling pathways
activated by fGfRs are heavily conserved, varying primarily in intensity (Raffioni et al.,
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1999). This intrinsic adjusting mechanism suggests that the intensity at which a given
pathway is stimulated may in fact be a crucial variable for biological function. In
addition. it ensures that the signaling cascades originating from FGFRs remain at
phsiological levels and consequently have physiologically relevant effects.
5.8.4 RPTP-a and Erkl/2 Activation
How is Erkl/2 activated in RPTP-c (-7-) mice and does its activation promote
axonal growth? To explain the elevated levels ofphospho-Erkl/2 observed in RPTP-a t
I-) mice, the catalytic substrate of this phosphatase would have to be an upstream
element in the MAPK pathway. For example, in a wild-type animal, the activated RPTP
a would repress the given upstream signaling effectors that activate Erk 1/2. Conversely,
in absence of RPTP-a or when in an inactive state. the upstream activators in these
pathways would remain phosphorylated and consequently, Erk 1/2 would be tumed on
(Figure 5-2).
The activation of MAPKs requires phosphorylation of both a tyrosyl and a
threonyl residue. Therefore. either a dual specificity phosphatase (DSP) ffiat can
dephosphorylate both phospho-Tyr and phospho-Thr or two distinct single specificity
phosphatases that can separately remove each phosphate group would be needed to
silence MAPKs (Tonks and Neel, 2001). For this reason, it is unlikely that RPTP-c
(which can only catalyze the dephosphorylation of tyrosyl groups) acts directly on the
MAPKs. It probably does so through intermediaries. AlternativeÏy. RPTP-a may
modulate Erk 1/2 by directly influencing the signaling of RTKs. This can be
accomplished either by limiting ligand independent signaling (Jallal et al., 1992) or by
controlling the phosphorylation levels of activated RTKs (Sorby and Ostman, 1996).
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Model for RPTPa-mediated activation ofErkl/2.
RPTPG (-I-) mice show endogenously elevated levels of activated Erkl/2, indicating that
RPTPa suppresses ErkÏ/2 in wild-type animais. Because Erkl/2 is activated by
phosphorylation of both a threonyl and a tyrosyl residue, RPTPY (being a tyrosine
phosphatase) could flot by itselftum off Erkl/2. Therefore, when in an active state, RPTPa
may either: 1) silence (de-phosphorylate) an activator ofErkl/2 (pink oval) or 2) activate a
repressor of Erkl/2 (orange oval). Both mechanisrns can either act alone or as part of a
signaling pathway. The pink square (3) represents an intermediary effector in a stimuiatory
pathway while the blue ovai (4) represents an effector in an inhibitory pathway.
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5.10 GENERAL CONCLUSIONS
The research presented in this thesis focused on strategies to promote the survival
and regeneration of RGCs afier axonal transection. Our approach consisted in altering
leveis of two selected genes that are abundantly expressed in the developing nervous
system: FGf-2 and RPTP-a. In the first study. presented in Chapter 2 of this thesis, we
made use of AAV vectors to re-express the FGF-2 gene within mature RGCs and
studied its effects on survival and regeneration. This work provided the first evidence
that a viral-based in vivo ocular gene therapy can be used to enhance axonai regrowth
afier acute injury of aduit CNS neurons. Furthermore, it demonstrated that fGF-2,
known to be an important modulator of axonal growth during development, may be
hamessed to play a beneficial role in aduit CNS regeneration.
These investigations were pursued in Chapter 3 by examining the signaling
mechanisms underlying the observed regrowth. These experiments identified a central
role for the MAPKs Erkl/2 in this process. Aithough our work strongly suggested the
participation of Erk 1/2 in FGf-2-mediated axonai regrowth, it is iikely that other, yet to
be identified pathways, need to be co-activated to ensure adequate regrowth.
In Chapter 4 of this thesis, we investigated the role of RPTP-a on RGC survival
and regeneration. Although the retinas and optic nerves of RPTP-a (-I-) mice did not
show any morphological or cellular alterations when compared to wiÏd-type animais, we
observed a significant increase in aduit RGC axonal regeneration. This enhanced growth
was once again accompanied by increased Erkl/2 activation.
The studies described in this thesis heiped identify two candidate moiecules,
fGf-2 and RPTP-a, whose leveis may 5e modulated to enhance CN$ axonai regrowth
244
in the aduit. The advent of novel and more penetrant strategies to regulate gene
expression as well as the combination with approaches designed to overcome the myelin
inhibitory environment are likely to yield even more promising resuits. Lastly, in this
thesis we have outlined strategies that demonstrate the merits of gene modulation as an
approach to enhance the regenerative capacities of aduit lesioned CNS fleurons.
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ABSTRACT
Injury-induced downregulation of neurotrophin receptors may limit the response
of neurons to trophic factors comprornising their ability to survive. We tested this
hypothesis in a model of CNS injury: retinal ganglion celi (RGC) death following
transection of the aduit rat optic nerve. TrkB rnRNA rapidly decreased in axotornized
RGCs to 5O% of the level in intact retinas. TrkB gene transfer into RGCs cornbined
with exogenous BDNF administration markedly increased neuronal survival: 76% of
RGCs remained alive at two weeks afler axotorny, a time when >90% of these neurons
are lost without treatment. Activation of MAP kinase, but not PI-3 kinase, was required
for TrkB-induced survival. These data provide proof-of-principle that enhancing the
capacity of injured neurons to respond to trophic factors can be an effective
neuroprotective strategy in the adult CNS.
Key words: retinal ganglion cells, axotorny, gene transfer, TrkB, MAP kinase, ceil
survival
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INTRODUCTION
Trauma or disease ofien leads to neuronal ceil death and loss of functional
connections. Strategies to promote the recovery of the injured central nervous system
(CNS) have been limited by the death of large numbers of neurons soon after damage.
Neurotrophins play important roles in the survival response of aduit neurons afier injury
(Lewin and Barde, 1996; Sofroniew et al. 2001; Huang and Reichardt, 2001). In the
visual system, brain-derived neurotrophic factor (BDNF) has been identified as a potent
survival factor for axotornized retinai ganglion ceils (RGCs) (Mey et al., 1993;
Mansour-Robaey et al., 1994; Aguayo et al. 1996; Peinado-Ramon et al., 1996; Kkicker
et ai., 1998; Chen and Weber, 2001), known to express the BDNF receptor TrkB (Jelsma
et al., 1993; Pérez et al., 1995; Rickman et al., 1995). for example, a single intravitreal
injection of BDNF supports the survival of virtually ail RGCs up to one week afier
axotorny (Mansour-Robaey et al., 1994). In contrast, nearly one-haif of axotornized
RGCs die in untreated retinas.
Long-terrn studies on the survival of RGCs have demonstrated that the effect of
exogenous BDNF is ternporary: it delays, but does flot prevent, the onset of RGC death
(Mansour-Robaey et ai., 1994; Di Polo et al., 1998, Ciarke et ai., 1998). Administration
of BDNF by repeated intravitreal injections or osmotic rninipumps failed to extend the
time-course of RGC protection (Mansour-Robaey et al., 1994, Clarke et ai., 1998).
Moreover, delivery of BDNF by adenovirus-infected retinal giial ceils provided a
sustained source of neurotrophin but resulted in transient RGC rescue (Di Polo et al.,
1998). The mechanisrn underiying this loss oftrophic support is poorly understood.
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A possible explanation for the short-lived neuroprotective effect of BDNF is that
the intrinsic capacity of RGCs to respond to this neurotrophin is compromised by injury
(Di Polo et al. 199$). To test this hypothesis we addressed the following questions. First,
are there axotomy-induced changes in TrkB gene expression in aduit RGCs? Because
TrkB mediates the response of RGCs to BDNF, we examined if axotomy leads to
detectable changes in TrkB mRNA synthesis. Second, does in vivo upregulation of TrkB
receptor expression extend RGC survival? b address this issue, we used recombinant
adeno-associated viral (AAV) vectors to deliver the TrkB gene into aduit RGCs. In
contrast to adenovirus, AAV evokes minimal immune response in the host (Xiao et al.,
1996; Xiao et al., 1997) and mediates long-terrn transgene expression that can persist in
the retina for at least one year afier vector administration (Dudus et al., 1999; Guy et al.,
1999).
Finally, what signaling pathways mediate survival triggered by TrkB activation
in adult RGCs in vivo? Upon binding to Trk receptors, neurotrophins stimulate multiple
signaling pathways, including the MEKlmitogen activated protein (MAP) kinase and the
phosphatidylinositol 3 (PI-3)/Akt kinase pathways (Segal et al., 1996; Kaplan and
Miller, 2000). Studies on the participation of these pathways in neurotrophin-induced
survival have been lirnited to neurons in culture (Xia et al., 1995; Bartleff et al., 1997;
Dudek et al., 1997; Crowder and Freeman, 199$; Meyer-Franke et al., 199$; Skaper et
al., 199$; Bonni et al., 1999; Dolcet et al., 1999; Klesse et al., 1999; Atwal et al., 2000;
Orike et al., 2001) or at early developmental stages in vivo (Anderson and ToÏkovsky,
1999; Hetman et al., 1999; Hee Han and Holtzman, 2000). Thus, the role of
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neurotrophin-activated signaling pathways in the survival of aduit CNS neurons in vivo
rernains undefmed.
In this study, we demonstrate that TrkB mRNA levels are reduced in RGCs soon
afier transection of the optic nerve and before the onset of ce!! death. TrkB gene delivery
to RGCs, in combination with exogenous BDNF, marked!y extends the survival ofthese
neurons fo!lowing axonal injury. Our resu!ts indicate that activation ofthe MEK/MÀPK
pathway, but not the PI-3K/Akt pathway, mediates TrkB-induced RGC rescue.
MATERIALS AND METHOUS
Quantitative hi Situ Hybridization
Antisense o!igonuc!eotide probes corresponding to base pairs (bp) 2324-236$ of
the tyrosine kinase dornain of ftill-!ength rat TrkB (44-mer) and bp 1 $99-1944 of the
tyrosine kinase dornain of full length rat TrkC (4$-mer) were labeled with 35S-dATP
(NEN, Markham, ON) using termina! deoxynucleotidyl transferase (GIBCO
Bioteclmo!ogies, Burlington, ON). These probes correspond to non-homologous regions
of TrkB or TrkC cDNAs, respectively. In sittt hybridization was perforrned on radial
cryosections (7-10 im) prepared from fresh retinal tissue. Hybridization was carried out
essentia!ly as described (Danger!ind et al., 1992). Briefly, sections were hybridized
overnight at 42°C with 1 0 cpm of radiolabeled probe in 1 ml of hybridization solution
in saline sodium citrate (SSC) containing formamide (50%), dextran sulfate (100 g/lt),
sarcosyl (1%), phosphate buffer (20 mM, pH 7.0), salmon sperm DNA (500 gI!t), and
dithiothreito! (200 mlvi). Following hybridization, s!ides were washed in SSC and then
dehydrated in ascending concentrations of ethanol. Slides were dipped in Kodak NTB2
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autoradiographic emulsion (Kodak, Rochester, NY), dried and stored in a light proof box
at 4°C for 1-2 months. Sections were then developed for 5 min in Kodak D-19 at 20°C,
rinsed and fixed for 5 min in Kodak fix. Tissue sections were counterstained with 0.25%
thionin (Sigma, Oakville, ON) and mounted in Entellan (VWR, Mississauga, ON).
Negative controls included sections hybridized with sense probes, sections treated with
RNAse A (50 tg/m1, Boehringer-Mannheim, Lavai, QC) at 37°C for 30 min and siides
incubated with 1 00-fold excess of unlabeled TrkB or TrkC receptor probe. An image
analysis system (Imagel, Universal Imaging Corp., West Chester, PA) was used to
determine the number of autoradiographic silver grains per neuron. The average number
of grains per RGC was counted for experimental and control retinas, mounted on the
sarne siide, and normalized to the levels found in the corresponding contralaterai intact
retina. Data and statistical analysis was performed using SigmaStat (Jandel, Corte
Madera, CA).
Preparation of Recombinant AAV Vectors
A construct containing a c-myc epitope tagged form of full-length rat TrkB,
provided by Dr. P. Barker (McGill University), was used to generate AAV vectors. The
TrkB gene was inserted downstream of the CMV promoter in plasmid pTR-UF5
(Zoiotukhin et al., 1996) containing the AAV terminal repeat sequences and a simian
virus 40 poiyadenylation sequence. An AAV control vector containing the GFP gene,
but lacking the TrkB gene, was generated in identical fashion. Packaging of AAV
vectors was performed as described previously (Hauswirth et al., 2000). Briefly, low
passage human 293 celis were co-transfected with pTR-UF5-TrkB and the helper
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plasmid pDG (Grimm et al., 199$) that contains both the AAV genes (rep and cap) and
the adenovirus genes required for AAV propagation. Afier harvesting the celis, the virus
was extracted by freezing and thawing the celis and the supematant was then clarffied by
low speed centrifugation. Crude celi lysates containing AAV were loaded onto Iodixanol
(Nycomed Pharma, Denmark) density step gradients for purification. The fraction
containing AAV was further purified by heparin affinity chromatography (Sigma).
Purified AAV was concentrated and desalted by centrifugation through Biomax 100K
filters (Millipore, Mississauga, ON) according to the manufacturer’s instructions. Viral
titers, determined by quantitative-competitive polymerase chain reaction and by
infectious center assay (Hauswirth et al., 2000), were in the order of 5 x 1012 physical
particles/rnl. No helper virus was used in this preparation to avoid contamination of
AAV stocks with adenovirus. Wild-type AAV contamination was below the levels of
detection (one part in 10v).
Surgical Procedures
Animal procedures were performed in accordance with the guidelines for the use
of experimental animals (Olfert et al., 1993). Ah surgeries were performed in female
adult Sprague-Dawley rats (1 $0-200 g) under general anesthesia (7% chloral hydrate;
0.42 mg per g of body weight, i.p.). Viral vectors (5 tl total volume) were injected into
the vitreous chamber in the dorsal hemisphere of the lefi eye using a 1 0-fil Hamilton
syringe fifted with a 32-gauge needle. The tip of the needle was inserted through the
sciera and retina into the vitreous space using a posterior approach. This route of
administration avoided injury to other structures of the eye, such as the iris or lens,
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shown to promote ROC survival (Mansour-Robaey et al., 1994; Leon et ai., 2000). The
right eye was lefi untouched and served as internai contralateral control for each animal.
for RGC survival experiments, ceils were retrogradeiy Iabeied with 2% FluoroGoid
(Fluorochrome, Engiewood, CO) in 0.9% NaCl containing 10% dimethyl sulfoxide
(DMSO) by application of the tracer to both superior coiliculi. Seven days later, the lefi
optic nerve was transected 0.5-1 mm from the optic nerve head. In some experimental
groups, the following agents were injected intravitreally in the superior hemisphere in a
total volume of 5 d at the time of axotomy: the MEK inhibitor PD9$059, 100-200 iM
in phosphate buffered saline (PBS) containing 20% DM50 (New England Biolabs
[NEB], Mississauga, ON); the PI-3 kinase inhibitor LY294002, 100-$00 tM in PBS
with 20% DMSO (Sigma); BDNF protein, 1 jig/pJ in PBS containing 1% bovine serum
albumin (provided by Regeneron Pharmaceuticals, Tarrytown, NY) or vehicle (PBS or
PBS containing 20% DMSO). Rats were sacrificed by intracardial perfusion with 4%
paraformaldehyde and both the left (optic nerve lesion) and right (intact control) retinas
were dissected, fixed for an additional 30 min and flat-rnounted vitreal side up on a glass
siide for examination ofthe ganglion ceil layer.
Immunocytochemistry
Rats were perfiised intracardially with 4% paraformaldehyde in 0.1 M phosphate
buffer (PB, pH 7.4) and the eyes were immediately enucleated. The anterior part of the
eye and the lens were removed and the remaining eye cup was immersed in the same
fixative for 2 hr at 4°C. Eye cups were equilibrated in graded sucrose solutions (10-30%
in PB) for several hottrs at 4°C, embedded in O.C.T. compound (Tissue-Tek, Miles
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Laboratories, Elkhart, IN) and frozen in a 2-methylbutane/liquid nitrogen bath. Radial
cryosections (6-12 im) were collected onto gelatin-coated slides and processed.
Sections were incubated in 10% normal goat serum (NGS), 0.2% Triton X-100 (Sigma)
in PBS for 30 min at room temperature to block non-specific binding. Each prirnary
antibody was added in 2% NGS, 0.2% Triton X-100 and incubated ovemight at 4°C.
Sections were then incubated with the appropriate secondary antibody for 1 ht at room
temperature, washed in PBS, mounted using an anti-fade reagent (Slowfade, Molecular
Probes, Eugene, OR) and visualized with fluorescent microscopy (Zeiss Axioskop 2
Plus) Antibodies: Anti-c-rnyc antibody (5 jig/ml; Oncogene, Cedarlane Laboratories,
Homby, ON), Anti-GFAP (5 ig/ml; Chemicon International, Temecula, CA), Anti
Vimentin (5 ig/pi; Chernicon), FITC-conjugated Isolectin B4 (20 jig/ml, Sigma) and
ED-1 (10 tg/rnl, Chemicon), fluorophore-conjugated goat anti-mouse IgG (red, 4 ig/ml,
AlexaTM 594, Molecular Probes).
Neuronal Quantification
For quantification of AAV-mediated TrkB expression in neurons in the ganglion
cell layer, histological sections of the retina were produced along the dorsal-ventral
plane of the eye and serial sections that passed through the optic nerve head, used as
reference, were analyzed. The entire number of labeled cells per section was then
counted using a fluorescent microscope. Six to eight serial sections per eye were
typically counted per experirnental animal. For neuronal survival studies, the ganglion
cell layer was examined in whole-mount retinas with fluorescence microscopy and
fluoroGold-labeled neurons were counted in 12 standard retinal areas as described
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(Villegas-Perez et al., 1993). Data analysis and statistics were performed using the
SigmaStat program (Jandel) by a one-way ANOVA or a Student’s t test (paired groups).
Western Blot Analysis
Fresh retinas were rapidly dissected and homogenized with an electric pestie (Kontes,
Vineland, NJ) in ice-cold lysis buffer: 20 mM Tris (pH 8.0), 135 mM NaC1, 1% NP-40,
0.1% SDS and 10% glycerol supplemented with protease inhibitors (1 mM
phenylmethyl sulfonyl fluoride, 10 jig/ml aprotinin, 1 tg/m1 leupeptin, and 0.5 mM
sodium orthovanadate). After incubation for 30 min on ice, homogenates were
centrifuged at 10,000 rpm for 10 mm, the supematants were rernoved and resedimented
for an additional 10 min to yield solubilized extracts. Altematively, 200-300 tg of
protein was imnmnoprecipitated with anti-pan Trk 203, provided by D. Kaplan, as
described (Stephens et al., 1994). Retinal extracts (75-100 tg) or irnmunoprecipitated
samples were resolved on 8% SDS polyacrylamide gels and transferred to nitrocellulose
filters (Bio-Rad Life Science, Mississauga, ON). To block non-specific binding, filters
were placed in 10 mlvi Tris (pH 8.0), 150 mM NaC1, 0.2% Tween-20 (TBST) and 5%
dry skim milk for 1 hr at room temperature. B lots were then incubated for 16-18 hrs at
4°C with each of the following primary antibodies: anti-phospho-p44/42 MAP kinase
(0.8 ig/ml, NEB), anti-p44/42 MAP kinase (20-$0 ng/ml, NEB), anti-phospho-Akt (0.6
ig/ml, NEB), anti-Akt (0.1 ig/ml, NEB) or anti-phosphotyrosine (4Gb, 1 ig/ml,
Upstate Biotechnology, Waltham, MA). Membranes were washed in TBST and
incubated in anti-rabbit or anti-mouse peroxidase-linked secondary antibodies (0.5
tg/m1, Amersham Pharmacia, Baie d’Urfé, QC) for 1 hr at room temperature. Blots
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were developed with a chemiluminescence reagent (ECL, Amersham Pharmacia) and
exposed to X-OMÀT (Kodak) imaging film.
RESULTS
TrkB mRNA Levels are Downregulated in Axotomized RGCs
We investigated the changes in TrkB gene expression in axotomized RGCs by
quantitative in situ hybridization. An oligonucleotide probe specific for the catalytic
domain of full-length rat TrkB was used in these experiments. Probe hybridization to
intact retinas produced a robust positive signal, visualized by dark field microscopy at
low magnification, in cells ofthe ganglion celi layer and inner nuclear layer (Figure lA).
One week afler axotomy, the hybridization signal was markedly reduced only in the
ganglion celi layer (Figure lB). No signal was detected in retinal sections hybridized
with a sense probe or treated with RNAse A (flot shown). The number of
autoradiographic silver grains was quantified in single RGC celi bodies, visualized with
thionin staining in intact and injured retinas using bright field microscopy (Figures YC
and 1D). Experimental and control retinas were mounted on the same siide and
processed under identical conditions. As early as three days afier axotomy, TrkB inRNA
in RGCs was decreased by 40% (11.9±4 grains/cell, mean ± standard deviation)
relative to unoperated contralateral retinas (l00%= 20.3±2 grains/cell) (Figure lE). The
decline in TrkB gene expression was detected prior to the onset of RGC death that
typically starts at five days post-axotomy (Berkelaar et al., 1994). The average number
of grains per RGC continued to decrease during the first week afier injury and remained
low, between 45% (8.9±4 grains/cell) and 60% (12±2 grains/cell) of the contralateral
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control levels, thereafier. These resuits indicate that the reduction of grain density in
RGCs can flot be attributed to ceil death caused by axotomy but to reduced TrkB mRNA
levels in surviving RGCs. Amacrine celis, which are known to express TrkB (Cellerino
and Kohier, 1997), populate the inner nuclear layer and the ganglion ceil layer (Perry,
1981) but do not project axons to the optic nerve. Because amacrine ceils are typically
smaller than RGCs, cellular profiles of less than 70 jim2 were identified as amacrine
celis as described (McKerracher et al., 1993). In contrast to RGCs, TrkB mRNA levels
in amacrine ceils remained unchanged after axotomy (Figure 1 F) confirming our ability
to distinguish between these two cellular populations.
AAV-mediated TrkB is Predominantly fxpressed by Aduit RGCs
For gene transfer experiments, a recombinant AAV vector containing a c-myc
tagged full-length rat TrkB gene under control of the CMV promoter was produced.
Intravitreal injection of AAV.TrkB resulted in TrkB protein expression exclusively in
the ganglion cell layer, as detected by immunostaining with an antibody against c-myc
(Figure 2A). No other retinal layer showed positive c-myc immunostaining. Robust c
myc labeling was localized on neuronal celi bodies and RGC axons in the fiber layer.
Intact contralateral retinas or retinas infected with a control virus did not show positive
c-myc staining. Because displaced amacrine ceils account for 40% of the total number
ofneurons in the ganglion ce!! layer ofthe rat retina (Perry, 1981), we sought to identify
the cellular targets of AAV infection in this system. For this purpose, we performed co
localization studies in retinas from eyes that received a single intravitreal injection of
AAV.TrkB fo!!owed by retrograde labe!ing of RGCs with the tracer FluoroGold applied
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to both superior colliculi. Double-labeling experiments demonstrated that the majority of
RGCs, visualized with FluoroGold (Figure 2B), also produced virally-rnediated TrkB
(Figure 2C). AAV.TrkB transgene expression reached a plateau at 3-4 weeks aller
administration of the vector and persisted for at least 10 weeks in the intact retina. The
rnechanism underlying the delay in the onset of gene product expression in vivo,
characteristic ofAAV vectors (Malik et al., 2000), remains undefmed but may be related
to the need to convert input viral single-stranded DNA to a double-stranded form prior
to gene expression (Ferrari et al., 1996).
To determine the efficacy of aduit RGC transduction by AAV, we quantified the
number of c-myc and FluoroGold-labeled celis in retinal sections at 4 weeks aller vector
administration. An average of 68% of FluoroGold-labeled neurons were also c-myc
positive, indicating that RGCs were successfully transduced by the AAV.TrkB vector
(Figure 2D). A srnall population of c-rnyc positive celis ($%) was flot labeled with
FluoroGold and may represent amacrine celis transduced by AAV or RGCs that did flot
incorporate the retrograde tracer. Immunostaining with an antibody against guai
fibrillary acidic protein (GFAP) or virnentin, in combination with c-myc, did flot show
co-Iocalization (not shown), indicating that glial cells in the retina were flot infected by
AAV. Taken together, these resuits indicate that RGCs are the primary target for AAV
transduction in the aduit iimer retina.
TrkB Upregulation Protects RGCs from Axotomy-Induced Ccli Death
The effect of AAV.TrkB on RGC survival in vivo was tested using the
experimental protocol outlined in Figure 3A. Four weeks aller intraocular injection of
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viral vectors, RGCs were retrogradely labeled and subsequently axotomized. Retinas
were examined histoiogicaiiy at 7, 14, 21 and 2$ days afier optic nerve transection to
determine the density of surviving RGCs (figure 38 and Table 1). A single intraocular
injection of AAV.TrkB resuited in moderate, but significant, neuroprotective effect at
one and two weeks afier axotomy. for example, AAV.TrkB supported the survival of
27% of RGCs compared to 9.6% neuronal survival induced by the control virus at two
weeks afier injury. We then examined if AAV.TrkB treatment combined with a single
intravitreal injection of BDNF protein at the time of axotomy could potentiate RGC
survival. This approach yielded markedly higher RGC densities at ail times examined
(Figure 38). At two weeks afier axotorny, AAV.TrkB with BDNF protected 76% of
RGCs while independent administration ofBDNF or AAV.TrkB promoted 38% or 27%
neuronal survival, respectively. This effect, although reduced, was stiii significant at
three and four weeks afler axotomy resulting in higher neuronal densities and befter
preservation of ceilular integrity than with AAV.TrkB (Figure 4A and 4B) or BDNF
alone.
To determine whether TrkB gene transfer was involved in this effect, we
examined the correlation between neuronal survival and transgene product expression.
At three weeks afier axotomy, virtually ail surviving RGCs (--96%) aiso expressed
AAV-mediated TrkB (Figures 4C and 4D). Positive c-myc staining was cleariy
visualized on the surface of RGCs that remained alive, suggesting that TrkB deiivered
by AAV was effectiveiy transported to the membrane. Together, these resuits strongiy
suggest that upregulation of receptor expression supports RGC survivai in this injury
mode!. Microglia and macrophages, that may have incorporated F!uoroGoid afier
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phagocytosis of dying RGCs, were excluded from our analysis of neuronal survival
based on their rnorphology which can be easily identified in retinal whole mounts
(Figure 4B). In addition, the identity of these celis was confirrned by immunostaining
with antibodies against the microglia and macrophage markers Isolectin-B4 and ED- 1
(not shown).
Retinal MAPK and Akt are Activated Following TrkB Gene Transfer
To identify the signaling pathways involved in AAV.TrkB-induced
neuroprotection we examined whether TrkB gene transfer had an effect on receptor
tyrosine phosphorylation, the initial step for transduction of survival signals. Western
blot analysis of imnrnnoprecipitated Trk proteins using an antibody against
phosphotyrosine dernonstrated TrkB activation at 5 weeks (Figure SA) and 10 weeks
(not shown) following intravitreal injection of AAV.TrkB. We then cornpared AAV
induced TrkB tyrosine phosphorylation with that produced by a single intravitreal
injection of BDNF recombinant protein. Robust TrkB tyrosine phosphorylation was
detected at 4$ hrs afier administration of BDNF (Figure 5A) but flot at 10 days afier
injection of the neurotrophin (not shown). These data indicate that AAV.TrkB induced
moderate but sustained levels of TrkB activation, while BDNF protein provoked robust
but transient stimulation of this receptor. Injection of PBS or AAV.GFP did flot have
any effect on TrkB activation (Figure SA).
We next exarnined the stimulation of known downstream components of the
TrkB signaling cascade, the MAP kinases Erkl/2 and Akt, using antibodies that
specifically recognized the phosphorylated forrns of these kinases. 0f interest, low but
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detectable levels of Erkl/2 and Akt phosphorylation were observed in intact unhijected
retinas indicating basal activation of these kinases (Figures 5B and 5C). In contrast,
intraocular injection of AAV.TrkB, in the absence of exogenous BDNF, resulted in
marked activation of both Erk 1 and Erk2 compared to the low levels of phosphorylation
observed in control retinas injected with PBS (Figure 5B) or AAV.GFP (not shown).
Similarly, a marked increase in Akt phosphorylation was observed following injection of
AAV.TrkB (Figure 5C). These resuits clearly demonstrate stimulation of both the
MAPK and the Akt pathways in RGCs following AAV-rnediated TrkB gene transfer. As
in the case of TrkB phosphorylation, AAV.TrkB-induced activation of Erkl/2 and Akt
was detected at 5 weeks and 10 weeks afier intraocular administration of the viral vector
(Figure 5B and 5C).
TrkB-Induced Survival of Axotomized RGCs In Vivo Occurs Via a MAPK
Dependent Pathway
To determine whether MAPK and/or Akt signaling were involved in TrkB
mediated survival of axotomized RGCs, pharmacological inhibitors of specific
components of each of these pathways were used. PD98059 selectively inhibits IVIEK
(Dudley et al., 1995), the upstream activator of MAPK, and LY294002 is a selective
inhibitor of PI-3K (Weber et al., 1997), an upstream Akt activator. First, we determined
the concentration of these compounds required to effectively block AAV.TrkB-induced
activation of retinal Erkl/2 and Akt in vivo. For this purpose, eyes were injected with
AAV.TrkB and four weeks later, the inhibitor PD9$059 or LY294002 was delivered by
a single injection into the vitreous chamber. Inhibition ofErkl/2 or Akt phosphorylation
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was analyzed by western blots of whole retinal homogenates collected at 48 hrs or 14
days afier administration of each compound (Figure 6). The inhibitory effect of
PD9$059 or LY294002 in vivo was dose dependent. Intravitreal injection of 200 1iM of
PD9$059 effectively blocked Erkl/2 phosphorylation (Figure 6A), and injection of $00
jiM of LY294002 inhibited Akt phosphorylation (Figure 6B). Because the volume of the
vitreous chamber in the aduit rat eye is approximately 60 pi, the final intravitreal
concentration ofthese drugs was -16.7 jiM for PD9$059 and 66.7 jiM for LY294002,
well within the range shown to work effectively in vitro (Atwal et al., 2000). 0f interest,
effective inhibition of AAV.TrkB-induced retinal MAPK and Akt activation was
sustained for at least 14 days following administration of these drugs (Figures 6A and
6B). There was no reduction in the phosphorylation of Erkl/2 in the presence of
LY294002 (Figure 6B). Similarly, phosphorylation of Akt was not decreased with
PD9$059 (Figure 6A). These results confirmed the specificity ofthe inhibitory effect of
each of these cornpounds in vivo. Exarnination of histological sections and whole
mounts of the treated retinas found no inherent toxic or pro-survival effect of these
chemicals.
We then carried out in vivo RGC survival assays after AAV.TrkB delivery in the
presence of PD9$059 or LY294002 injected intravitreally at the time of optic nerve
transection (Figure 7 and Table 1). Administration of PD98059 (200 iM) resulted in
complete inhibition of the survival effect produced by TrkB gene transfer. In this
situation, RGC density was low and similar to that found in retinas treated with the
control virus AAV.GFP. In contrast, blockade of PI-3K activation with LY294002 ($00
iM) did flot change the neuroprotective effect induced by AAV.TrkB. These results
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demonstrate that while the MEK/IVIAPK pathway is essential for TrkB-mediated
survival of injured aduit RGCs in vivo, the PI-3KIAkt pathway has no apparent role in
this survival effect.
DISCUSSION
Injury-induced changes in the expression of critical components of survival
pathways may exacerbate the death of CN$ neurons. Here we demonstrate that
expression of TrkB, a key player in BDNF-induced survival, is downregulated in aduit
RGCs following axotorny close to the eye. The striking reduction in TrkB rnRNA within
two weeks of axotomy correlated with the inability of RGCs to survive in response to
BDNF, despite sustained neurotrophin delivery (Di Polo et al., 1998). Downregulation
of neuronal Trk receptors has been reported in the damaged rat spinal cord (Kobayashi
et al., 1997; Liebl et al., 2001) and brain (Venero et al., 1994) suggesting that this is a
common response to acute injury arnong sorne CNS neurons. In contrast to TrkB, BDNF
rnRNA levels have been shown to increase transiently in cells of the ganglion celi layer
afier optic nerve crush (Gao et al., 1997), but there is no evidence that this local
upregulation delays the onset of RGC death. Taken together, these resuits suggest that
reduced TrkB expression in injured RGCs contributes to their desensitization to
exogenous, and possibly endogenous, BDNF.
This hypothesis was tested by increasing the capacity of axotomized RGCs to
respond to BDNF following TrkB gene delivery. A key issue in the success of these
experirnents was to identify a vector system for efficient infection of adult RGCs in vivo.
Previous studies showed that intravitreal injection of AAV resulted in transduction of
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ceils in the ganglion celi layer (Grant et al., 1997; Ah et al., 199$; Dudus et al., 1999),
but given that both RGCs and amacrine neurons populate this retinal layer, the specific
cellular tropism of this virus was flot established. Our data indicate that RGCs are the
main target for AAV infection in the inner retina. Furthermore, we show that an average
of 68% of the total RGC population was effectively infected by AAV and, in some
individual retinas, up to 75% of RGCs were transduced. Interestingly, heparan sulfate
proteoglycan, the primary receptor responsible for AAV attachment to the host ceil
(Summerford and Samulski, 1998), is expressed on adult RGCs (A. Di Polo,
unpublished observations) providing a likely mechanism behind the tropism ofthis virus
in the inner retina.
Two main findings support our conclusion that AAV.TrkB promotes the survival
of RGCs by augmenting their capacity to respond to BDNF. First, the neuroprotective
effect of AAV.TrkB dramatically increased when it was combined with a single
intraocular injection of BDNF. This survival effect was apparent at ail times examined
but was particularly striking at two and three weeks afier axotomy. for example, an
average of 76% of RGCs remained ahive at two weeks post-axotomy, a time when
typically less than 10% of these neurons survive in the absence of treatment. Although
the total number of neurons in ail experimental groups was lower at three weeks afier
injury, the combined effect of AAV.TrkB and BDNF yielded an -6-fold higher number
of surviving neurons than AAV.TrkB alone. furthennore, AAV.TrkB and BDNF
administration effectively extended RGC survival by at least 10 days, a substantiai
amount of time compared to the shorter effect of BDNF protein alone (Mansour-Robaey
et ai., 1994; Peinado-Ramon et al., 1996; Clarke et al., 199$) or BDNF gene transfer (Di
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Polo et at., 199$) which delayed RGC death by only 2 days. To our knowledge, this
level and extent of survival lias flot been previously achieved in a model of acute RGC
death.
Secondly, we found a tight correlation between expression of AAV-mediated
TrkB and neuronal survival. At three weeks after axotomy, —96% ofthe surviving RGCs
expressed c-rnyc tagged TrkB suggesting that upregulation ofthis receptor increased the
capacity of these neurons to respond to BDNF. Interestirigly, studies using highly
purified post-natal day 8 RGC cultures have shown that TrkB intemalization is likely to
contribute to the loss of trophic responsiveness afler axotorny (Meyer-Franke et al.,
199$; Shen et al., 1999). Although we can not rule out the possibility that TrkB
intemalization restricts RGC survival in this model, our resuits suggest that within the
first weeks of injury a sufficient quantity of virally-delivered TrkB is available to elicit
celi survival following trophic stimulation, perhaps overwhelming any internalization
process.
Our data demonstrate that although both MAPK and Akt pathways were
activated following TrkB gene transfer, only selective inhibition of IvIEK blocked
AAV.TrkB-induced survival while PI-3K inhibition had no effect. This finding strongly
suggests that the MEK/I\4APK pathway, but not the PI-3KIAkt pathway, is necessary for
AAV.TrkB-induced survival of axotomized RGCs. MEK inhibition has also been shown
to block the ability of early post-natal RGCs to survive afler axonal injury (Shen et al.,
1999). Therefore, the MEK/MAPK pathway appears to be a common survival signaling
mechanism used by both developing and adult axotomized RGCs in response to TrkB
stimulation. MEKJ’MAPK activity may regulate the survival of RGCs by activating the
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transcriptional factor CREB, which is known to mediate BDNF-induced survival of
cultured cerebellar neurons (Bonni et al., 1999). 0f interest, CREB phosphorylation in
RGCs lias been observed following BDNF stimulation in mouse retinal organ cultures
(Wahlin et al., 2000).
It is now well established that Trk activation leads to the stimulation of multiple
signaling pathways in the sarne neuron (Segal and Greenberg, 1996; Kaplan and Miller,
1997; Klesse et al., 1999). Recent in vitro studies in NGF-dependent neonatal
sympathetic fleurons, have indicated that while TrkA uses PI-3K to stimulate celi
survival, TrkB uses both PI-3K and MEK (Atwal et al., 2000). There is growing
evidence, however, indicating that the specific role of each of these pathways on Trk
induced survival appears to be tightly dependent on neuronal type and injury modality.
Although the PI-3K pathway is critical in growth factor-rnediated survival upon trophic
deprivation in a variety of PNS and CNS neurons in vitro (Kaplan and Miller, 2000), the
MAPK pathway has been implicated in the survival induced by neurotrophins following
physical or chernical injury. MAPK signaling is also responsible for the in vitro
protection of cerebellar granule neurons from oxidative stress (Skaper et al., 1998),
cortical neurons from camptothecin-induced apoptosis (Hetman et al., 1999), and
sympathetic neurons from cytosine arabinoside toxicity (Anderson and Tolkovsky,
1999). In vivo, the MAPK pathway has been shown to protect the neonatal brain from
hypoxic-ischemic injury (Hee Han and Holtzman, 2000). What then is the role of PI
3K’AKT activation in adult RGCs following TrkB stimulation? Although flot apparently
involved in BDNF/TrkB-induced survival, this pathway may mediate other, as yet
undefined, functions closely related to the RGC response to trophic stimulation such as
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axonal regrowth. Interestingly, the PI-3K pathway has been implicated in RGC
protection by insulin growth factor and tumor necrosis factor alpha (Kermer et al., 2000;
Diem et al., 2001) suggesting that different neurotrophic factors promote the survival of
aduit RGCs by distinct intracellular signaling mechanisms.
In sumrnary, our findings indicate that downreguiation of TrkB foilowing RGC
injury is a key mechanisrn underlying the short-lived survival effect produced
by exogenous BDNF. We report a nove! neuroprotective strategy based on TrkB gene
delivery in vivo that significantly enhances the survival of RGCs following axotomy.
This strategy may have therapeutic potential in the injured CNS, however, future studies
are required to resolve important issues such as the efficacy of this approach in modeis
of protracted neuronal death and to evaluate the functional state of the rescued neurons.
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FIGURES
Figure 1. TrkB mRNA in intact and injured aduit rat retinas
Dark fleld micrographs after in situ hybridization using a probe that selectively
recognizes the tyrosine kinase domain of ftill-length rat TrkB are shown for intact (A)
and axotomized (B) retinas. TrkB mRNA is predominantly expressed in RGCs and
displaced amacrine celis in the ganglion ce!! layer (GCL), as well as in amacrine ce!ls in
the inner nuc!ear layer (TNL). Afier transection of the optic nerve, TrkB inRNA was
reduced only in ceils ofthe GCL (B, I week afier axotorny). Bright field rnicrographs of
the RGC layer of intact (C) and axotornized retinas (D, I week afler axotomy) from
sections counterstained with toluidine blue were used to quantify the number of grains
corresponding to the TrkB probe on neuronal ceil bodies. Size criteria were used to
distinguish RGCs (>70 jim2) from displaced amacrine cells (<70 tm2). The non cross
reactivity of the TrkB probe with TrkC, another neurotrophin receptor found in neurons
of the ganglion cell layer, was established by using a 1 00-molar excess of either
unlabeled TrkC probe or TrkB probe in the hybridization solution. Unlike the excess of
TrkB probe, the TrkC probe did not compete out the TrkB hybridization signal (not
shown). (E) Time-course of TrkB iuRNA downregulation in axotornized RGCs was
assessed by quantitative in situ hybridization. The average number of grains per RGC
was normalized to the level found in contralateral intact retinas (100%). TrkB rnRNA
was reduced in RGCs, but not in arnacrine celis (f), to —50-60% of the levels in intact
control retinas (n4-6 per time point, P<0.001). This decrease in TrkB gene expression
was detected as ear!y as 3 days afier axotomy before the onset of RGC death. ONL:
outer nuclear layer, OPL: outer plexiforrn layer, TNL: inner nuclear layer, IPL: inner
plexiform layer, GCL: ganglion ceil layer. Scale bars: 50 im (A,B) and 25 im (C,D).
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figure 2. AAV-mediated TrkB gene product expression in aduit RGCs
Fluorescent microscopy images of retinal sections following intraocular injection of
AAV.TrkB. (A) Virally-mediated TrkB was visualized using an anti-c-myc antibody
that stained neuronal celi bodies in the ganglion ceIl layer as well as RGC axons in the
fiber layer. (B) RGCs were identified by retrograde labeling upon application of the
tracer fluoroGold to the superior colliculus, the main target for these neurons in the rat
brain. (C) $uperimposition of the images in (A) and (B) demonstrates that the vast
rnajority of RGCs expressed the AAV.TrkB gene product. Adjacent sections labeled
with FluoroGold alone did flot show bleed-through between filters (flot shown). Scale
bar: 10 tm. (D) Quantification of the number of ceils in the ganglion ce!! layer
expressing AAV-rnediated TrkB protein at 4 weeks afler intraocu!ar injection of the
vector. The total number of RGCs per retina! section was assessed by their FluoroGold
label (FG+) and compared to the number of cel!s co-stained with an anti-c-myc antibody
(c-myc+), that recognized AAV-mediated TrkB, and FluoroGold. An average of 68% of
the total number of RGCs per retinal section expressed the AAV.TrkB transgene (n=4,
P<0.001). Few c-rnyc positive cel!s ($%) were flot labeled with F!uoroGold (FG-).
These resuits indicate that RGCs are the prirnary cel!u!ar target for AAV infection in the
inner retina.
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Figure 3. Effect of TrkB gene transfer on the protection of axotomized RGCs in
vit,o
(A) Outiine of the experimental protocol used to test the effect of AAV.TrkB on RGC
survival. Four weeks afler intraocular injection of viral vectors, the tirne required for
transgene expression to reach a plateau in the aduit rat retina, RGCs were retrogradely
labeled with FluoroGold and subsequently axotornized. RGC survival was assessed by
quantification of fluorescent neurons in whole-rnounted retinas. (B) Quantitative
analysis of RGC survival following intravitreal injection of: AAV.TrkB (gray bars),
BDNF recombinant protein (hatched bars), AAV.TrkB and BDNF protein (solid bars),
and AAV.GFP (open bars) at 7, 14, 21 and 2$ days afier optic nerve transection (n= 3-15
rats per group, Table 1). The density of RGCs in intact unoperated retinas is shown as
reference (stippled bar). The neuroprotective effect of AAV.TrkB was greatly enhanced
when combined with a single intravitreal injection of BDNF at the time of axotorny. The
synergistic effect of AAV.TrkB and BDNF was significantly larger than independent
administration ofAAV.TrkB or BDNF protein at ail times exarnined (P <0.00 1).
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Figure 4. Correlation of RGC survival and AAV-mediated TrkB expression in
injured retinas
FIat-rnounted retinas show FluoroGold labeled RGCs afier intravitreal administration of
AAV.TrkB and BDNF protein (A) or only AAV.TrkB (B) at 3 weeks afler axotomy.
Microglia that may have incorporated FluoroGold afier phagocytosis of dying RGCs
were distinguished by their morphology (arrows) and excluded from our quantitative
analyses. The identity of these celis was also confirrned by immunostaining using
microglia and macrophage rnarkers (not shown). Scale bar: 20 Jlm. (C) Fluorescent
rnicroscopy images of retinal sections following AAV.TrkB and BDNF administration
show co-localization of anti-c-myc labeling, used to visualize AAV-mediated TrkB, and
FluoroGold, used to identify surviving RGCs, at 3 weeks afler axotorny. Scale bar: 10
tm. (D) Quantification of the number of celis in the ganglion celi layer co-stained with
FluoroGold (FG+) and anti-c-rnyc (c-myc+) indicate that an average of —96% of
surviving RGCs express AAV-mediated TrkB protein. The population of RGCs labeled
with both markers (FG+, c-myc+) is not significantly different from the total number of
surviving RGCs (FG+) (n=4 per experimental group, p=O.769). These data suggest that
TrkB upregulation increases RGC responsiveness to BDNF and enhances neuronal
survival.
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Figure 5. In vivo activation of retinal components of the BDNF/TrkB signaling
pathway following TrkB gene transfer to RGCs
(A) Tyrosine phosphorylation of retinal TrkB at 5 weeks afier a single intraocular
injection of AAV.TrkB was examined by immunoprecipitation of --300 jig of retinal
protein with an anti-pan Trk (203) antibody followed by Western blot analysis using
anti-phoshotyrosine (4G10) antibody. Controls included anti-pan Trk
immunoprecipitated samples from retinas at 5 weeks of AAV.GFP injection and 4$ hrs
afier BDNF or PBS injection. The bottom panel shows the same blot probed with an
antibody that recognizes the intracellular domain of TrkB (TrkB) (B) Activation of the
MAP kinases Erkl and Erk2 was investigated using Western blots of total retinal
extracts (75-100 jig) probed with an antibody that selectively recognizes both Erkl/2
phosphorylated on Thr202/Tyr204 residues. Stimulation ofErkl/2 was detected at 5 and
10 weeks afler intravitreal injection of AAV.TrkB. Controls include retinal samples
collected at 48 hrs or 10 weeks afier injection of BDNF protein. Boffom panel shows the
same blot re-probed with a p44142 MAP kinase antibody to visualize total Erk protein.
(C) Akt activation at 5 and 10 weeks afier TrkB gene transfer was detected using a
phospho-Akt specific antibody that recognizes Akt phosphorylated on Thr308. Controls
are similar as for (B). Bottom panel shows the same blot re-probed with an anti-Akt
antibody that allows visualization of total Akt protein.
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Figure 6. Selective inhibition of AAV.TrkB-induced activation of retinal MAPK
and Akt
(A) Western blots of whole retinal homogenates show dose-dependent blockade of
AAV.TrkB-induced activation of Erkl/2 with PD9$059, a selective inhibitor of MEK.
Inhibition of Erkl/2 phosphorylation was observed at 4$ hrs and 14 days following
intraocular injection of 200 tM of PD98059. The intravitreal concentration of this
compound was ‘—16.7 tM based on the estimated volume ofthe vitreous chamber in the
aduit rat eye (—60 tl). Phosphorylated Erkl and Erk2 were visualized with an antibody
against phospho-MAPK (Thr2O2ITyr2O4 residues, top panel) and total Erk protein was
visualized in the sarne blot reprobed with p44142 MAP kinase antibody (bottom panel).
Intraocular injection of 200 tM of PD9$059, which effectively inhibited ErklI2
activation, did flot block Akt phosphorylation (right panels). This resuit confirms the
biochemical specificity of the pharmacological inhibitor PD9$059 (B) Akt
phosphorylation induced by TrkB gene transfer was blocked at 48 hrs and 14 days after
single intravitreal injection of $00 1iM LY294002 (intravitreal concentration: ‘--66.7
tM), a selective inhibitor of PI-3K. Activated Akt was visualized with an antibody
against phospho-Akt (Thr3O$, top panel), total Akt protein was visualized in the same
blot reprobed with an anti-Akt antibody (bottom panel). Administration of $00 1iM of
LY294002, which inhibited Akt stimulation, did not block ErklI2 phosphorylation
confirming the specificity ofLY294002 (right panels).
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Figure 7. TrkB uses MAPK activation to promote the survival of aduit RGCs in
vivo
(A) Effect of the pharmacological inhibitors PD9$059 and LY294002 on AAV.TrkB
induced RGC survival. The density of RGCs that survived following TrkB gene transfer
with AAV.TrkB was significantly reduced by specific inhibition of the MEK!MAPK
pathway with a single intraocular injection ofPD9$059 (200 1iM) at the tirne ofaxotorny
(P<0.00l, t test). In contrast. AAV.TrkB-induced neuronal survival was flot significantly
changed by injection of LY294002 ($00 iM), a specific inhibitor of PI-3K (P= 0.79$, t
test).
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Table 1. Survival ofAxotomized RGCs following In Vivo Gene Transfer
RGCs/mm2 ± S.E.M. (% of intact contralateral retinas)
Treatment Time After Axotomy
AgentViral Vector 1 week 2 weeks 3 weeks 4 weeksInj ected*
1131±53 220+32 104+24 38+2AAV.GFP — (50%), n=3 (10%), n=5 (5%), n=3 (2%), n=3
1692±190 620+60 124+10 152+10AAV.TrkB - (75%), n=4 (27%), n=7 (6%), n$ (7%), 11=3
2203±24 1732+ 150 817±79 378+88AAV.TrkB BDNF Protein (97%), n4 (76%), n4 (36%), n=5 (17%), n=5
1981+42 866+32 381+62 226+26BDNF Protein
— (87%), n=4 (38%), n=5 (17%), n4 (10%), n4
594+81
—
—AAV.TrkB LY294002
— (26%),n6
227±15
—
—AAV.TrkB PD9$059 — (10%), n=5
210+17
—
—AAV.GFP LY294002
— (9%), n=3
234+13
—AAV.GFP PD98059
— (10%), n=3
* Intravitreal injection performed at the time ofaxotomy
Contralateral intact retinas: 2271 + 64 RGCs/mm2 (100%), n15
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1. Introduction
Gene transfer technology is gaining ground as a tool to investigate and promote
neuroprotection in the retina. In the past few years, a number of studies have established
proof-of-principle for the efficacy of gene delivery using viral vectors to enhance
neuronal survival in animal models of retinal diseases. Several factors have contributed
to the progress in this area such as the elucidation ofthe genetic basis of inherited retinal
diseases, the availability of natural, experimental or transgenic animal models, and the
development of recombinant viral vectors suitable for in vivo gene delivery.
The design of appropriate neuroprotective strategies is the flrst step in tackling
the complex problem of neuroprotection in the retina. A sensible strategy should
consider several factors including: j) the ceil type affected, ii) the mechanism and cause
of death, iii) the appropriate target ccli for gene transfer, iv) the time-course of death, y)
the developrnental stage of the experimental animal at the moment of therapy, vi) the
optimal viral vector for gene delivery, vii) the time-course of vector-mediated transgene
expression, and viii) the available animal models. There may be as many
neuroprotective schernes as there are retinal diseases or injury models. The goal ofthis
chapter is to provide the reader with an updated account of current methods and tools for
viral gene transfer that may serve as a guide to investigate neuroprotection in the retina.
2. Neuroprotective strategies
A variety of gene delivery strategies have been expiored to promote neuronal
survival in the retina following injury or disease. A gene transfer protocol that leads to
the complete and permanent rescue of degenerating retinal neurons is yet to be
33$
established. However, the following strategies successftilly enhanced ce!! survival by
delaying, in some cases considerably, the time-course of neurodegeneration.
2a) Gene supplementation: Many retinal disorders are due to genetic defects that resuit
in a lack of one or more essential gene products. Delivery of a hea!thy copy of the
mutated gene to the affected celi may restore loss-of-function deficits and lead to
neuroprotection. This approach has been tested in the retinal degeneration (rat) mouse, a
mode! of autosomal recessive human retinitis pigmentosa (RP). Defects in the rod
specific cGMP phosphodiesterase B-subunit (B-PDE) underlie irreversible and rapid
photoreceptor loss in this model (Bowes et al., 1990; Pittier and Baehr, 1991). Transient
rescue of the rd phenotype was achieved following delivery of the wild-type B-PDE
cDNA into the retina using severa! viral vectors: adenovirus (Ad) (Bennet et al., 1996),
encapsidated Ad (gutted vector) (Kumar-Singh and Farber, 199$), adeno-associated
virus (AAV) (Jornary et al., 1997a) and lentivirus (LV) (Takahashi et al., 1999).
Furthermore, Ah et ah. demonstrated that supplementation ofthe peripherin-2 gene using
AAV vectors resulted in the preservation of outer segment ultrastructure and function
for up to 10 months in the rds mouse (Ahi et al., 2000), a mode! for autosomal dominant
RP and macular dystrophy.
2b) Ribozyme therapy: Retinal diseases caused by dominantly inherited mutations may
result in the production of abnorma! gene products that affect cellular trafficking,
metabohism and function. Cehl death due to accumulation of these toxic products can be
minimized by delivery of ribozymes, small RNA molecules that can be designed to
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cleave mutant RNA transcripts while leaving the wild-type mRNAs intact. Lewin et al.
demonstrated morphological and frmnctional protection of photoreceptors following
AAV-delivery of ribozymes in a mutant rhodopsin transgenic rat model of autosomal
dominant RP (Lewin et al., 199$). Long-term studies on the effectiveness ofthis form of
therapy indicated that the progression of photoreceptor loss was considerably delayed
for up to $ months of age (LaVai! et al., 2000).
2c) Neurotrophic factor therapy: The main limitation ofthe gene correction therapies
mentioned above is that the genetic basis of prevalent forms of retinal disorders, such as
glaucoma or age-related macular degeneration, remains unknown. In addition, retinal
diseases that arise from mutations in several genes (jolygenic) or a combination of
environmental and genetic factors represent a challenge in the design of potential gene
therapies. Alternative therapies would involve the use of neurotrophic factors, with a
broad spectrum of action, capable of providing a more generic forrn of neuroprotection.
Neurotrophic factors bind to specific ce!! surface receptors triggering intracellular
signaling pathways that !ead to neuronal survival (Lewin and Barde, 1996; Kaplan and
Miller, 2000; Huang and Reichardt, 200 la). Because most neurotrophic factors are
secreted and diffuse well within the retina, this type of approach allows to se!ect either
the affected cell or its supporting cells as targets for gene transfer. For example, delivery
of the brain-derived neurotrophic factor (BDNF) gene to Mtiller glial celis using an Ad
vector resulted in temporary protection of retinal ganglion celis in an optic nerve
axotomy rat mode! (Di Polo et al., 199$). Ad-mediated delivery of ciliary neurotrophic
factor (CNTF) has been shown to slow photoreceptor loss in the rd and rds mouse
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(Cayouette and Grave!, 1997; Cayouefte et al., 199$). Basic fibroblast growth factor
(bFGF) delivered by Ad vectors delayed retinal degeneration in the Royal College of
Surgeons (RCS) rat (Akimoto et al., 1999). More recently, AAV-mediated delivery of
bFGF delayed photoreceptor celi death in transgenic rats carrying a mutant rhodopsin
(Lau et al., 2000a) and retinal ganglion cell loss afler axotomy (Sapieha et al., 2001).
2d) Inhibition of apoptosis: Apoptosis or programmed ce!! death appears to be a
common mechanism of neuronal loss in the injured or degenerating retina. Retinal
ganglion cells have been shown to die by apoptosis after optic nerve axotomy and in
experimental glaucoma (Berkelaar et al., 1994a; Garcia-Valenzuela et al., 1995a;
Quigley et al., 1995). Photoreceptors also die by apoptosis in several inherited mouse
models ofRP (Chang et al., 1993; Portera-Cailliau et al., 1994), the RCS rat (Tso et al.,
1994), light-induced retinal damage (Abler et al., 1996) and experimental retinal
detachment in the rat (Cook et al., 1995). The identification of intracellular components
of the ce!! death program (e.g. bd-2 family members and caspases) has motivated
experimental strategies involving transfer of anti-apoptotic genes. For example, gene
delivery of bel-2 using Ad resulted in moderate protection of photoreceptors in the rd
mouse model (Bennett et al., 1998a). Recently, Ad-rnediated gene transfer of the X
linked inhibitor of apoptosis protein (XIAP) resulted in partial protection of retinal
ganglion celis following axotomy (Kugler et al., 2000) and high intraocular pressure
(McKinnon et al., 2001).
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3. Selection of a gene delivery system
Genes can be introduced into celis via non-viral and viral vectors. Non-viral
methods include liposome-mediated DNA transfer, DNA carried on ballistic metal
particles (“gene gun”) and micro-injection techniques (Mahato et al., 1999). These gene
transfer methods ofien yield low DNA transduction rates that result in limited transgene
expression in vivo. In contrast, viral vectors have the ability to efficiently infect
proliferating and post-mitotic cells and support adequate transgene expression levels.
Tmprovements in the design ofthese vectors and the methods to increase viral titers and
purity have contributed to their popularity. What makes a viral system suitable for
therapeutic use? Let us imagine an ideal vector with the following characteristics: j) it
can transduce a large number of target cells; ii) it mediates gene expression specifically
in the target cells; iii) it allows stable expression of the delivered gene product at
adequate levels; iv) it is safe, entailing no toxic or immunogenic response in the target
tissue; y) it has no limitation in the size of DNA that it can accommodate; and vi) it is
easy to produce in large volumes of high purity, high titer stocks. Although such perfect
vector does flot yet exist, there are a number of useful viral vectors available for gene
transfer research. Here we will focus on Ad, AAV and LV vectors, the most widely used
vectors in retinal neuroprotection research (Table 1). The following sections are not
intended to endorse any vector in particular but to highlight their advantages and
disadvantages for different gene transfer applications.
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4. Adenovirus (Ad)
Ad vectors are an efficient tool to study the effect of in vitro and in vivo gene
expression on neuroprotection. The major advantages of this system are that Ad can
efficientiy infect post-mitotic ceils and that it can be easiiy grown to high titers. Ad
contains a linear double-stranded DNA genome of approximateiy 36 kilobases (kb)
encapsidated in an icosahedrai protein sheli. Immediate early genes (Fi, E2, E3 and E4)
orchestrate viral gene transcription and suppression of the host immune response, whiie
late genes are necessary for viral assembly (Shenk, 1995). Most recombinant Ad belong
to the group C Ad type 2 or 5. Ad vectors were initially generated with deletions of the
early region 1 (AE1), that contains genes required for virus repiication (Bett et al., 1994),
rendering vectors repiication defective and more suitabie for gene transfer into
mammalian ceils. A major disadvantage ofthese early Ad vectors is the strong cytotoxic
and immune response elicited upon infection of the host ceils (Kovesdi et al., 1997).
Recent versions of Ad vectors have been produced in which the entire viral genome,
except for the terminal repeat regions required for viral assembly, has been repiaced by
exogenous gene sequences. These so-cailed “gutiess” vectors exhibit considerably
reduced immune response (Morsy et al., 199$; $chiedner et al., 199$b), but can oniy be
produced in the presence of a helper virus that provides ail the proteins required for viral
replication (Parks et ai., 1996). Because it is ofien difficult to fully separate the “gufted”
vector from the helper virus, we will focus here on novei methods to produce
recombinant Ad vectors without the need for helper virus (see below).
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4a) Ad tropism in the retina
Although Ad vectors show efficient transduction of a wide variety of celi types
in vitro, the cellular tropism for viral infection in vivo appears to be more complex. Our
studies using Ad vectors injected into the vitreous chamber of aduit rat eyes
demonstrated that MtÏller ceils, the predominant guai ceil in the retina, is the main target
for Ad infection in vivo (Di Polo et al., 199$). This approach has proved to be useful for
delivery of genes encoding diffusible neurotrophins to promote neuroprotection of
axotomized retinal ganglion celis. Ad vectors have also been shown to efficientiy
transduce the retinal pigment epithelium (RPE) following subretinal injections (Bennett
et al., 1994; Li et al., 1994). Together, these studies indicate that non-neuronal celis in
the aduit retina are the preferred cellular targets for recombinant Ad. Nevertheless, some
experimental conditions support limited Ad transduction of retinal fleurons. For
example, intraocular administration of Ad in animais at early developmental stages may
resuit in modest infection of photoreceptors (Bennet et al., 1996). In addition,
introduction of AU to the brain (e.g. superior coiliculi) or to the transected optic nerve
stump resuits in retrograde transport of viral particles that mediate gene expression in
retinal ganglion celis (Cayouette and Gravel, 1996; Kugler et al., 2000). Because ail
these studies involved transgenes directed by the ubiquitous cytomegalovirus (CMV)
promoter, it is iikely that the presence of ceilular receptors for Ad in non-neuronal
retinal ceil types mediates the observed virai tropism in vivo. The coxsackievirus and
adenovirus receptor (CAR) protein involved in AU attachrnent and infection has been
identified (Bergelson et al., 1997). In addition, integrins avB3 and ab135 participate in
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Ad internalization (Wickman et al., 1993). The specific cellular localization of these
receptors in the retina remains to be defined.
4b) Immunological response to Ad and transgene expression
Most studies have shown robust Ad-mediated transgene expression detectable
soon afier vector administration, but this expression is transient and decreases within a
few weeks. This has been attributed mainly to a host immune reaction to viral and
transgene products in which the infected celis are targeted for rapid T-ce!! mediated
clearance (Hoffman et al., 1997; Reichel et al., 199$). This is supported by the
observation that Ad-mediated gene expression is prolonged in immunodeficient anirnals
(Hoffman et al., 1997). It is possible that other factors such as promoter silencing or !oss
of viral DNA, since the Ad genome remains episorna!, contribute to this !imited
expression (Isenmann et al., 2001). As such, AU represents an attractive system in gene
therapy applications that require the expression of a gene product for a lirnited arnount
oftirne. For applications that require sustained transgene expression, several approaches
have been explored. Repeated administration of Ad to enhance transgene expression has
proved to be inefficient due to the production of neutralizing antiviral antibodies (Yang
et al., 1994; Yang et al., 1995b). Alternative strategies have been implemented to by
pass the natural immune response. Daily administration of inmmne-suppressant drugs,
delivered by subcutaneous injections (Di Polo et al., 199$) or osmotic minipumps, can
effectively sustain transgene expression in the retina for several months. Sirni!arly, co
administration of modulators of the immune response, such as CTLA4-Ig, prolong Ad
mediated gene expression (Ah et al., 199$a).
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The ocular immune response elicited by Ad has been shown to depend on the
route of administration of the vector. It is now clear that injection of Ad vectors into the
vitreous space leads to a stronger immunological reaction than subretinal injection
(Bennet et al., 1996; Hoffman et al., 1997). This fmding highlights important differences
in the ocular immune privilege response between the intravitreal and subretinal
compartments following Ad injection. Interestingly, the immune response triggered by
intravitreal administration of Ad vectors lias been shown to promote a moderate degree
of neuroprotection (Di Polo et al., 199$; Reichel et al., 199$). This bas been partially
attributed to the production of cytokines and neurotrophic factors by activated T celis
(Noalem et al., 2000).
4c) Preparation of Ad vectors
Fi or E1/E3 de!eted Ad vectors are widely used in most gene transfer
applications. Most methods to generate such vectors rely on standard molecular biology
and tissue culture techniques. Traditional protocols for the production of recombinant
Ad involve homologous recombination oftwo pieces ofDNA: j) a plasmid carrying the
gene of interest, usually replacing the E 1 genes, and the 5’ end of the Ad genome, and ii)
the 3’ end of the AU genome. Both DNA constructs are co-transfected into low passage
293 ceils, a human embryonic kidney ce!! !ine engineered to express the El gene
products in trans to allow replication and propagation of AU (Graham et al., 1977).
Recombination events result in the production of functional viral particles that have
incorporated the gene of interest into their genome. Single viral clones are identified as
plaques using standard overlay techniques and are further characterized by polymerase
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chain reaction (PCR) or dot-blot analysis of viral DNA. Viral clones containing the gene
of interest are then propagated in 293 ceils. The purification of Ad preparations is
routinely done by cesium chloride gradient ultracentrifugation and the viral titer is
established using standard plaque titration assays. A detailed protocol ofthis method has
been described elsewhere (Csaky, 2001). Commercial kits for the production of Ad
vector using this technique are available (Qbiogene, Carlsbad, CA).
This approach has proved to be useful but time-consuming due to the low
efficiency of homologous recombination in mammalian celis and the need for repeated
rounds of plaque purification to eliminate contamination with wild-type virus. A
modification of this approach has been developed where Ad is reconstituted in yeast
(Ketner et al., 1994) or bacteria (Crouzet et al., 1997; He et al., 199$) which are
endowed with a more efficient recombination machinery and are easier to manipulate
than mammalian celis. In addition, the recombinant viral DNA is isolated from single
clones allowing to generate homogeneous Ad preparations, free of contaminating wild
type virus, following transfection into 293 ceils.
Recently, a novel method that does flot require homologous recombination has
been developed to generate E1/E3- or E1/E4-deleted recombinant AU by in vitro ligation
(Mizuguchi and Kay, 1998, 1999). f irst, the gene of interest is inserted into a shuttie
plasmid to generate an expression cassette. Then, this cassette is excised and ligated into
another vector containing the complete AU genome with E1/E3 or E1/E4 deletions. The
resulting recombinant Ad DNA is grown and purified following transformation into
bacteria. This DNA is then used to transfect 293 ceils where viral particles canying the
desired expression cassette are propagated. Because transfection is donc with DNA from
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a single clone, there is no need to screen plaques following transfection. Commercial
kits to generate recombinant Ad by this method are available (Adeno-XTM, Clontech
Laboratories, Palo Alto, CA). One drawback of this technique is the need to transform
bacteria and transfect 293 ceils with large plasmids which may result in poor yields.
Alternative methods using cosmid technology have been designed to select clones
containing fuil-size genomes while exciuding small and incompÏete DNAs that are oflen
produced following transformation of bacteria with large plasmids (Danthiime and
Werth, 2000).
5. Adeno-associated virus (AAV)
AAV is a member of the parvoviridae family initially identified as a contaminant
of Ad stocks. AAV requires a helper virus (e.g. Ad or herpes simplex virus) for
replication. The wild-type virus houses a single stranded genorne of 4680 base pairs (bp)
containing two genes, rep and cap, that encode proteins involved in replication and
encapsidation, respectively. The AAV genome is flanked by two identical 145-bp
inverted terminal repeats (TIRs) which are essential for packaging, replication or
integration. Recombinant AAV vectors derived ftom human parvovirus AAV-2 have
been produced by substituting all viral sequences, except for the ITRs, for a transgene of
interest (McLaughlin et al., 198$; Samulski et al., 1989). However, packaging of
functional AAV particles requires the presence of the rep and cap proteins typically
provided in trans. The recombinant AAV system lias several advantages for in vivo gene
transfer research: j) it is not pathogenic and has flot been implicated in the etiology of
any known human disease (Bems and Bohensky, 1987); ii) it mediates long-terni
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transgene expression that persists for several months in vivo (Dudus et al., 1999; Guy et
al., 1999b); iii) the absence of viral sequences resuits in minimal immune response or
cytotoxicity in the target tissues (Xiao et al., 1996, 1998); and iv) it can efficiently infect
post-mitotic ceils in vivo (Podsakoff et al., 1994).
In the absence of helper virus, wild-type AAV can integrate at a specific site on
the q arm of chromosome 19 to establish latent infection (Kotin et al., 1990b). However,
the lack of rep proteins has been shown to compromise integration specificity leading to
random insertion of recombinant AAV (FloUe et al., 1994; Ponnazhagan et al., 1997b).
Although viral integration into the genome may contribute to the stability of AAV
mediated transgene expression, a careful evaluation of the risks associated with
insertional mutagenesis is required before implementing AAV-based therapies. A
disadvantage of AAV vectors has been the size constraint for packaging genes larger
than 4.7 kb. Although methods have been developed to increase the size of delivered
transgenes by trans-spiicing of two independent vectors co-administered to the same
tissue (Yan et al., 2000), this remains a limitation of the AAV system. The laborious
work needed to produce AAV vector stocks has ofien been regarded as a disadvantage
of this vector system, however, recent availability of reagents and improvernents in the
protocols, described below, have greatly facilitated the preparation of high-titer and pure
AAV stocks.
5a) AAV tropism in the retina
AAV-mediated gene expression can be restricted to photoreceptor celis when
under the control of a well characterized murine rhodopsin promoter sequence (Flannery
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et al., 1997). More recently, retinal ganglion celis have been identified as the primary
targets for AAV infection in the inner retina following intravitreal injection of viral
vectors (Cheng et al., 2002a) Thus. subretinal injection ofAAV vectors results mainly in
gene transfer to photoreceptors and RPE cells, while intravitreal injection allows
infection of celis in the ganglion celi layer. Unlike Ad, AAV appears to have a
preferential tropism for retinal neurons rather than gliat celis. This is consistent with
studies in the brain showing AAV transduction of subsets of neurons rather than
astrocytes, oligodendrocytes or microglia (Kaplitt et al., 1994; Bartlett et aï., 199$).
Interestingly, genetic modification of capsid protehis has been shown to allow AAV
targeting of ceils normally resistant to infection (Girod et al., 1999).
5b) Time-course of AAV-mediated transgene expression
Recombinant AAV vectors have a slow onset of detectable transgene expression
in the retina, which typically reaches a plateau between 1 and $ weeks following
administration of the vector depending on the animal species (Beimett et al., 2000). In
rodents, peak expression is nomially found 3 to 6 weeks post-injection of the vector
(Bennett et al., 1997; Ah et al., 199$b; Guy et al., 1999b; Cheng et al., 2002a). Sirnilar
time-dependent increases in AAV-mediated expression have been observed in brain (Lo
et aI., 1999), muscle (Fisher et al., 1997) and hiver (Snyder et al., 1997a). The
mechanism for this in vivo delay to reach peak expression levels in the retina has flot
been determined, but may be related to the requirement of the single-stranded AAV
genome to be converted to a double-stranded form for the transgene to be expressed
(Ferrari et al., 1996; Malik et al., 2000). This feature of AAV-mediated gene expression
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should be taken into consideration when designing neuroprotective strategies.
Experimental paradigms with early onset and fast retinal neurodegeneration may be less
amenable to AAV-based therapies.
5c) Preparation ofAAV vectors
Because AAV depends on the presence of certain Ad helper genes to replicate
and mount an effective infection, traditional methods have relied on the use of Ad for
packaging recombinant AAV. These protocols involve co-transfection of two constructs,
a vector plasmid carrying the transgene expression cassette and a helper plasmid that
provides the rep and cap genes, into ceils infected with helper Ad. Although separation
of the resulting recombinant AAV ftom Ad has been routinely performed on cesium
chloride (CsCl) gradients, column chromatography or by heat-inactivation, Ad remains a
frequent contaminant of these preparations. The presence of helper virus can resuit in
unwanted cellular host immune response (Monahan et al., 199$) confounding the
interpretation ofthe resuits following in vivo gene transfer of contarninated AAV stocks.
These concems were addressed by the developrnent of constructs that provide the
essential helper genes in a plasmid, but lack the structural and replication Ad genes
(Grimm et al., 1998; Matsushita et al., 199$; Salvetti et al., 199$; Xiao et al., 199$). For
example, the AAV rep and cap genes and the Ad helper genes have been introduced in a
single helper plasmid, pDG (Grimm et al., 1998), eliminating the need for Ad infection.
In addition, the use of helper plasmids lias been shown to improve the titer of
recombinant AAV stocks possible due to strong cap gene expression that enhances virus
encapsidation (Grimm and Kleinschmidt, 1999).
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Current methods of AAV preparation in most laboratories are based on co
transfection of low passage 293 celis with a vector plasmid containing the transgene of
interest flanked by the ITRs and a helper plasmid. Once the AAV particles are
assembled within the host celis, the virus is extracted by freezing and thawing the cells
and subsequently purified. Traditional AAV vector purification protocols that involve
precipitation of the virus with ammonium sulfate followed by repeated rounds of CsC1
density gradient centrifugation lead to poor viral recovery and low infectivity. A new
purification strategy based on density gradient purification using iodixanol has been
reported (Hauswirth et al., 2000). Iodixanol (Nycomed Pharma, Roskilde, Denmark) is a
non-ionic iodinated density gradient media which, unlike CsC1 gradients, does not
promote aggregation of AAV and celi proteins that normally make the purification of
AAV particles difficult. The fraction containing the AAV is further purified on a
heparinlagarose column. This step relies on the high affinity of this virus for heparan
sulfate proteoglycan (Summerford and Samulski, 1999), its main cellular receptor for
attachment and intemalization (Summerford and Samulski, 199$). The eluted fraction
containing the virus is then concentrated and its titer is estimated.
In the absence of helper virus, AAV can flot mount a productive (lytic) infection.
Exposure of ceils to AAV does not resuit in the formation of plaques as with Ad.
Consequently, indirect methods are used to estimate how much virus is present in a
given stock. Because not all virion particles are necessarily capable of successful
infection, virus quality is ofien assessed as the ratio of physical particles to infectious
particles in a givefi stock. A quantitative competitive (QC)-PCR method is currently
used to estimate total viral particles or copies of recombinant AAV genomes (Conway et
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al., 1997). DNA dot blot analysis can also be used to estimate total viral particles
(Snyder et al., 1 997b), but it is more time-consuming and unreliable than PCR-based
methods. Infectious particles are determined by an infectious center assay (ICA) using
the C12 celi une (Clark et al., 1995b) that contains integrated wild type AAV rep and
cap genes. ICA involves infection of C12 celis with the AAV preparation followed by
infection with Ad. The recombinant AAV genorne is amplified in those ceils
successfully infected by AAV virions. Subsequently, the number of ceils expressing
detectable amounts of recombinant AAV DNA are quantified using radiolabeled probes
(Hauswirth et al., 2000).
Methods for manufacturing high-titer AAV stocks based on transient transfection
of 293 ceils in the absence of infectious helper virus have proved particularly useful for
pre-clinical studies which require rapid testing of therapeutic genes in a variety of
animal models. While this method provides versatility, it is laborious and expensive to
scale up due to the large amounts ofDNA needed for transfection and the low efficiency
of co-transfection protocols. As AAV vectors move toward the clinical arena, improved
rnethods to produce large quantities of pure, high-titer stocks are required. Packaging
ceil lines engineered to contain the AAV rep and cap genes have been particularly
useful (Clark et al., 1995b; moue and Russeil, 1998). The transgene of interest can be
delivered to packaging cells via a recombinant Ad to generate recombinant AAV stocks
in the presence of helper Ad (Gao et al., 1998; Liu et al., 1999). Altematively, the rep
and cap genes have been delivered via a recombinant herpesvirus to cells that carry a
stably integrated AAV provirus with the transgene of choice (Conway et al., 1999).
These strategies are prornising for scaling up AAV stocks, but they inevitably resuit in
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contamination with helper viruses and require thorough purification prior to any clinical
application.
6. Lentivirus (LV)
LV, a genus of retroviruses, consists of two identical singie-stranded RNA
molecules and enzymes required for replication within a viral protein core. Foilowing
virus intemalization, the viral RNA is reverse transcribed into doubie-stranded DNA and
transported to the ceil nucleus (Panganiban, 1990). Virai DNA is then permanently
integrated into the host genome to become a provirus. The retrovirus genome contains
gag, pol and env genes flanked by long-terminal repeats (LTRs). These genes encode
proteins essential for repiication, encapsidation, intemalization and reverse transcription.
Replication-deficient recombinant retrovirai vectors have been generated by substitutirig
ail viral genes for a transgene of interest with the exception of the cis-acting sequences
required for vector propagation, such as the reverse transcription initiation site and the
packaging site (Coffin, 1996). Functionai recombinant retrovirus particles can be
generated in culture when the gag, pol and env gene products are provided li trans.
Most retroviral vectors can only transfer genes into celis that are actively
proliferating (Roe et al., 1993b). Thus, their use in neuroprotective strategies which
typically involve gene transfer into ftilly differentiated ceils is rather limited. An
exception to this rule are LVs, such as the human immunodeficiency virus (FIIV), which
can efficiently infect non-mitotic ceils (Lewis and Emerman, 1994b). This ability relies
on nuclear localization signais in the preintegration complex that allow entry into the
nucleus without the need for nuclear membrane fragmentation (Roe et al., 1993b). Other
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advantages of the LV system are its relatively large cloning capacity, close to 10 kb; its
ability to mediate high levels of transgene expression in vivo and the lack of immune
response in the target tissues (Naldini et al., 1996b; Kafri et al., 1997). Recently,
recombinant LV was shown to efficiently infect hematopoietic stem celis extending its
potential use as a therapeutic vector (Miyoshi et al., 1999).
The main concem with LV vector systems is the risk of generating replication
competent recombinant (RCR) virus during the production of viral stocks. Because HIV
is a human pathogen, considerable work bas been done to increase biosafety of LV
production systems. The latest methods to generate safer HIV-based vector systems are
described below. Other concems include low vector titers and the risks associated with
insertional mutagenesis as the vector integrates into the host genome. The issue of
transgene silencing stiil requires further investigation. The lack of immune response
associated with LV recombinant infection and its ability to stably integrate into host
DNA are promising features for persistent gene expression. A systematic study of the
time-course of expression mediated by LV vectors in the retina should resolve this issue.
6a) Cellular tropism of LV vectors
LV-mediated gene transfer and expression in the retina in vivo was first
characterized by subretinal injection of a vector carrying the green fluorescent protein
(GFP) gene (Miyoshi et al., 1997). Using the ubiquitous CMV promoter, the main
cellular targets of LV vectors were shown to be photoreceptors and RPE ceils with some
bipolar and Miiller celis. When a rhodopsin-specific promoter was used, transgene
expression was restricted to the photoreceptor layer (Miyoshi et al., 1999; Takahashi et
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al., 1999). The infection paftem of LV vectors following intravitreal injection remains to
be characterized.
An attractive feature of HIV-based vectors is their abiiity to efficiently infect
celis in vitro. for example, RPE primaly cultures have been transduced with LV to
express GFP. Transgene expression persisted in the infected RPE ceils foliowing their
transplantation into the subretinal space of a host (Lai et al., 1999). NIV-based vectors
have been shown to efficienly transduce human CD34 hematopoietic stem celis that
were capable of iong-term engrafirnent of non-obese diabetic/severe combined
immunodeficient (NOD/SCID) mice (Miyoshi et al., 1999). Recently, fleurai stem ceiis
have been isoiated from the RPE in the ciliary margin of the aduit eye (Tropepe et al.,
2000). These ceils can express retinai specific markers when they are differentiated in
vitro. Thus, ex vivo transduction of stem ceiis using HIV-based vectors followed by
retinai transplantation may be useful in the design ofneuroprotective strategies.
6b) Preparation of LV vectors
LV has a more complex genome and, consequently, a more compiicated repiication
cycle than other retroviruses. In addition to the three structural gag, poi and env genes,
LV has additional reguiatory genes: vi)Ç vpr, vptt, tat, rev and nef genes (Trono, 1995).
Traditional methods to generate recombinant LV vectors invoived a vector piasmid with
ail viral genes deleted, containing only the transgene of interest flanked by the essentiai
cis-acting elements. The viral proteins required for virus propagation were provided in
trans by co-transfection of a helper plasmid into 293 celis. This procedure resulted in
low titer preparations and in high risk for generating RCR virus. This is a major concem
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because the considerable overlap that exists between cis-acting sequences in fflV
vectors and helper constructs increases the chance of homologous recombination leading
to the production of RCR viral particles.
A better understanding of the FIIV replication cycle has led to new advances in the
field of LV vector packaging. The latest generation of LV vectors have only three of the
nine HIV-1 genes: gag, which encodes the main structural proteins; p01, responsible for
the production of viral replication proteins and rev, encoding a regulator required for
gag and pol gene expression. The HIV envelope lias been substituted by other viral
envelope proteins such as the vesicular stomatitis virus G-protein (VSV-G) due to its
high stability and broad tropism (Yee et al., 1994). Methods to generate recombinant LV
particles from three or four separate transcriptional units containing gaglpoÏ, rev, VSV
G and the transgene of interest following transfection into 293 ceils have been recently
described (Naldini et al., 1996b; Duil et al., 1998b). By distributing the required
sequences in multiple plasrnids, the risk of creation of RCR virions was minimized. In
addition, the overlap between vector and helper sequences was markedly reduced.
The safety level for production of LV has been ftirther improved by the development
of self-inactivating (SIN) NIV- 1 -derived vectors. Two independent research groups have
reported HIV-based vectors in which the regulatory sequences (promoter and enhancer
elements) contained in the 3’ LTR have been deleted (Miyoshi et al., 1998b; Zufferey et
al., 199$). By eliminating these cis-acting elements, the virus loses its capacity for gene
expression directed by both LTRs resulting in inactivation of the integrated virus in the
infected ceils. In addition, the expression of the transgene of interest can only be
controlled by an internai heterologous promoter. A stable, high-output packaging ceil
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une to produce this latest generation of LV vectors has been recently reported (Xu et al.,
2001). These resuits represent the latest advancement in the efforts to render HW-based
vectors safe for clinical use. Although these nove! vectors greatly minimize the risk of
RCR virus infection to users during manipulation and preparation, the biosafety of LV
vectors in vivo has yet to be demonstrated.
7. Summary
Several independent research laboratories have recently established proof-of
principle for the efficacy of gene therapy for neuroprotection in animal models of retinal
injury or disease. Three viral systems, Ad, AAV and LV, have been used for most gene
delivery applications to the retina both in vitro and in vivo. The pros and cons inherent to
each of these vectors need to be carefully weighed when designing a gene transfer
strategy. Recent progress in the methods to create these recombinant viruses has greatly
increased the ability of researchers to generate high-titer and pure stocks while reducing
production times. In addition, the likelihood of adverse reactions in the host tissues and
the risk of RCR virus generation have been minimized. As these viral vectors progress
toward pre-clinical and potential clinical human trials, highly stringent standards for
their efficacy, biosafety, ease for scaling up production and purity will be expected.
Future in vivo characterization of these viral vectors will be essential to ftilly assess if
these requirements are met for clinical applications.
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APPENDIX C
AAV.FGF-2, AAV.FGF-5 OR AAV.FGF-1$ PROMOTES TRANSIENT
SURVIVAL 0F AXOTOMIZED RGCS
We investigated the neuroprotective effects of FGf-2, fGf-5 and fGF- 18 on
aduit RGCs following acute optic nerve lesion. In order to achieve sustained levels of
these factors, we employed AAV technology as described in chapter 2 ofthis thesis. One
week aller axotorny, FGF treated eyes displayed a rnarked increase in RGC survival
cornpared to their GFP controls. AAV.FGF-2 injected eyes showed 74% survival,
AAV.FGf-5 treated eyes, 68% survival and AAV.FGF-18 eyes bore 67% survival.
Control AAV-GfP injected eyes yielded 49% survival. Two weeks following optic
nerve transection, RGC numbers in treated eyes dropped to control levels. AAV.fGF-2
treated eyes declined to 13% survival, AAV.FGF-5 and AAV.FGF-18 injected eyes to
12% while control AAV.GFP injected yielded 10% survival. These experiments suggest
that AAV rnediated gene transfer of members of the fGF farnily (FGF-2, FGF-5 or
FGF-1 8) transiently protects lesioned RGCs (Figure 1).
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Appendix D
FGFR1 IS UPREGULATED IN PHOTORECEPTOR CIELS FOLLOWING
OPTIC NERVI TRANSECTION
To determine whether optic nerve transection influenced FGFR1 levels in the
retina, axotomized retinal samples were analyzed by western blot and
immunohistochemistry on cryosections. Surprisingly, Western blot of total retinal
hornogenates, revealed a pronounced increase in FGFR1 protein afier optic nerve
transection (Figure 1. A). We then sought to identify the source of this increase by
imrnunohistochernistry on retinal cryosections. Interestingly, we localized the increase in
FGFRY predorninantly on photoreceptor cells while observing only a minimal increase
in RGCs (Figure 1. B). Three days following lesion, immunohistochernical labelling
significantly intensified in photoreceptor celi bodies of the outer nuclear layer (ONt)
and to a considerably lesser extent in the ganglion ceil layer (GCL). At 5 days post
axotomy, the enhanced signal persisted in the ONL but returned to basal levels in the
GCL. This pattem was observed for at least 14 days following axotomy. These resuits
demonstrate that FGFR1 protein is upregulated in photoreceptor cell bodies following
optic nerve axotomy. Scale bars: 100 irn (B)
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APPENDIX E
o TECHNICAL LIMITATIONS WHEN INHIBITING ERK 1/2 AND AKT IN THE
MOUSE RETINA
We previously reported that intraocular injection of PD98059 or LY294002 at a
concentration of 200 tM or $00 iM, respectively, effectively inhibited Erkl/2 or Akt
activation in the aduit rat retina (Cheng et al. 2002). Injection of these compounds into
RPTPa (-I-) mice eyes, however, failed to block Erkl/2 or Akt activation (Figure 1.
A,B). The use of higher concentrations of these inhibitors resulted in the formation of
dense precipitates that had toxic effects in vivo.
In some cases, intraocular injection of these inhibitors even caused a slight
increase in activation of retinal Erkl/2 or Akt (Figure lA). These resuits could be partly
attributed to retinal injuty during injection which has been shown to increase FGF-2,
FGFR-1 and CNTF levels in the retina (Wen et al., 1995; Cao et al., 1997; Cao et al.,
2001), leading to further stimulation ofretinal Erkl/2 or Akt. Given that the mouse eye
is considerably smaller than the rat eye, it is expected that the injury effect produced by
the proportionately larger needle will have a dramatic effect on the expression and
release of endogenous factors in the mouse retina. Although these are extremely
important experiments that are worth pursuing to investigate the role of both Erkl/2 and
Akt in axonal growth in RPTPa (-I-), the technical difficulties encountered preclude us
from carrying out this work using this approach and further studies in vitro will be
required to fiuly address this issue.
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APPENDIX F
ARTICLE CONTRIBUTIONS
As first author in the article “Fibroblast Growth Factor-2 Gene Delïvery In
Vivo Stimulates Axonai Regeneration of Aduit Retinal Ganglion Ceils After Acute
Optic Nerve Injury” (Chapter 2) I carried out ail of the technical procedures; i.e.
surgeries, immunohistochemical and biochemical analysis. furthermore, I perforrned the
rnajority ofthe data analysis, wrote the initial version ofthe rnanuscript and collaborated
in the writing ofthe subsequent versions with Adriana Di Polo.
As first author in the article “Extraceilular Signal-Regulated Kinases 1/2
Mediate Retina] Ganglion Ccli Axon Regeneration lnduced by Fibroblast-Growth
Factor-2” (Chapter 3) I perforrned ail of the technical procedures, wrote the initial
version of the manuscript and collaborated in the writing of further versions with
Adriana Di Polo.
As first author in the article “Receptor Protein Tyrosine Phosphatase Sigma
Inhibits Axon Regrowth in the Aduit Injured CNS”(Chapter 4), I carried out all of
the surgical procedures, immunohistochemistry and biochemistry and data analysis.
Moreover, I wrote the first version of the manuscript and collaborated with Adriana Di
Polo in the writing of subsequent versions.
In the article “TrkB Gene Transfer Protects Retinai Gangiion Celis from
Axotomy-Induced Death lit Vivo” (Appendix A) rny contribution consisted in
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performing certain surgeries and certain Western blot analysis as well as generating the
graphs in figures 3 and 7 in the manuscript.
